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Chapter 1: Introduction 
Single cells analysis & flow cytometry 
Cells are the smallest structural, functional unit in living organisms. Cells are studied to better 
understand disease mechanisms, for example in immunology in the cases of HIV1 or 
autoimmune diseases such as diabetes2 or asthma3. Patterns in haematology are also studied for 
cellular functions or leukaemia.4 In environmental science, microorganisms such as 
phytoplankton are studied to detect toxic species and to see if the same species composition is 
found over time as this reflects good water quality.5,6 Between cells a large variability in genes 
and proteins (markers) expressed may be observed and measuring the average marker 
expression does not capture this cellular heterogeneity. For this reason, each single cell should 
be analysed separately to obtain a system-wide view on the cell variability. The cellular 
variability in environmental flow cytometry may be used to divide the phytoplankton into 
different species and further differentiate between subspecies. In clinical flow cytometry the 
white blood cells may be divided into major cell types and may be further differentiated into 
smaller subtypes. More specifically, the analysis of cells can be linked to three different goals: 
1) Phenotyping: find which cell (sub)types are more or less present and correlated with each 
other upon response; These contain many general differentiation markers to differentiate 
between the major cell types.7 
2) Cell activation: Which markers are more expressed upon response to disease or contaminants 
in a specific cell (sub)type; These contain a small set of differentiation markers to find the cell 
(sub)type of interest and a (larger) set of activation markers to measure the activation of these 
cells.8,9 
3) Rare cell discovery; These contain highly specific markers to find the rare cell subtype. This 
may be highly useful for minimal residual disease, where after therapy a very small number of 
tumour cells are left which could potential lead to relapse.10 
Single cells may be analysed by RNA sequencing and protein or metabolite mass spectrometry 
to fully capture the cellular heterogeneity.11 These techniques usually produce large amount of 
biomarkers such as mRNA, proteins and metabolites, on only a few single cells measured and 
are therefore most often used in qualitative research. For example, describing the cellular 
heterogeneity within one individual. Qualitative comparison between individuals is also done, 
namely this one group of individuals has cells that are positive for a specific marker while other 
individuals only have cells that are negative for that specific marker (rare cell discovery). 
Positive and negative is not quantified but may be based on a threshold defined by isotype 
controls or by measuring an aliquot with all markers except for the specific marker of interest, 
so called fluorescence-minus-one (FMO). All cells measured in the FMO or isotype control 
should not express the specific marker.12 
In a quantitative comparison the one group of individuals have cells with a higher or lower 
expression of a specific marker compared to other individuals (cell activation) or have relatively 
more or less cells of a specific cell (sub)type (phenotyping). For quantitative research a high 
throughput method is needed to measure many single cells. This is especially important in rare 
cell discovery. Only when many cells are measured, a cluster of rare cells may be statistical 
significant, if proper tested.13 Moreover, the measurements needs to be stable over time and 
sensitive in quantitative research, i.e. the technical variance needs to be lower than the variance 
of interest. For example, it cannot be that if the same sample is measured in one month, nothing 
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is wrong and when measured in the other month the patient suffers from a deadly disease 
(clinical) or the water sample is extremely toxic (environmental). 
Flow cytometry is a high throughput technique generating data of potentially millions of cells 
per sample. It is one of the most widely used analytical instrument in modern hospitals.14 Flow 
cytometry measures spectroscopic properties of single cells and is the way to quantify cells with 
a specific phenotype between samples. Spectroscopic properties include forward light 
scattering, sideward light scattering and fluorescence. The forward light scattering is correlated 
to the size of a cell and the sideward light scattering measures the internal complexity or 
granularity of a cell. Fluorescent dyes may be used to bind to cellular components such as DNA 
or RNA. In clinical flow cytometry, antibodies conjugated to fluorescent dyes may bind specific 
proteins on the cell membrane or inside the cells.4 Leukocytes (white blood cells) from 
peripheral blood and bone marrow are the most clinical studied cells with flow cytometry as 
they are the main defenders against pathogens in our body. Also other types of cells may be 
measured.15 In environmental flow cytometry the autofluorescence of phytoplankton is 
measured, depending on the species, phytoplankton may contain specific mixtures of differently 
fluorescent chlorophyll complexes.5,6 
The number of fluorescent dyes used in clinical flow cytometry is limited (up to seventeen in 
200416) due to fluorophore overlap. Many markers need to be measured to fully capture the 
complete cellular heterogeneity. To overcome fluorophore overlap, mass cytometry was 
developed to use antibodies conjugated to lanthanides instead of fluorophores. The single cells 
are then measured with inductive coupled plasma time-of-flight mass spectroscopy. This 
technique was very promising as it may allow analysis of up to 100 markers. However, the 
technique is limited due to the lanthanide purity and so far, only up to 34 lanthanides have been 
used.17,18 Moreover, the technique suffers from large technical variability over time. Even after 
correcting with beads, still a fold change of 1.3 is left between measurements.19 A 1.3 fold 
change is reasonable when comparing one or two markers at a time, but disastrous when 
analysing all 34 markers simultaneously with multivariate analysis in a quantitative 
comparison. For this reason, barcoding was developed where a unique barcode tag was used 
for each sample and subsequently all samples were measured together. The unique barcode can 
then be used to figure out which cell belongs to which sample.20,21 Barcoding may be very 
useful for drug discovery where many drugs are tested on single cells, where barcoding removes 
the time factor. However, barcoding is less useful in a clinical setting, because not all patients 
come in the hospital at the same time. 
Flow cytometry suffers from less technical variability in general compared to mass cytometry 
and also because the laser intensity is corrected with the use of fluorescent beads to maintain 
the reproducibility over time and also across laboratories.10,22,23 Nowadays, the flow cytometer 
is also upgraded to handle up to 50 fluorophores by adding more lasers and using new 
fluorescent dyes with less fluorophore overlap. One example is quantum dots which are 
semiconducting nanocrystallites where the size of the particle determines the emission, namely 
smaller sized particles shift to blue.24,25 In theory a single particle size will have a single 
wavelength emission, however with the current technology only particles can be made with a 
size distribution. These particles do have a much smaller emission band than classical 
fluorescent dyes such as fluorescein. Another example of new fluorescent dyes are polymer 
dots which are semiconducting polymers. Quantum dots mainly have an emission in the visible 
region while semiconducting polymers may also have emission in ultraviolet and near 
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infrared.26 Moreover, the polymer dots are much brighter and may be used to detect single 
molecules. Polymer dots do have a broader emission band than quantum dots.27 While flow 
cytometry may be able to measure up to 50 markers, so far only 27 markers have been used due 
to fluorophore overlap and the complex design of which antibody needs to be conjugated to 
which dye.28 Preferably, bright dyes to low frequent proteins and vice versa. Nevertheless, the 
argument to use mass cytometry because it may measure much more markers than flow 
cytometry is no longer valid. Especially, when spectral flow cytometers29 become common as 
current flow cytometers have one photodetector per dye, a correction for fluorophore overlap 
is much easier with the whole spectra, see data pre-processing below. 
 
Scheme 1: Schematic representation of a basic flow cytometer. Black circles are single cells, in 
yellow is the laser beam, in orange is the sheath fluid, the cylinders are photodetectors and the 
blue rectangles are semi-permeable mirrors. 
Flow cytometer technology 
A sample is injected into the flow cytometer and runs together with a laminal flow of sheath 
fluid into a funnel. This causes the cells to align in a single file and are well-separated from 
each other, see Scheme 1. A focused laser beam shines on the cells one by one, excites the 
autofluorescence of the cells as well as fluorescent dyes in or on the cell. Photodetectors detect 
photons coming from each cell and convert it into an electronic signal. The electronics digitize 
the signal in a data file.30 Recent advances in flow cytometry increased the number of detectors 
and lasers which allows for more markers or fluorescent properties measured per single cell.31 
In flow cytometry the number of photons emitted by a fluorophore and the number of 
photoelectrodes created on a dynode is Poisson distributed. A Poisson distribution means that 
the error is dependent on the intensity of the signal. For this reason, a log amplifier is used when 
converting the analogue signal to a digital signal. A log amplifier increases the sensitivity in 
the low range of signal intensity and reduces the variance in high intensity signals.32 
  
6 
 
Flow cytometry data 
For each sample ten-thousands to millions of single cells are measured on a relatively few 
markers in flow cytometry. The number of cells measured between samples may vary greatly 
and can be rearranged into a multiset structure. In a multiset structure all single matrices are 
concatenated variable (column) wise, where each set contains the cells measured in one 
sample/measurement. 
Data pre-processing 
Data pre-processing is used to remove unwanted variance and to focus on the biological relevant 
variance.33 Most statistical methods used for data analysis require the data to be Gaussian 
distributed. Each (sub)type of cell can be described as a Gaussian distribution with a specific 
mean and standard deviation of the spectroscopic properties. The log amplifier requires the data 
to be log transformed to obtain again the linear scale and for the data to behave as multimodal 
Gaussian distributions. Often the global mean of the data is uninformative. More interesting is 
the deviation from the mean, for this reason mean centring is often used, which subtracts the 
global mean. Finally, the difference in variance between each spectroscopic property measured 
with the flow cytometry is often caused by technical variability, such as different quantum yield 
of the dye used. In some cases, a small variance in a specific protein may be of greater biological 
influence than big variance in another specific protein. For these reasons scaling is applied by 
dividing each variable by its standard deviation. After these common pre-processing steps, the 
data is multi Gaussian distributed with a global mean of zero and global standard deviation of 
one for every variable measured. 
Another common pre-processing step in clinical flow cytometry prior to log transformation is 
compensation. Fluorescent dyes do not emit a single wavelength but a spectrum. The dyes are 
designed into panels, in such a way that the overlap is minimized, however still a significant 
“spillover” from one dye into another channel may still be present. Single-stain experiments 
may then be used to calculate the amount of spillover of each fluorophore in another channel 
and to create a spillover matrix. The spillover matrix can be used to compensate (rotate) the 
data in such a way that each channel corresponds only to the dye measured on that channel. 
However, the Poisson distribution of the data introduces a spreading error for high signals after 
compensating the data, see Figure 1. Additionally, currently compensation is performed 
through linear (oblique)rotation of the obtained data. This thereby cannot consider dye-dye and 
cell-dye interactions that would require non-linear transformations, based on more advanced 
instrumental calibrations. A way of circumventing the spreading error is to measure more than 
one channels per fluorescent dye. With more detectors per dye, the spectra of each dye may be 
unmixed.29 
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Figure 1: Two markers plotted against each other after compensation and inverse hyperbolic 
sine transformation. Due to the large fluorophore overlap between APC and APC-Alexa 700, 
a spreading error occurs after compensation. The spreading error is poison distributed, namely 
the variance of the measured single cells is dependent on the signal intensity. This can be seen 
by looking at the minimum value of CD14, which is dependent on the intensity of CRTH2 and 
vice versa. 
The spreading error causes negative values after compensation.34 Negative values may also be 
caused by background subtraction. Background subtraction is sometimes used in the machine 
to reduce the variability of the unbound dye in the solution between samples.35 Log 
transformation is not possible if the data contains negative values. Bi-exponential functions are 
used as alternative to transform the data to a Gaussian multimodal distributed data, which are 
capable of handling negative values. One popular bi-exponential transformation is the inverse 
hyperbolic sinus function, see equation 1, where x is the original data value, z the transformed 
data value and c a cofactor used to determine the width of the linear part around zero.36 The 
inverse hyperbolic sine function is further adapted for flow cytometry data, called logicle 
transform.37-39 An additional advantage of these two alternative transformations is that they may 
further optimize/stabilize the variance between low and high intensity signals.40 Care has to be 
taken however, as these alternative transformation may split the signal around zero into a 
negative and positive value when a too-small cofactor is chosen.41 “Peak Splitting” is especially 
detrimental for the interpretation of multidimensional models.42 For this reason a visual 
inspection of the transformed data is always needed.43 
Equation 1 𝑧 = 𝑙𝑛(𝑥/𝑐 + √1 + (𝑥/𝑐)2) 
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Chemometrics and the multivariate advantage 
In chemometrics, the chemical data science, multivariate statistics are used to analyse and 
interpret chemical data. Chemometrics uses multivariate data analysis that can handle collinear 
data to extract the information of interest from the data.44-46 Multivariate data analysis uses the 
multivariate advantage where multiple variables together describe a phenomenon, which cannot 
be found by analysing the variables separately. In Figure 2, two variables are plotted separately 
in two histograms and show how an obese individual (blue) has more cells with a high 
expression of CD16 and low expression of CD14 compared to the lean individual (orange). No 
relation between CD14 and CD16 may be observed from these two univariate histograms. 
Figure 3 shows a bivariate plot of CD14 versus CD16 and shows a unique relationship between 
two markers. Cells have a very high expression of CD14 and low expression of CD16, the 
classical monocytes. Other cells have a very high expression of CD16 but low expression of 
CD14, these could be either Natural Killer (NK) cells or non-classical monocytes. Also, a 
continuum between these two cell types may be observed, which are both high in CD14 and 
CD16, these cells are intermediate monocytes. Other cell types are both low for CD14 and 
CD16. The multivariate advantage can thus already be seen when plotting two markers against 
each other. 
However, we humans can only observe two dimensional projections with our eyes (a third 
dimension could be possible if plotted as a colour). To go beyond two variables, a common 
practice in clinical flow cytometry is selecting a group of cells in one bivariate plot and plot 
them in the next bivariate plot, so called Boolean gating strategies.47,48 Figure 4 shows an 
example of a simple Boolean gating strategy where cells with low CD56 expression and high 
HLA-DR are selected and then plotted in a next bivariate plot of CD14 versus CD16. The CD14 
versus CD16 plot now mainly contains monocytes (HLA-DR high expression) and NK cells 
(CD16 high and CD56 high expression) are removed. Now we can conclude that the obese 
individual has more intermediate and non-classical monocytes compared to the lean individual. 
Multiple sequential gates may be present in advanced sequential Boolean gating strategies. 
However, bivariate sequential Boolean gating is very subjective and biased. In Figure 4 the gate 
is very hard to define, a higher threshold in HLA-DR reduces the number of monocytes, a lower 
threshold increases other cells both low in CD14 and CD16 expression, in the next plot. Another 
drawback is that the research is hypothesis driven, you may only find what you are looking for. 
Moreover, it only uses two variables at a time, using more variables together as in multivariate 
data analysis may reveal more information. 
One of the most common multivariate data analysis methods in chemometrics is Principal 
Component Analysis (PCA).46,49 PCA is a dimension reduction technique that finds new linear 
combinations of the variables that maximize the variance in the data in so called Principal 
Components. These Principal Components consists of scores and loadings. The scores are the 
new coordinates of the single cells measured in the projected space and the loadings show the 
variable contributions of the principal components. These can be combined into a biplot as 
shown in Figure 5. The origin of the loadings (arrows) is the global mean of the data. In the left 
bottom of the plot are group of dots (scores of single cells) where the loading CD16 and CD56 
points towards and loading CD14 and HLA-DR points away from, these cells are NK cells 
(high in expression of CD16 and CD56, low in expression of CD14 and HLA-DR). The right 
side of the plot is in direction of loading HLA-DR and show the monocytes (HLA-DR high), 
but also shows the trend of classical monocytes (CD14 high, HLA-DR higher), via intermediate 
to non-classical monocytes (CD14 low and CD16 high). Moreover, it shows that the 
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intermediate cells have an increased expression in CD11b, CD11c and CX3CR1. The upper left 
shows other cells that have low marker expression for all markers, all loadings point away from 
these cells. To conclude the multivariate advantage is already clear from univariate to bivariate 
as it reveals the unique relationship between CD14 and CD16. The multivariate advantage 
increases with Boolean bivariate gating, where we could distinguish non-classical monocytes 
from NK cells. Finally, PCA revealed all the relationships in only one projection, especially 
that the intermediate monocytes have a higher expression of CD11b, CD11c and CX3CR1. 
 
Figure 2: Histogram of the protein expression of CD14 and of CD16 of cells measured from an 
obese (blue) and lean (orange) individual. 
 
Figure 3: Bivariate plot of CD14 versus CD16, each dot is a single cell measured of an obese 
individual (blue) or lean individual (orange) 
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Figure 4: Boolean gating of monocytes based on CD56 versus HLA-DR, results in only 
monocytes in the CD14 versus CD16 plot. Each dot is a single cell measured of an obese 
individual (blue) or lean individual (orange) 
 
Figure 5: Principal Component Analysis biplot of cells form an obese individual (blue) and a 
lean individual (orange). Each dot is a score of a single cell measured. The arrows show the 
loadings and the original variable contribution in the reduced space. For example, the cells in 
the lower left corner have the markers CD56 and CD16 pointing towards them and thus have 
a high expression of these markers. CD14 and HLA-DR are pointing away from these cells thus 
have a low expression of these markers. 
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Clustering 
Clustering of the data is very popular in the field of flow cytometry. Figure 4 showed an 
example of ‘visually finding’ clusters in the data using sequential Boolean bivariate gating, 
using prior biological information on the cell populations. Setting the Boolean gates may be 
very subjective and for this reason automated methods have been developed to define the 
gates.50 These automated methods are also being developed for defining different 
phytoplankton species.51 Based on differentiation markers it is easy to distinguish between 
major cell types. In the above example, NK cells could be easily distinguished between 
monocytes. However, gates may be very subjective and artificial in defining classical, 
intermediate and non-classical monocytes, see Figure 3 and 4. These cells lie in a continuum, 
especially when looking at the expression of activation markers such as CD11b, CD11c and 
CX3CR1. Adding more markers to the analysis will only show more of a continuum.17 For this 
reason clustering methods have been developed that model the data with a high number of 
clusters, such as SPADE and FLOWSOM, to capture the complete continuum.52-54 
Visualization of data 
Visualization of data is very important for the interpretation of biomedical information within 
the many cells of an MFC sample. For the next example we used an asthma individual with an 
abnormal high number of eosinophils. An immunophenotyping panel is used containing only 
differentiation markers to distinguish the major and sub cell types. The data is gated using 
sequential Boolean bivariate gating and each cell (sub)type is plotted as different colour. Very 
high number of eosinophils, high number of monocytes, neutrophils, CD8 and CD4 T cells and 
finally a very small number of basophils, Th2 cells, Tc2 cells, double negative T cells and 
double positive T cells. The data was only selected on singlets based on forward scattering area 
and forward scattering height. 
Figure 6 shows the first two components of a PCA model, these describe the maximum variance 
and gives a global view of the data. The smaller populations, such as Th2 (brown), TC2(violet), 
basophils (pine green) are spread out and some populations can only be separated in other 
Principal Components. 
Another popular dimension reduction method is t distributed Stochastic Neighbourhood 
Embedding (t-SNE).55,56 Stochastic Neighbourhood Embedding converts the high-dimensional 
Euclidean distance between data points into probabilities that represent similarities using 
Gaussian probability density functions. In the lower dimensional map, a similar similarity is 
calculated using t-distributed probability density functions. The points in the low dimensional 
map are moved using a gradient descent method to minimize the Kullback-Leibner divergence, 
which is a distance metric between the Gaussian probability in the high dimensional space and 
the t-distributed probability in the low dimensional map. Figure 7 shows a typical t-SNE plot. 
Some of the small cell populations are now in separated tiny compacted clusters, such as the 
Th2 cells (brown) and the basophils (pine green). However, the Tc2 cells are inside the CD8 
populations and without the information of the gates are unable to retrieve. Also, the CD4 
population and neutrophil population are split while no biological reason could explain the split. 
The high number of eosinophils are also a big cluster. Thus, the size of a cell (sub)type is 
somewhat maintained in t-SNE. 
The big difference between t-SNE and PCA is that t-SNE preserves the local structure but loses 
the global view. In t-SNE the cluster size may be determined by number of connected cells and 
their heterogeneity caused by biological or measurement variation. In PCA, a rare cell subtype 
12 
 
with low number of cells may be spread out if much variance is present. However, the 
relationship between clusters observed and the marker expression within each cluster are shown 
by the loadings. In t-SNE each cluster needs to be additionally analysed separately to define 
what types of cells are in the cluster. In some cases, t-SNE may split up a cluster without any 
biological reason such as the CD4 cells in Figure 8. PCA is also nested, which means that each 
time you repeat the analysis the same PCA space will be spanned and each additional PC does 
not change the previous PC. In t-SNE the map will each time be different but each time the 
same clusters will be observed, if used until convergence. 
Visualization of many clusters found with clustering are done with a minimum spanning tree in 
combination with the Kamada Kawai layout, which shows the clusters connected to each other 
in a tree with multiple branches.57 One popular cluster method is based on Self Organizing 
Maps (SOM).54,58,59 In each training iteration the Euclidian distance of a subset of cells to a grid 
of clusters centres is calculated. Each cluster node and each neighbouring clusters are updated 
according to the nearest cells to those clusters. This is repeated until it converges and is 
relatively a fast method as it only calculates the Euclidean distance for subset of cells each time. 
Figure 8 shows an example of the SOM of the asthma individual in a minimum spanning tree 
representation. The SOM is mainly dominated by the larger number of eosinophils and shows 
many nodes with minimum difference. Most clusters have only one cell type in it, but the 
basophils (pine green) and Tc2 (violet) are inside a cluster with other cells, so probably more 
nodes are needed to separate them. However, adding more nodes also leads to a harder to 
interpret tree. 
Another clustering method SPADE, uses agglomerative hierarchical clustering. Each cell starts 
in its own cluster and clusters with a low Euclidean distance to each other are merged until a 
user defined number of clusters is left. This requires to compute the distance matrix of the 
complete data, which is too large to fit in a memory of an average desktop computer. For this 
reason, SPADE down samples the data considering the local density, such that large cell 
populations are less often sampled and small cell populations are complete in the down sampled 
data. In Figure 9 a SPADE tree is show, the major cell populations neutrophils (yellow), 
monocytes (pink), Eosinophils (dark green), CD4 (cyan) and CD8 (light green) cells contain 
the same number of clusters due to the down sampling. The smaller cell populations are in own 
cluster and again the basophils (pine green) and Tc2 (violet) are inside a cluster with other cells. 
Another visualization method based on PCA, is called FLOOD. This method first uses PCA to 
describe the variability in control individuals and subsequently subtracts this information from 
responder individuals or patients and creates a second PCA model on the subtracted data to 
highlight the response variability.60 
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Figure 6: Principal Component Analysis biplot of cells from an asthma individual with 
abnormal high proportion of eosinophils. Each round corresponds to a single cell and is 
coloured according to cell subtype they belong to as defined with sequential Boolean bivariate 
gating. The arrows show the loadings and the original variable contribution in the reduced 
space. 
 
Figure 7: t-SNE plot of cells from an asthma individual with abnormal high proportion of 
eosinophils. Each round corresponds to a single cell and is coloured according to cell subtype 
they belong to as defined with sequential Boolean bivariate gating. 
14 
 
 
Figure 8: Self Organizing Map of cells from an asthma individual with abnormal high 
proportion of eosinophils. Each pie chart corresponds to a cluster of single cells and is coloured 
according to the relative amount of cell subtypes found in it, as defined with sequential Boolean 
bivariate gating. 
 
Figure 9: SPADE tree of cells from an asthma individual with abnormal high proportion of 
eosinophils. Each pie chart corresponds to a cluster of single cells and is coloured according 
to the relative amount of cell subtypes found in it, as defined with sequential Boolean bivariate 
gating. 
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Quantitative comparison between samples 
The above methods are mainly used as visualization and explorative research. Only a qualitative 
comparison may be made between the Figures. The high throughput and high number of cells 
measured with minimal technical variability also allows for a quantitative comparison. 
However, the single cells may not be directly compared between individual samples. The single 
cells of each sample first need to be converted in a cellular distribution of each sample. In 
conventional flow cytometry research, the relative number of cells in each Boolean gate are 
counted and compared between samples or the expression of an activation marker in a Boolean 
gate are compared between samples.61 As discussed before, these gates are very subjective and 
hypothesis driven. Moreover, small changes between subpopulations are often overlooked. One 
of the most popular multivariate methods available today for discriminant analysis between 
samples is Citrus. Citrus first creates a cellular distribution using hierarchical clustering, similar 
to SPADE. Subsequently uses a lasso regularized classification method to find the subset of 
clusters that best predicts a sample’s group. This usually results in a few clusters that are 
discriminating between sample groups.62 A few clusters are easier to interpret than the many 
clusters seen in Figure 8 and 9. However, the few clusters found do not fully describe the whole 
continuum of the data and may miss valuable immunological information. 
Scope and outline of the thesis 
This thesis highlights the advantage of the high throughput of flow cytometry and shows a 
quantitative analysis method that is able to describe the continua in cellular distributions in the 
data and to compare between measurements/samples. Flow cytometry data contains 
information on four hierarchical levels, that range from the individual markers of the cell to the 
differential expression of functionalized cells in (clinical) phenotypes: 
1) The multivariate (co)-expression of markers on single cells 
2) Aggregation of cells into populations with similar marker expression 
3) Representation of cell populations in a specific individual 
4) Differentiation of this representation in specific (clinical) phenotypes 
Most current methods only cover a part of these levels. We developed a method that covers 
those four levels and is based on PCA. PCA is most suited as we can easily plot the loadings 
on top to see the original marker expression. In the PCA space clusters may be visible but also 
continua may be observed. Moreover, PCA allows for easy projection of new samples and 
therefore, the method may be used to predict new samples and is easily cross validated and 
tested for statistical significance.63 Projection and cross validation are also done in cluster-based 
methods such as Citrus. In theory, building histograms based on the PCA space is very similar 
to clustering using the Euclidean distance, because PCA maximizes the variance of the data. 
Therefore, the same classification prediction may be achieved but a PCA based method results 
in a higher interpretability of the data. All significant cells inside clusters and/or continua may 
be highlighted in the PCA space and the loadings show the marker expression of these cells. 
In the second chapter, we developed a method called DAMACY (Discriminant Analysis of 
Cytometry data) where we build N-D histograms based on the PCA space to quantitatively 
compare two sample groups using OPLS-DA.64 In this method we highlight areas of cells in 
the PCA space important for discrimination. The advantage is that we can easily plot the 
loadings on top of it and see the original marker expression. To conclude DAMACY can be 
used to visualize the difference between groups based on the marker variability between single 
cells. 
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In the third chapter we extended this method to use multiple aliquots measured with different 
sets/panels of fluorophore markers. The number of fluorophores used in a flow cytometry 
experiment is limited due to the fluorophore overlap. By using multiple panels for specific cell 
types, we may study a large part of the immunological complement. In this chapter we also 
show that OPLS-DA in combination with Variable Importance on Projection (VIP) may be used 
to find all the cell signatures that are significantly discriminating between sample groups. This 
in contrast to Citrus may describe almost entirely the immunological change between sample 
groups, instead of only the most discriminating cell (sub)type. 
In the fourth chapter we show how to consider the multiset structure of flow cytometry. Each 
sample may have a different number of cells measured. Just concatenating the data and 
performing the multivariate data analysis leads to a model where samples which have more 
cells measured contribute more to the model. For this reason, the ‘standard’ multivariate data 
analysis methods need to be rewritten in order to deal with the different number of cells 
measured. We show the effect on simulated data with popular multivariate methods such as 
PCA, t-SNE and SOM. 
In the fifth chapter we use PCA to describe the normal cells and remove them in order to find 
disease specific cells. This might especially be useful for heterogeneous disease, where each 
patient has a different small cell (sub)type causing the disease. 
In the sixth chapter we show how flow cytometry may be used for on-line measuring of 
phytoplankton in the river water. Phytoplankton in the Meuse river were hourly measured over 
a whole year and DAMACY models were made to predict natural factor, such as day/night 
cycle, day length and water temperature. Contaminations of the river correlated with a large 
deviation between the natural factors and the predicted natural factors based on the 
phytoplankton. This method may thus be used to monitor the river water quality and to detect 
yet unknown contaminants that are affecting phytoplankton. 
In the seventh chapter we use Stimulated Raman Spectroscopy (SRS) to distinguish 
microplastics. The advantage of SRS is the sensitivity for very small particles and is reasonably 
fast if only a few wavenumbers are used. We used sparse-PLS-DA analysis to find the minimum 
set of wavenumbers used to discriminate between the six major plastics. This technique may be 
used inside a flow cytometer to detect microplastics inside single cells. 
In the eight chapter we summarize how DAMACY and ECLIPSE can be used to extract 
additional information from the flow cytometry data as well as improved interpretation 
compared to existing methods. We also discuss future improvements and propose how these 
methods can be extended for experimental design data and to incorporate confounding 
variables. 
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Abstract 
Multicolour Flow Cytometry (MFC) produces multidimensional analytical data on the 
quantitative expression of multiple markers on single cells. This data contains invaluable 
biomedical information on 1) the marker expressions per cell, 2) the variation in such 
expression across cells, 3) the variability of cell marker expression across samples that 4) may 
vary systematically between cells collected from donors and patients. Current conventional and 
even advanced data analysis methods for MFC data explore only a subset of these levels. The 
Discriminant Analysis of MultiAspect CYtometry (DAMACY) we present here provides a 
comprehensive view on health and disease responses by integrating all four levels. We validate 
DAMACY by using three distinct datasets: in vivo response of neutrophils evoked by systemic 
endotoxin challenge, the clonal response of leukocytes in bone marrow of acute myeloid 
leukaemia (AML) patients, and the complex immune response in blood of asthmatics. 
DAMACY provided good accuracy 91-100% in the discrimination between health and disease, 
on par with literature values. Additionally, the method provides figures that give insight into 
the marker expression and cell variability for more in-depth interpretation, that can benefit both 
physicians and biomedical researchers to better diagnose and monitor diseases that are reflected 
by changes in blood leukocytes. 
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Introduction 
Multicolour Flow Cytometry (MFC) is a powerful analytical technology that is used to measure 
(co)-expression of multiple markers at a single cell resolution. A typical sample for MFC 
analysis may contain large numbers of cells (>10000), characterized by the binding of several 
fluorescently labelled antibodies that represent expression of specific cellular markers1. The 
analysis of such marker (co)-expression has been essential in unravelling systematic and 
comprehensive patterns in e.g. haematopoiesis, cellular function and disease mechanisms 2. 
The information in MFC data is widely used for multiple objectives, the most prominent being: 
identifying cell subpopulations using two-dimensional gating and interpreting cell populations 
associated with a clinical phenotype.3 Analysis of variability at the single cell level will provide 
clinically relevant information. Generally, MFC datasets contain information on four 
hierarchical levels, that range from the individual markers of the cell to the differential 
expression of functionalized cells in clinical phenotypes: 
1) The multivariate (co)-expression of markers on single cells 
2) Aggregation of cells into populations with similar marker expression 
3) Representation of cell populations in a specific individual 
4) Differentiation of this representation in specific clinical phenotypes 
 
Several existing methods for MFC data analysis may predict accurately the phenotype a sample 
presents, but fail to quantitatively link the interplay between specific markers to e.g. disease 
specific cells 4. Several methods use e.g. median fluorescence intensity or work with sequential 
two-dimensional gating steps to select specific cells. Two-dimensional multiple gating regions 
of interest are subjectively defined in bivariate plots, but important information is lost during 
every sequential two-dimensional gating step. Therefore, these methods can be viewed as 
multiple-univariate or multiple-bivariate and miss the comprehensive link between the four 
levels. Either approach does not employ the expression of more than two markers of a single 
cell, such that the MFC data is not interpreted to its full potential. 
Recently, several multivariate methods have been developed that provide a canonical view on 
the (co)-expression of all markers. Fischer Information Nonparametric Embedding (FINE)5 
uses Multidimensional Scaling to observe variability between samples, which may be used to 
explore response-related patterns. However, the link FINE draws between marker expression 
and variability between individuals is non-linear, such that relevant connections can only be 
drawn from post hoc interpretation of the model results. Likewise, the ViSNE6 approach 
visualizes the aggregation of cells for each individual by reducing the dimensions with a non-
linear t-Distributed Stochastic Neighbour Embedding (t-SNE), such that the representation of 
single-cells (level 2) cannot be directly linked to the multivariate co-expression of markers 
(level 1). Moreover, neither method allows a projection of an individual sample (level 3) into 
the multidimensional model space to evaluate their similarity to samples in the calibration set 
on which the model was fitted (level 4). Several other methods that were specifically developed 
for MFC data analysis, use specific representations of the cellular composition of a sample 
(level 2) to find biomarkers for a clinical phenotype. Frequency Difference Gating7 (FDG), 
another method uses probability binning to get an equal number of cells in each bin, based on 
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those measured in the control samples and then identifies bins differentially expressed in a 
specific (clinical) phenotype. The SPADE method constructs hierarchical clusters to 
differentiate cell populations 8 that may be associated to a specific clinical phenotype.9 Also 
Citrus 10 uses hierarchical clustering to find such discriminating cell populations with an 
alternative regression approach called lasso-regularized logistic regression. Although these 
three approaches are multivariate and linear, they fail to show how the multivariate marker (co)-
expression (level 1) underlies the cell diversity (level 2). Interpretations of such co-expressions 
are limited to qualitative comparisons between the expression of single markers in a multiple-
univariate comparison. 
Another common method in flow cytometry is Principal Component Analysis (PCA), which 
reduces the dimensions in order to study the most prominent variation in (co)-expression of all 
markers across all cells exhibited by specific clinical phenotypes.11,12 Two methods, Automated 
Population Separator (APS)13 and Flow cytometric Orthogonal Orientation for Diagnosis 
(FLOOD)14 use PCA. The advantage of PCA is that you can represent the single cells together 
with the interrelated expressions of the markers in a biplot. The APS method creates a PCA 
model for every phenotype based on all the cells of the individuals in that phenotype. Next, a 
new measurement is projected into each PCA model and the closest clinical phenotype is 
selected as the predicted phenotype. FLOOD builds a PCA model based on the marker 
variability in healthy individuals and subsequently models the variability only observed in 
responding individuals. FLOOD then counts the number of responding cells. However, some 
cells may be more specific for a clinical phenotype than others. Therefore, it would be better to 
use regression to give specific cells higher weights. 
In this paper we present Discriminant Analysis of MultiAspect CYtometry (DAMACY), a 
multivariate method that uses PCA biplots and multivariate regression based on Partial Least 
Squares (PLS) to quantitatively compare the leukocyte compositions of multiple individuals, 
specifically those correlated to the discrimination of individual groups based on their immune 
response. Thereby, DAMACY can integrate all four levels of MFC information (Table 1) and 
in this way, differentiate between clinical phenotypes based on quantified co-expression of 
multiple markers on different cell populations. 
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Results 
We demonstrate the strength that DAMACY has to describe homeostasis and deviations in the 
haematological and immunological system by three complementary case studies. We acquired 
the first dataset to study the in vivo effect of lipopolysaccharide (LPS) on blood neutrophils. 
The second data set focussed on the identification of tumour cells within bone marrow samples 
of patients with acute myeloid leukaemia (AML). We obtained the third dataset from total 
leukocytes isolated from patients with different phenotypes of asthma. The control group in this 
article is stated as controls and the other group as challenged individuals. 
For benchmarking against other methods, we evaluated the predictive ability of DAMACY in 
two Flow Cytometry: Critical Assessment of Population Identification Methods (FLOWCAP) 
II challenge datasets4. The 99% accuracy on the AML and 100% accuracy on the HIV Vaccine 
Trials Network (HVTN) datasets of DAMACY is comparable to the other evaluated methods. 
we provide more details in the supplementary material. 
Lipopolysaccharide challenge 
Intravenous administration of lipopolysaccharide (endotoxin) elicits a systemic inflammatory 
response syndrome in humans (SIRS) 15. Neutrophils demonstrate a characteristic difference in 
expression of CD16 and CD62L, together with a larger array of alterations in co-expressed 
surface markers 15. 
The DAMACY model on the LPS data (Figure 1) required two Base Principal Components 
(PCs) to explain 65% of the total variability across cells within all samples. Specifically, the 
first PC explains considerably more variability in challenged individuals (59%) than in controls 
(19%), which indicates that the Base model describes considerable response-specific cell 
variability. The score distributions show that this response entails a distinctive ‘bean’ shape 
following a continuous gradient in marker expression (see figure right panel Figure 2) that is 
not observed in control individuals. 
 
Figure 1: Shows a biplot of the cells of a typical control (left) and a typical LPS-responding individual 
(right). Each dot represents a score, thus a single cell. The model loadings are represented by vectors 
and indicate how each surface marker contributes to the cell variability in a specific direction. The 
percentage given is the explained variance per PC of that individual.  
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Qualitative comparison of both biplots show clear differences induced by LPS. The individual 
cell scores can however not be directly quantitatively compared between individuals: such 
comparison needs to transcend the single-cell level. This could be achieved by gating the cells, 
however the observed continuous distribution in marker expression prohibits setting a discrete 
gate. Therefore, we used a small binsize to bin the cell scores in order to retain as much 
resolution in the marker expression as possible. Supplementary Figure 1 shows the cellular 
distribution of a typical sample in an unsmoothed histogram, which is very grainy and therefore 
poorly comparable between samples. Histogram smoothing resolves the continuous distribution 
that underlies these bins, which can be much better quantitatively compared between samples 
(Figure 2). 
 
Figure s1: Unsmoothed histograms of the biplots shown in Figure 1. The right panel shows a 
histogram of a typical LPS-responding individual. The darker bin, the more cells are present 
in that location based on the same PCA as Figure 1. The same loadings are plotted on top as 
vectors and indicate how each surface marker contributes to the cell variability in a specific 
direction within the model. 
 
Figure 2: smoothed histograms of the biplots shown in Figure 1 of a typical control (left) and a typical 
LPS-responding individual (right). The darker bin, the more cells are likely present in that location. 
The same loadings are plotted on top as vectors and indicate how each surface marker contributes 
to the cell variability in a specific direction. 
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The immune response of neutrophils to LPS, can be interpreted by quantitative comparison of 
these smoothed histograms. We performed this comparison by OLPS-DA, which leads to 
perfect diagnosis of the LPS-specific response (Figure 3, right). The blue and red regions 
indicate the most discriminative bins, coloured according to their weight in the discriminant 
model, where blue bins contain a larger fraction of cells in challenged and red bins larger 
fractions in the control samples. The cross-validated prediction scores (Figure 3, left) show the 
classification of each sample as either challenged or control based on these weights. 
Two benchmarks, coloured in orange and blue in Figure 3, encircle the 80% bins most highly 
occupied by single cells. The area with the most decreasing cell fraction decreases upon LPS 
response (coloured most intensely red in Figure 3) is also encircled by the blue benchmark, 
which indicates that peripheral blood of responders contains a considerable fraction of cells 
with this surface marker expression, identified as normal mature neutrophils, even upon 
response.16 
The most intensively in- or decreasing bins in the leukocyte map may be subdivided into three 
distinct regions that we gated for further inspection (Supplementary Figure 2 and 3). Control 
samples contain a higher fraction of cells near ■ than responders. These cells have an average 
expression of all markers. Cells near + are more abundant in LPS responders; their expression 
of CD11b, CD11c, CD16 and CD69 is higher. Cells near ▷ are also more abundant in LPS 
responders, but the expression of CD11b, CD11c, CD16 and CD69, is lower than average while 
they co-express more CD62L. The elongated shape of the blue coloured bins near ▷ along the 
CD62L loading shows that cells vary considerably in their expression of this marker. The 
expression of CD32 and CD64 is not oriented towards any specific region, and therefore does 
not associate with specific groups of cells responding to LPS. The large loading of CD32 
Figure 3: DAMACY model of LPS data. The left panel shows the average prediction score of controls 
(red rounds) and LPS-responding individuals (blue crosses) based on the results of the double cross-
validation. The right panel shows negative weights as red and positive weights as blue. The blue 
contour depicts where most cells of the enlarged cross are. The red contour depicts where most cells 
of the enlarged round are. The loadings of the Base model are plotted on top as black vectors and 
indicate how each surface marker contributes to the cell variability in a specific direction. The marker 
expression of cells near ▷, ■, + are discussed in the text. 
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indicates that the expression of this marker varies considerably between all neutrophils. The 
small CD64 loading shows it does not contribute to the modelled marker expressions. 
 
Figure s2: DAMACY immunological cell map, which is the same as in the right panel of Figure 
4. Negative weights are depicted as red and positive weights as blue. Now three regions are 
highlighted based on the intensity weights. The original cells that lie inside these contours can 
be gated. 
 
 
Figure s3: Shows the original median logarithmic fluorescence intensity of each marker of each 
gate depicted with the same colors as in Figure s2. 
The continuum in marker expression could not be observed in the bivariate plot of the most 
prominent surface markers CD62L and CD16 (supplementary Figure 4). Rather, these two 
markers alone show a fully independent and orthogonal behaviour for all cells. However, when 
observing the linear relationships between all markers simultaneously in DAMACY, a much 
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more gradual continuum is observed. The median fluorescence intensity of the cells within the 
three gated regions (supplementary Figure 3) shows that considerable overlap exists in single 
marker expression between the gated regions. Thus, the multivariate marker co-expressions 
provide a much more distinctive view on the immune response to LPS than single-marker 
evaluation of the same data. 
 
Figure s4: Expression of CD62L and CD16 of a challenged individual. 
Acute Myeloid leukaemia 
AML is characterised by an expansion of abnormal immature myeloid cells in both the bone 
marrow and peripheral blood. The cellular composition of 15 bone marrow samples was 
analysed by MFC using the EUROFLOW ALOT screening approach.17 Nine bone marrow 
samples were from AML patients and six from individuals with absence of any leukemic clones 
in the bone marrow (controls). 
DAMACY analysis correctly discriminated between controls and AML patients (Figure 4) with 
98% accuracy in a six-fold cross leave-sample-out validation with 20 iterations.10,18,19 The 
haematological map (right panel) shows an intense red region near ▲ with cells that are 
underrepresented in AML patients and an intense blue region near □ with cells that are 
overrepresented in AML. The cells near ▲ have a higher expression of cMPO compared to 
cells near □; cells in both regions are myeloid because they have average or high expression of 
cMPO and low expression of other markers. Another, less intensely blue region near ◇ contains 
B-cells with higher expression of CD19 and cCD79a. The T-cell populations position near ☆, 
with relatively high expressions of CD7 and sCD3. These latter populations are coloured less-
intensely blue and are therefore decreasingly important in the observed AML. DAMACY may 
show specific AML responses, namely a higher amount of myeloid cells and not in T cells or 
B cells. An additional finding is the lower expression of cMPO in myeloid cells in AML 
individuals. 
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Asthma phenotypes 
Asthma is a heterogeneous disease characterised by symptoms of wheezing, cough, 
breathlessness and chest tightness. Current diagnosis is based on symptoms and variable airflow 
limitation.20 In the current analysis we compared 24 asthma patients to 10 healthy controls. 
Their blood samples were characterized by eight antibodies: CD3, CD4, CD8, CD14, CD16, 
CD123, CD193 and CD294 (CRTH2). This surface marker panel specifically differentiates 
between asthma-associated cell types, such as eosinophils, type 2 T helper cells (Th2-cells), 
type 2 cytotoxic T cells (Tc2) and basophils. The CRTH2-antibody was included to measure 
the presence of the PGD2 receptor.21-23 
Each individual measurement was centred in the Base model by median based on the whole 
dataset, as this led to highest prediction accuracy among all evaluated methods. Systematically 
evaluation of Top models based on all combinations of these Base components showed that 
histograms of components 1 and 3 provided 91% accuracy in discriminating mild/severe asthma 
patients versus controls. 
The OPLS-DA model (Figure 5 right panel) shows the leukocyte map. Many different coloured 
regions can be found in Figure 5 where the centroid point is denoted with a symbol. The marker 
expression profiles of the areas are given in Table 2. In the origin are the neutrophils which is 
likely due to median centering with neutrophils as the most common cell type. The neutrophil 
with average CD16 expression is more represented in controls, while the neutrophils with 
higher CD16 expression and with lower expression are more represented in asthma patients. 
This CD16 pattern was also seen in the LPS data. In asthma patients the CD3+CD4+ T cells 
express more CD4 and the CD3+CD8+ T cells more CD8 compared to control individuals. 
Naturally, asthma patients have more eosinophils. Monocytes and CD4/CD8 double negative 
T cells on the other hand are slightly more represented in controls. Basophils are not correlated 
to any of the two groups. Th2 cells and Tc2 cells overlap with the CD4 and CD8 cells, 
Figure 4: DAMACY model of AML data. The left panel shows the average prediction score of controls 
(red rounds) and AML patients (blue crosses). The right panel shows negative weights as red and 
positive weights as blue. The loadings of the Base model are plotted on top as black vectors and 
indicate how each marker contributes to the cell variability in a specific direction 
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respectively. The leukocyte map gives, in one overview, the cell types that are more represented 
in asthma patients. 
 
Figure 5: DAMACY model of asthma data. The left panel shows the average prediction score 
of the OPLS-DA model of controls as red rounds and asthma individuals as blue crosses. The 
right panel shows negative weights as red and positive weights as blue. The loadings of the 
Base model are plotted on top as black vectors and indicate how each surface marker 
contributes to the cell variability in a specific direction within the model. The symbols indicate 
the centroid of that coloured area that are representative for different cell populations (see 
table 2). 
Table 1: Expression profile of the different areas marked with symbols in Figure 5. The 
expression profiles are checked by conventional sequential two-dimensional gating. 
Symbol Expression Cell type Proportionally more 
represented in: 
■ CD3+ CD8−CD4++ CD4 T cell Asthma 
□ CD3+ CD8−CD4+ CD4 T cell Control 
▲ CD3+ CD4−CD8++ CD8 T cell Asthma 
△ CD3+ CD4−CD8+ CD8 T cell Control 
♠ CD3+CD8+ CD4+ Double Positive T cells Asthma 
◇ CD3+CD4−CD8− Double Negative T cells Control 
⌂ CD14+ Monocyte Control 
▼ CD16+ Neutrophil Asthma 
origin CD16med Neutrophil Control (median cell) 
▽ CD16dim Neutrophil Asthma 
► CD16dimCRTH2+ Eosinophil Asthma 
☆ low expression Debris/dead Cells Control 
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Discussion 
The systematic integration of MFC data into four distinct levels (see Table 1) can be 
quantitatively linked together to improve the interpretation of comprehensive cell variability in 
surface marker co-expression. DAMACY combines multivariate ordination and classification 
of markers, cells, individuals and clinical phenotypes. The four levels provide adequate 
diagnoses in our complementary case studies and link this to individualized responses in single 
cells and in co-expression of several surface markers. 
Table 2: The four information levels of multidimensional flow cytometric data. 
Information level DAMACY output 
1) The multivariate (co)-expression of markers on single cells 
 
PCA (loadings) 
2) Aggregation of cells into populations with similar marker 
expression 
PCA (scores) 
3) Representation of cell populations in a specific individual Histograms 
4) Differentiation of this representation in specific clinical 
phenotypes 
Leukocyte map based 
on OPLS-DA weights. 
For example, LPS leads to emergence of cells reduced in their expression of CD62L and other 
cells considerably reduced in CD16 expression (Figure 3). Cells which highly express CD16 
and lowly express CD62L are also high in expression of CD11b and CD11c, a relationship 
between surface marker expressions that can be directly interpreted from the Base loadings 
within the leukocyte map. These cells are absent in homeostasis and can be used as diagnostic 
for acute inflammation. 
The histograms show that rather than discrete populations, the neutrophil compartment of LPS 
responding individuals contains cells with a continuum of co-expression levels of these 
markers that cannot be observed in the separate expression levels. Relative differences in 
expression throughout this entire continuum may be distinct between groups of individuals, 
which may not be observed in SPADE and Citrus that rely on presence of discrete 
populations/clusters. To alleviate this, SPADE and Citrus use hierarchical clustering with many 
clusters in order to model the continuum. However, too many clusters results in difficulties in 
interpretation, while too few clusters may not capture all the information present. Because 
DAMACY does not use clustering but PCA, the clusters or continuum will appear as is present 
in the data, with easy to interpret figures as the vector loadings show the relative marker 
expression. Individualized aspects of this expression can be visualised within the DAMACY 
framework by superimposing cell variability within an individual sample onto the leukocyte 
cell map. The latter shows that this variability indeed involves up-regulation across the entire 
continuum for a specific individual (Figure 3). The predictive scores, finally, quantify the 
difference between both groups of individuals, and allow a robust, comprehensively 
statistically validated result. These results show higher percentages of cells that are 
simultaneously low in CD62L and high in CD11b are indicative of endotoxemia, although the 
expression of these markers may vary across cells. These cells form a relatively larger 
proportion of the neutrophil population in some challenged individuals than in others; clearly 
there is considerable heterogeneity across all four levels that may be interpreted by DAMACY. 
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Amir et al. have described that single-cell data has many non-linear relationships, which cannot 
be used by a linear method such as PCA.6 Non-linear relationships do, however, not disappear 
in linear models, as the biplot representation of the cell variability in LPS shows (Figure 2 and 
3) a bean-like shape due to that healthy cells have a high expression of both CD16 and CD62L 
highly, whereas cells responding to LPS either express CD16 or CD62L highly. These effects 
were also observed with FLOOD14. However, FLOOD looks for response specific cells per 
individual, while DAMACY focuses more on the ratio of specific cells between controls and 
challenged individuals and gives a general leukocyte map for all challenged individuals. Non-
linear methods such as ViSNE6 and FINE5 have the drawback that the quantitative view on 
marker co-expressions is lost from the model. Also linear clustering methods like SPADE8 and 
Citrus10 allow only qualitative interpretation of marker co-expression, either through 
similarities between heatmaps of individual markers or by plotting the histograms of the 
individual markers of a single cluster as is done in Citrus and in the non-linear binning of FDG.7 
These methods thus fail to quantitatively connect the variability in marker (co)-expression on 
single cells with the ratio between these cells between MFC samples of different phenotypes. 
The clinical value of DAMACY 
The information content within MFC data revealed in a quantitative model strongly depends on 
the specific choices made in collecting the data and in data processing that precedes modelling. 
The analysed sample may consist of a relatively homogeneous cell population or can interrogate 
a much broader mixture of cells, such as the whole blood and bone marrow analysed in the 
asthma and AML studies presented here, respectively. The results on the FLOWCAP 2 data 
show how the quantitative potential of DAMACY is on par with the most advanced methods 
benchmarked in this challenge. The discriminatory Top model may extract the response-related 
information on cell variability in marker expression from the Base model histograms, both for 
a priori gated homogeneous neutrophil populations (LPS) and in peripheral blood (asthma). 
DAMACY shows to be also very informative for other sample types, like bone marrow samples 
from the AML study. 
Diagnostic ability is however not the only, and certainly not the most challenging, issue in 
current MFC data analysis. The challenge is finding all variability in biological samples that is 
relevant to the studied response and thus disregarding all irrelevant variability. This implies that 
markers can be disregarded in the future leading to more focused experiments. The asthma 
dataset contains some older asthma patients outside the confidence interval of the age of the 
controls. The current model is unable to separate the variance caused by age from the disease 
and this would be possible if future experiments contain age matched controls. In that way, the 
method will minimize the variance explained caused by age and maximize the variance caused 
by the disease. 
Cell distributions, identified by the Base model histograms, may vary greatly across individuals, 
and even systematically in aspects that do not align with the studied classification. An 
unsupervised PCA-based Top model may be very helpful for such observations 
(supplementary). In the LPS study this model reveals a dim/bright marker profile that varies 
systematically among individuals in both groups, which therefore remains enveloped in the 
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OPLS-DA Top model. Also, the superimposing of individual histograms (Figure 3) may be a 
key advantage of DAMACY for this. 
Conclusion 
The DAMACY method can be used to objectively discriminate specific clinical phenotypes and 
provides a completely statistically validated model that proves insightful in a range of case 
studies. The method does not require any input on cell characteristics relevant to the experiment 
and is thereby unbiased to the prior knowledge of the researcher. The DAMACY model is able 
to quantitatively link individual variability in a clinical phenotype to specific cell populations 
with typical levels of marker co-expression that provide a novel, broad view on responses in 
health and immunological/haematological diseases. 
 
Methods 
Data 
Subjects with asthma and normal subjects participating in the LPS challenge study gave 
peripheral blood. All data were obtained by using standardized protocols. All studies and 
sample collection were approved by the medical ethics committees of University Medical 
Center Utrecht (asthma patients/UMCU) and Radboud University Medical Center (LPS 
challenge/RadboudUMC), the Netherlands. These participants gave their written informed 
consent. AML data were from bone marrow and were extracted from Anonymized flow 
cytometry list mode data sets (fcs files). These data sets were originally acquired as part of the 
UMCUtrecht institutional work up scheme for evaluation of leukaemia. 
 
Acute myeloid leukaemia data (AML) 
Bone marrow samples were analysed for the presence of AML by MFC for diagnostical 
purposes using the acute leukemia orientation tube (ALOT) as described by the EuroFlow 
consortium.17 The ALOT tube is a single 8-color-tube designed for the identification of an 
expanded population of immature blast like cells, including AML blasts. The 8-color panel 
consists of detection of CD3 (cytoplasmic and surface), MPO (cytoplasmic), CD79a 
(cytoplasmic) and the surface expression of CD19, CD34, CD45 and CD7. The uncompensated 
list mode fcs data files of bone marrow samples (100.000 stained cells) of 9 AML patients and 
6 individuals where no haematological malignancy could be detected in the BM, were used in 
this study. The flowcytometric analyses were performed on a FACSCanto II (Becton 
Dickinson). 
Lipopolysaccharide (LPS) challenge 
In the LPS challenge dataset there are 16 individuals: 8 healthy controls and 8 that have 
undertaken the LPS challenge. Flow Cytometry measurements were performed during an 
endotoxin trial (NCT01374711; www.clinicaltrials.gov). Details regarding the Flow Cytometry 
experiments that provided the data to illustrate the method are described in the Online 
Supplement I; source data can be accessed through www.flowrepository.org ID: FR-FCM-
ZZEE. This dataset has been extensively analysed in two earlier publications. 
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Asthma 
The asthma dataset contains 24 asthma patients (aged 22-78, x̄ = 57) and 10 healthy controls 
(aged 25-57, x̄ = 40) were recruited at the respiratory outpatient clinics of the Churchill Oxford 
University Hospital, UK. The study received ethical approval, and written informed consent 
was obtained. After inclusion patients filled out symptom questionnaires, sputum induction was 
performed, blood was taken, and patients underwent FeNO measurement and lung functional 
testing. All patients were receiving appropriate asthma treatment at the time of blood 
withdrawal. Blood cells were stained with a panel of 8 antibodies including CD3, CD4, CD8, 
CD14, CD16, CRTH2 (CD294), CD123 and CD193. After staining, red blood cells were lysed 
using a FACS Lysing solution (Becton Dickinson). Cells were measured on an LSR Fortessa 
flow cytometer (Becton Dickinson). 
MFC data can be arranged into matrix 𝐗 = [
𝐗11
⋮
𝐗𝐼𝐺
] of size (∑ 𝑁𝑖𝐺
𝐼𝐺
𝑖𝑔=11
×  𝐽) for analysis by 
DAMACY, where 𝑁𝑖𝑔  is the number of cells per individual  𝑖𝑔 = 11, … 𝐼1, … 1𝐺 , … 𝐼𝐺 ; 𝑔 =
1, … . . 𝐺 indicates the pre-defined groups of individuals with 𝑔 = 1 representing the control 
group and 𝑔 = 2 the patient/challenged group, with 𝑗 = 1,… , 𝐽 indicates the markers. The data 
of each individual can analogously be denoted as 𝐗𝑖𝑔 = [
𝐱1𝑖𝑔
𝑇
⋮
𝐱𝑁𝑖𝑔
𝑇
] of size (𝑁𝑖𝑔 ×  𝐽) and the data 
of each class as  𝐗𝑔 = [
𝐗1𝑔
⋮
𝐗𝐼𝑔
] of size (∑ 𝑁𝑖𝑔
𝐼𝑔
𝑖𝑔=1𝑔
×  𝐽). 
 
Stage 1: Data pre-processing 
Data pre-processing is used in multivariate analysis, to remove artefacts and thereby enhance 
the biologically relevant information24. First, we log-transformed the matrix  𝐗  to 𝐗log =
𝐥𝐨𝐠10(𝐗) or in the case of negative values we prior subtracted the minimum value. Then we 
centred the data, to create a common point of reference to quantify the variability in marker 
expression between all cells. 
(1) A 
 𝐦𝑖𝑔
T = 
∑ 𝐗log𝑖𝑔
𝑁𝑖𝑔
𝑛=1
 
𝑁𝑖𝑔
 
B 
𝐦T =
∑ ∑ 𝐦𝑖𝑔
T𝑰𝑔
𝑖𝑔=𝟏
𝐺
𝑔=1
∑ 𝐼𝑔
𝐺
𝑔=1
 
C 𝐃mc = 𝐗log −  𝟏𝐦
T 
 
where 1 is a column vector of length ∑ 𝑁𝑖𝑔
𝐼𝑔
𝑖𝑔=1𝑔
 and matrix 𝐃𝑚𝑐 holds the mean-centred data 
of dimensions equal to 𝐗. 
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MFC data has a specific “multiset structure” 25, i.e. single cells are measured per individual. 
Differences in the number of cells measured for each individual therefore need to be taken into 
account to base the resulting model equally on all samples. To equally weight each individual 
in the calculation of the mean, first the individual-specific vector 𝐦𝑖𝑔
T  needs to be calculated, 
from which the overall mean 𝐦T across all individuals can be subsequently calculated. This 
mean-centring removes the ‘offset’ of the marker expression from the eventual model and puts 
focus on variability in marker expression among single cells. The multiset structure opens up 
the possibility for alternative centring approaches. For example, centring each individual using 
𝐦𝑖𝑔
T or specific to one of the group 𝐦𝑔
T, see supplementary. 
After centring, equation 2 scales the centred data to adjust and equalize the relative 
contributions in expression of each marker within the eventual model. 
(2) 
 
A 
𝐬𝐓 = √
∑ ∑ 𝑣𝑎𝑟 (𝐃𝐦𝐜𝑖𝑔)
𝐼𝑔
𝑖=1
𝐺
𝑔=1
∑ 𝐼𝑔
𝐺
𝑔=1
 
B 𝐒 =  𝐝𝐢𝐚𝐠(𝐬𝐓) 
C  𝐗𝐜𝐬 = 𝐃𝐦𝐜𝐒
−𝟏 
with 𝐗cs  containing the scaled data matrix of size  (∑ 𝑁𝑖𝑔
𝐼𝑔
𝑖𝑔=1𝑔
×  𝐽 )  and 𝐒  of dimensions 
(𝐽 ×  𝐽) a vector where the diagonal element contains the standard deviation of each surface 
marker across all cells. Note that equation 2A calculates the mean variance of each centred set, 
such that the resulting standard deviation is determined by each sample equally. 
Scaling removes any differences in the absolute variability in expression between different 
surface markers that may be caused for example by differences in quantum yield of the used 
dyes, or in differences in variability in expression between different surface markers, regardless 
of their bioactivity. 
Like for the centring, scaling may also be performed with scaling constants specific to each 
individual 𝐬𝑖𝑔
T  or specific to one of the groups 𝐬𝑔
𝐓, see supplementary. 
Stage 2: Base model 
PCA (Principal Component Analysis) 
Principal Component Analysis (PCA) is the most widely used method for dimension reduction, 
that reduces the data dimensionality while retaining most of the variability expressed in the 
originally measured variables 26. 
PCA decomposes the pre-processed data 𝐗cs into two matrices 
26 according to equation 3. 
(3)  𝐗cs = 𝐓𝐛𝐚𝐬𝐞𝐏𝐛𝐚𝐬𝐞
𝐓 + 𝐄 
where 𝐓𝐛𝐚𝐬𝐞  of size (∑ 𝑁𝑖𝐺
𝐼𝐺
𝑖𝑔=11
×  𝐾) contains the PCA scores, 𝑘 = 1, … , 𝐾  indicates the 
Principal Components (PCs), 𝐏𝐛𝐚𝐬𝐞 of size (𝐾base  ×  𝐽) containing the loadings and 𝐄 being 
the residuals. 
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The result of the decomposition consists of single-cell scores 𝐓𝐛𝐚𝐬𝐞 = [
𝐓𝐛𝐚𝐬𝐞,1𝑔
⋮
𝐓𝐛𝐚𝐬𝐞,𝐼𝐺
] that express 
the cell variability within each individual in 𝐓𝐛𝐚𝐬𝐞,1𝑔  of dimensions (𝑁𝑖𝑔 × 𝐾base) . The 
contribution of each surface marker to this variability is described in the loadings; both the 
scores and loadings are expressed in a number of 𝐾base Principal Components (PCs), where for 
MFC data  𝐾base < 𝐽 << 𝑁𝑖𝑔 . The cell variability that is not contained in this simplified 
representation is given in the model residual 𝐄. The loadings of different PCs are mutually 
orthogonal and therefore constrained as 𝐏𝐛𝐚𝐬𝐞
T 𝐏𝐛𝐚𝐬𝐞 = 𝐈. 
When the total number of cells 𝑁𝑖𝑔 differs greatly per individual, the loadings 𝐏𝐛𝐚𝐬𝐞
𝐓  will be 
highly biased towards those individuals for which most cells have been measured. To avoid 
this, the standard PCA model in equation 3 can be slightly adjusted to account for this, see 
equation 4. 
(4) A 
 𝐗csn =
[
 
 
 
 𝐗11N11
−
1
2 
⋮
𝐗𝐼𝐺N𝐼𝐺
−
1
2
]
 
 
 
 
 
 B 𝐗csn = 𝐓𝐛𝐚𝐬𝐞∗𝐏𝐛𝐚𝐬𝐞∗
𝐓 + 𝐄 
 C 𝐓𝐛𝐚𝐬𝐞 = 𝐗cs𝐏𝐛𝐚𝐬𝐞∗ 
 
The relations between cell variability and the related expression of markers can be combined in 
a biplot27(see Figure 2). 
Histogram Construction 
The scores 𝐓𝑖𝑔  cannot be quantitatively compared between individuals, as each individual score 
relates to a single cell within only one individual. In order to describe and then compare the 
cellular distributions between individuals, we can transform each score submatrix 𝐓base𝑖𝑔  into 
a histogram matrix 𝐇𝑖𝑔  of size (∏ 𝐹
𝐾
𝑘=1 ), with 𝑓 = 1,… , 𝐹  indicating the bins within the 
histograms. 
We determine the bin width according to the range of the scores on every PC, according to 
equation 5. 
(5) 
𝛿𝑘 = 
percentile99.95(𝐭𝑘) − percentile0.05(𝐭𝑘)
𝐹
 
where 𝐭base,𝑘 is the vector of length ∑ 𝑁𝑖𝐺
𝐼𝐺
𝑖𝑔=11
 that contains the base model scores for all cells, 
for Principal Component 𝑘base . Note that the bin width is determined for all individuals 
simultaneously, without taking into account the 0.1% extreme values. 
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Each histogram bin will contain a different number of cells for each histogram 𝐇𝑖𝑔.This is why 
we normalize each histogram by summing the area under each multidimensional distribution to 
1, according to equation 6. 
(6) 
𝐇𝑖𝑔 = 
𝐇𝑖𝑔
N𝑖𝑔
 
 
As the number of cells that is measured per sample is most often non-informative due to the 
analytical MFC protocol. Furthermore, the histograms can be plotted together with the marker 
loadings from the PCA model, resulting in a biplot (Figure 2). This histogram reveals the cell 
variability, among which discrete populations can be identified. 
Histogram Smoothing 
Both biological and instrumental variability may cause slight differences in measured marker 
intensities. This may lead to cells being placed in adjacent bins for different individuals. To 
reduce the influence of such shifts we apply a Gaussian multidimensional smoothing on every 
histogram28. This smoothing emphasizes the relations of adjacent bins and facilitates their 
comparability. The binsize 𝛿𝑘 (equation 5) and the degree of smoothing of this algorithm are 
highly related parameters, as a histogram with fewer bins requires less smoothing because more 
cells are captured by the same bin.29 A number of 𝐹 = 500  bins and smoothing factor 5 
provided sufficient resolution in marker expression explained by the PCA scores to be 
interpretable and to provide sufficient discriminatory power for 𝐾base = 2. We extended the 
histogram smoothing algorithm to 𝐾base > 2 in the supplementary. 
 
Stage 3: Top model 
The PCA base model in equation 3 can reveal the relations between many markers with respect 
to cell variability across many individuals. However, the clinical phenotype of each individual 
𝑖𝑔 is not used in the Base model. We therefore subject the histograms to supervised, multivariate 
modelling to find those bins in the histogram that are most distinctive for either control or 
challenged individuals. We first vectorise the histograms, such that every histogram 𝐇𝑖𝑔  is 
rearranged into a row vector 𝐡𝑖𝑔
T  of length 𝐹𝐾base . These vectors can then be collected in a 
second matrix 𝐂 with dimensions(∑ 𝐼𝑔
𝐺
𝑔=1  ×  𝐹
𝐾base). The systematic differences between the 
histograms of different groups 𝑔  can be predicted by Orthogonal Partial Least Squares 
Discriminant Analysis or OPLS-DA.30 The columns (bins) in matrix 𝐂 with small variance (<
10−6) are omitted, as these do not contribute much to the top model. 
OPLS-DA uses PLS regression31 to distinguish multivariate patterns between different groups 
of samples. Compared to the more conventional PLS-DA algorithm 32, an Orthogonal Signal 
Correction (OSC) filter removes all the variation across histograms that is orthogonal and 
therefore uncorrelated to the response 30,33. The latter are encoded in a binary “dummy” vector 
𝐲. The OPLS-DA model is given in equation 7: 
(7) 𝐂∗ = 𝐭top𝐩top
𝐓 + 𝐓𝐨𝐏𝐨
𝐓  + 𝐄OPLS 
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where 𝐭top  contain the predictive scores of length ∑ 𝐼𝑔
𝐺
𝑔=1  and 𝐩top of length 𝐹
∗ contain the 
corresponding loadings, matrices 𝐓𝐨  and 𝐏𝐨
𝐓  are respectively the scores and loadings of the 
space that is uncorrelated to 𝐲 and are not further considered in this study, like the model 
residuals in matrix 𝐄OPLS of size (∑ 𝐼𝑔
𝐺
𝑔=1  ×  𝐹
∗). 
In addition to the model results above, the OPLS-DA algorithm provides a weight-vector 𝐰top 
of length 𝐹∗ that indicates per bin whether it is important for either group in 𝐲. Scores 𝐭top 
indicate how well the challenged individuals can be distinguished from their control 
counterparts 𝑖1. 
Leukoctye map and Prediction Score 
The weight vector can be refolded into an (𝐹 × 𝐹) matrix 𝐖𝐭𝐨𝐩, when the components 𝑲𝐛𝐚𝐬𝐞 =
2 in the base model. This corresponds to the original histograms 𝐇𝒊𝒈, forming a leukocyte map. 
This map shows which histogram bins, hence which cells, are over- or underrepresented in 
either group and can be interpreted together with the predictive scores 𝐭OPLS . Each single cell 
increases the individual score positively or negatively, when it ends up in a positively or 
negatively weighted bin in the leukocyte map. Low-weight bins do not contribute to the contrast 
between control and challenged individuals. 
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Software 
Function for Matlab are available at 
http://www.ru.nl/science/analyticalchemistry/research/software/. 
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Figures: 
 
 
 
 
  
Figure s5: Schematic overview of the DAMACY algorithm 
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Algorithm 
Below you find the complete algorithm of Discriminant Analysis of Multi Aspect flow 
Cytometry data (DAMACY): 
1) Import the data and arrange it as matrix 𝐗  = [
𝐗11
⋮
𝐗𝐼𝐺
]  of size  (∑ 𝑁𝑖𝐺
𝐼𝐺
𝑖𝑔=11
×  𝐽)  for 
analysis by DAMACY, where 𝑁𝑖𝑔  is the number of cells per individual  𝑖𝑔 =
11, … 𝐼1, … 1𝐺 , … 𝐼𝐺; 𝑔 = 1,… . . 𝐺 indicates the pre-defined groups of individuals with 
𝑔 = 1 representing the control group and 𝑔 = 2 the patient/challenged group, with 𝑗 =
1, … , 𝐽 indicates the surface markers; The data of each individual can analogously be 
denoted as 𝐗𝑖𝑔 = [
𝐱1𝑖𝑔
𝑇
⋮
𝐱𝑁𝑖𝑔
𝑇
] of size (𝑁𝑖𝑔 ×  𝐽) and the data of each class as  𝐗𝑔 = [
𝐗1𝑔
⋮
𝐗𝐼𝑔
] of 
size (∑ 𝑁𝑖𝑔
𝐼𝑔
𝑖𝑔=1𝑔
×  𝐽). 
2) Set all negative values to 1 and log-transform the data: 𝐗log = 𝐥𝐨𝐠10(𝐗) 
3) Separate the data into test and training set using leave one of each group out validation 
for small datasets or use 7 cross-validation for larger datasets (>50 individuals per class) 
or use a predetermined training and test set like the FLOWCAP II challenge. 
4) Separate the training data in a training set and a calibration set using leave one of each 
group out validation for small datasets or use 7 cross-validation for larger datasets (>50 
individuals per group). 
5) Mean centre the data using equation 1 or supplementary equation s1, s2. Note: only use 
training data to calculate mean of multiple individuals. 
6) Scale the data using equation 2 or supplementary equation s3,s4. Note: only use training 
data to calculate standard deviation of multiple individuals. 
7) Perform simultaneous component analysis (SCA) on training data using equation 4. 
8) Project the test data onto the SCA model using equation 4C. 
9) Define binsize using equation 5. 
10) Create histograms 𝐇  of size ( ∑ 𝐼𝑔
𝐺
𝑔=1  × ∏ 𝐹
𝐾𝑏𝑎𝑠𝑒
𝑘𝑏𝑎𝑠𝑒=1
), with 𝑘𝑏𝑎𝑠𝑒 = 1,… , 𝐾𝑏𝑎𝑠𝑒 
indicating the components used in the base model, 𝑓 = 1,… , 𝐹  indicating the bins 
within the histograms, by counting the number of cells per bin per individual and 
normalize it using equation 6. 
11) Smooth the histogram using supplementary equation s5, with 𝐈  being the identity 
matrix, for matrix 𝐃1 holds that 𝐃1𝐇 = ∆𝐇 and for matrix 𝐃2 holds that 𝐃2𝐇 = ∆
2𝐇, 
λ is the smoothing factor, this equation results in smoothed histogram Ĥ𝑖𝒈  of size 
(∏ 𝐹
𝐾𝑏𝑎𝑠𝑒
𝑘𝑏𝑎𝑠𝑒=1
) 
12) Refold the smoothed histograms Ĥ into matrix 𝐂 with dimensions(∑ 𝐼𝑔
𝐺
𝑔=1  ×  𝐹
𝐾base) 
13) Remove the columns (bins) in matrix 𝐂 with small variance (< 10−6), resulting in 
matrix 𝐂∗  with dimensions (∑ 𝐼𝑔
𝐺
𝑔=1  ×  𝐹
∗) , with 𝐹∗  being the bins with sufficient 
variance. 
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14) Perform Orthogonal Partial Least Squares – Discriminant Analysis (OPLS-DA) on train 
data with equation 7 
15) Predict the test data with ŷ = (𝐂test
∗ − 𝐂test
∗ 𝐖𝐨𝐏𝐨
𝐓)𝐰top𝐩top
𝐓 𝐪 
16) Go back to step 4 until you have a prediction for every individual in the training set for 
every model based on the different settings of parameters such as way of pre-processing, 
principle components used in the base model, number of bins, smoothing factor and 
number of orthogonal latent variables in the OPLS-DA top model. 
17) Based on the prediction of calibration set select the optimal parameters. 
18) Go back to step 3 until you have a prediction for every individual using the optimal 
parameters. 
19) Perform OPLS-DA on complete data with equation 7 
20) Refold weight vector 𝐰top  into an (𝐹 × 𝐹)  matrix 𝐖𝐭𝐨𝐩 , when the components 
𝐾base = 2 in the base model. 
21) Plot matrix 𝐖𝐭𝐨𝐩 with red intensity for negative weights and blue intensity for positive 
weights. 
Equations used in the algorithm: 
(1) A 
 
B 
𝐦𝑖𝑔
T = 
∑ 𝐗log𝑖𝑔
𝑁𝑖𝑔
𝑛=1
 
𝑁𝑖𝑔
 
𝐦T =
∑ ∑ 𝐦𝑖𝑔
T𝑰𝑔
𝑖𝑔=𝟏
𝐺
𝑔=1
∑ 𝐼𝑔
𝐺
𝑔=1
 
 
C 𝐃mc = 𝐗log −  𝟏𝐦
T 
 
(s1) A 
 
B 
𝐦𝑖1
T = 
∑ 𝐗log𝑖1
𝑵𝑖1
𝑛=1   
𝑁𝑖1
 
𝐦1
T =
∑ 𝐦𝑖1
T𝑰𝟏
𝑖=1
𝐼1
 
 
C 𝐃mc = 𝐗log −  𝟏𝐦1
T 
 
 
(s2) A 
 
B 
𝐦𝑖𝑔
T = 
∑ 𝐗log𝑖𝑔
𝑵𝑖𝑔
𝑛=1   
𝑁𝑖𝑔
 
𝐃mc𝑖𝑔 = 𝐗log𝑖𝑔 − 𝟏𝑖𝑔𝐦𝑖𝑔
T  
 
(2) 
 
A 
𝐬𝐓 = √
∑ ∑ 𝑣𝑎𝑟 (𝐃𝐦𝐜𝑖𝑔)
𝐼𝑔
𝑖=1
𝐺
𝑔=1
∑ 𝐼𝑔
𝐺
𝑔=1
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 B 𝐒 =  𝐝𝐢𝐚𝐠(𝐬𝐓) 
 C  𝐗𝐜𝐬 = 𝐃𝐦𝐜𝐒
−𝟏 
 
(s3) 
 
A 
𝐬1
𝐓 = √
∑ 𝑣𝑎𝑟 (𝐃𝐦𝐜𝑖1)
𝐼1
𝑖=1
𝐼1
 
 B 𝐒1 =  𝐝𝐢𝐚𝐠(𝐬1
𝐓) 
 C  𝐗𝐜𝐬 = 𝐃𝐦𝐜𝐒1
−𝟏 
 
(s4) 
 
A 𝐒𝒊𝒈 =  𝐝𝐢𝐚𝐠 (𝐬𝑖𝑔
𝐓 ) 
 B  𝐗𝐜𝐬𝒊𝒈 = 𝐃𝐦𝐜𝑖𝑔𝐒𝑖𝑔
−𝟏 
 
 
 
(4) A 
 𝐗𝐜𝐬𝐧 =
[
 
 
 
 𝐗𝟏𝟏𝐍𝟏𝟏
−
𝟏
𝟐 
⋮
𝐗𝑰𝑮𝐍𝑰𝑮
−
𝟏
𝟐
]
 
 
 
 
 
 B 𝐗𝐜𝐬𝐧 = 𝐓𝐛𝐚𝐬𝐞∗𝐏𝐛𝐚𝐬𝐞∗
𝐓 + 𝐄 
 C 𝐓𝐛𝐚𝐬𝐞 = 𝐗𝐜𝐬𝐏𝐛𝐚𝐬𝐞∗ 
 
(5) 
𝛿𝑘 = 
𝐩𝐞𝐫𝐜𝐞𝐧𝐭𝐢𝐥𝐞𝟗𝟗. 𝟗𝟓(𝐭𝑘) − 𝐩𝐞𝐫𝐜𝐞𝐧𝐭𝐢𝐥𝐞𝟎. 𝟎𝟓(𝐭𝑘)
𝐹
 
 
(6) 
𝐇𝑖𝑔 = 
𝐇𝑖𝑔
N𝑖𝑔
 
  
(s5) (𝐈 + 𝟐 λ𝐃𝟏
𝐓𝐃𝟏 + λ
2𝐃𝟐
𝐓𝐃𝟐) Ĥ𝑖𝑔 = 𝐇𝑖𝑔 
 
(7) 𝐂∗ = 𝐭top𝐩top
𝐓 + 𝐓𝐨𝐏𝐨
𝐓  + 𝐄OPLS 
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Overview of pre-processing options visualized with simulated data 
Like discussed in the main paper, multivariate analysis is used to reduce or remove artefacts to 
enhance the biologically relevant information. Centring is used to remove shifts from the data 
and scaling is used to remove the differences in scales of marker expression; each marker 
becomes equally important. These two pre-processing steps can be used in three different ways 
due to the unique “multiset structure” of flow cytometry data, i.e. multiple single cells are 
measured for each individual. The three ways are to centre/scale using the mean/standard 
deviation of cells per individual, of all control individuals or of all individuals. 
These different pre-processing strategies were tested on simulated data. These simulated data 
consisted of two normal distributions, mimicking a cell population. One ‘control’ distribution 
was drawn from a normal distribution with true mean μ = 4,0 and true standard deviation σ = 
0.5, 2 and the other ‘challenged’ distribution from a normal distribution with true mean μ = 4,4 
and true standard deviation σ = 2, 0.5, seen in Figure s6. This figure shows that the challenged 
population has a different shape and is shifted compared to the control population. 
 
Figure s6: Shows the simulated cells in red for 'control' population and in blue for the 
'challenged' population 
Multicolour flow cytometry (MFC) data can be arranged into matrix 𝐗  = [
𝐗11
⋮
𝐗𝐼𝐺
]  of 
size (∑ 𝑁𝑖𝐺
𝐼𝐺
𝑖𝑔=11
×  𝐽) for data analysis, where 𝑁𝑖𝑔 is the number of cells per individual  𝑖𝑔 =
11, … 𝐼1, … 1𝐺 , … 𝐼𝐺; 𝑔 = 1,… . . 𝐺 indicates the pre-defined groups of individuals with 𝑔 = 1 
representing the control group and  𝑔 = 2  the patient/challenged group, with 𝑗 =
1, … , 𝐽 indicates the surface markers. The data of each individual can analogously be denoted 
as 𝐗𝑖𝑔 = [
𝐱1𝑖𝑔
𝑇
⋮
𝐱𝑁𝑖𝑔
𝑇
] of size (𝑁𝑖𝑔 ×  𝐽)  and the data of each class as  𝐗𝑔 = [
𝐗1𝑔
⋮
𝐗𝐼𝑔
] of size 
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(∑ 𝑁𝑖𝑔
𝐼𝑔
𝑖𝑔=1𝑔
×  𝐽) . Prior to pre-processing all negative values are set to 1 and data is log 
transformed 𝐗 to 𝐗log = 𝐥𝐨𝐠10(𝐗). 
 
The first three figures show the centring without any scaling performed and visualize the 
following: 
Centring based on the control individuals is given by equation s1: 
(s1) A 
 𝐦𝑖1
T = 
∑ 𝐗log𝑖1
𝑵𝑖1
𝑛=1   
𝑁𝑖1
 
B 
𝐦1
T =
∑ 𝐦𝑖1
T𝑰𝟏
𝑖=1
𝐼1
 
C 𝐃mc = 𝐗log −  𝟏𝐦1
T 
 
With 𝐦𝑖𝑔
T  being the average surface marker expression of one individual. The overall mean 𝐦1
T 
is the average surface marker expression based on all controls. 1 is a column vector of 
length ∑ ∑ 𝑁𝑖𝑔
𝐼𝑔
𝑖𝑔=1
𝐺
𝑔=1  and matrix 𝐃𝑚𝑐 holds the mean-centred data of dimensions equal to 𝐗. 
Note that only the cells of the controls are taken into account, denoted with 𝐗log𝑖1 . Centring 
based on the control individuals will remove the shift of the control cells and will emphasize 
the difference between control (new mean mcontrol = 0,0) and challenged (new mean mchallenged = 
0,2). 
Centring based on all the data from both the groups is given by equation 1: 
(1) A 
 
B 
𝐦𝑖𝑔
T = 
∑ 𝐗log𝑖𝑔
𝑁𝑖𝑔
𝑛=1
 
𝑁𝑖𝑔
 
𝐦T =
∑ ∑ 𝐦𝑖𝑔
T𝑰𝑔
𝑖𝑔=𝟏
𝐺
𝑔=1
∑ 𝐼𝑔
𝐺
𝑔=1
 
 
𝐦𝑖
T = 
∑ 𝐗log𝑖
𝑵𝒊
𝒏=𝟏   
𝑁𝑖
 
𝐦T =
∑ 𝐦𝑖
T𝑰
𝒊=𝟏
𝐼
 
 
C 𝐃mc = 𝐗log −  𝟏𝐦
T 𝐃mc = 𝐗log − 𝟏𝐦
𝐓 
 
The overall mean 𝐦𝐓 is the average marker expression based on all individuals. Centring based 
on all the data will put both groups around the origin (mcontrol = 0, -2; mchallenged = 0,2). Note that 
here the complete dataset is taken, denoted with 𝐗log𝑖𝑔 in equation 1A. 
Finally, centring per individual is given by equation s2: 
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(s2) A 
 
B 
𝐦𝑖𝑔
T = 
∑ 𝐗log𝑖𝑔
𝑵𝑖𝑔
𝑛=1   
𝑁𝑖𝑔
 
𝐃mc𝑖𝑔 = 𝐗log𝑖𝑔 − 𝟏𝑖𝑔𝐦𝑖𝑔
T  
 
Where 𝟏𝑖𝑔is a column vector of length 𝑁𝑖𝑔. Finally, centring per individual will remove the 
individual shift of both groups (mcontrol = mchallenged = 0,0). Note that the mean centring is done 
per individual, resulting in an individual mean-centred data matrix 𝐃mc𝑖𝑔 , seen in equation s2B. 
Scaling based on the control population is given in equation s3: 
(s3) 
 
A 
𝐬1
𝐓 = √
∑ 𝑣𝑎𝑟 (𝐃𝐦𝐜𝑖1)
𝐼1
𝑖=1
𝐼1
 
B 𝐒1 =  diag(𝐬1
𝐓) 
C  𝐗𝐜𝐬 = 𝐃𝐦𝐜𝐒1
−𝟏 
 
with 𝐗cs containing the scaled data matrix of size (∑ ∑ 𝑁𝑖𝑔
𝐼𝑔
𝑖𝑔=1
𝐺
𝑔=1 ×  𝐽 ) and 𝐒1 of dimensions 
(𝐽 ×  𝐽) vector where the diagonal element contains the standard deviation 𝐬1
𝐓 of each surface 
marker based on all cells of control individuals. Scaling based on the control population (σ = 
0.5, 2) will remove the shape of the control (new standard deviation scontrol = 1, 1) and emphasize 
the shape of the challenged population (new standard deviation schallenged = 4, 0.25). Note that 
the standard deviation is based on only the control individuals 𝐃mc𝑖1. 
Scaling based on the complete data is given in equation 2: 
(2) 
 
A 
𝐬𝐓 = √
∑ ∑ 𝑣𝑎𝑟 (𝐃𝐦𝐜𝑖𝑔)
𝐼𝑔
𝑖=1
𝐺
𝑔=1
∑ 𝐼𝑔
𝐺
𝑔=1
 
B 𝐒 =  𝐝𝐢𝐚𝐠(𝐬𝐓) 
C  𝐗𝐜𝐬 = 𝐃𝐦𝐜𝐒
−𝟏 
 
Where 𝐒  of dimensions (𝐽 ×  𝐽) vector where the diagonal element contains the standard 
deviation of each surface marker 𝐬𝐓 based on all cells all individuals. Scaling based on the 
complete data will keep the same difference in shape between control (scontrol = 0.34, 1.37) and 
challenged (schallenged = 1.37, 0.34), but the variables are now equally important (s = 1,1). 
Scaling based on the complete data is given in equation s4: 
(s4) A 𝐒𝑖𝑔 =  𝐝𝐢𝐚𝐠 (𝐬𝑖𝑔
𝐓 ) 
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 B  𝐗𝐜𝐬𝒊𝒈 = 𝐃𝐦𝐜𝑖𝑔𝐒𝑖𝑔
−𝟏 
Where 𝐒𝑖𝑔  of dimensions (𝐽 ×  𝐽) vector where the diagonal element contains the standard 
deviation of each surface marker 𝐬𝑖𝑔
𝐓  based on all cells of one individuals. Scaling per individual 
will remove the shape of both groups (scontrol = schallenged = 1, 1). 
 
Figure s7: Shows the resulting pre-processed simulated data for each pre-processing 
combination. The red rounds are cells belonging to the ‘control’ population and the blue 
triangles are cells belonging to the ‘challenged’ cell population. The columns contain the 
different scaling option going from no scaling, scaling based on controls, scaling based on 
complete data to individual scaling. The rows show the different centring options from centring 
based on controls, centring based on complete data to centring per individual. 
This simulation in Figure s7 shows that based on the way of pre-processing, the resulting data 
structure can be very different. One of the interesting options is centring and scaling based on 
only the control individuals, which emphasizes the difference between control and challenged 
cell populations. Another interesting way is the individual centring and scaling wich leads to 
two identical cell populations, this is can be used if you are only interested in the representation 
of this cell population and not in shifts of the populations. 
We found that in the case of asthma and in the lipopolysaccharide challenge data, the best 
prediction was achieved when we used individual centring and scaling based on all the 
individuals. In this way you keep the difference in expression of surface markers, but shifts in 
the data are removed. In the Acute Myeloid Leukemia (AML) data large shifts were observed, 
which were expected since the leukemic cells can express aberrant markers which normal 
muyeloid cells do not express. This is why centring and scaling based on all the cells yielded 
the best results. 
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Data description 
Subjects with asthma and normal subjects participating in the LPS challenge study gave 
peripheral blood. All data were obtained by using standardized protocols. All studies and 
sample collection were approved by the medical ethics committees of University Medical 
Centers Utrecht (asthma patients/UMCU) and Radboud University Medical Center (LPS 
challenge/RadboudUMC), the Netherlands. These participants gave their written informed 
consent. AML data were from bone marrow and were extracted from Anonymized flow 
cytometry list mode data sets (fcs files). These data sets were originally acquired as part of the 
UMCUtrecht institutional work up scheme for evaluation of leukaemia. 
 
Acute myeloid leukaemia data (AML) 
Bone marrow samples were analysed for the presence of AML by MFC for diagnostical 
purposes using the acute leukemia orientation tube (ALOT) as described by the EuroFlow 
consortium.[1] The ALOT tube is a single 8-color-tube designed for the identification of an 
expanded population of immature blast like cells, including AML blasts. The 8-color panel 
consists of detection of CD3 (cytoplasmic and surface), MPO (cytoplasmic), CD79a 
(cytoplasmic) and the surface expression of CD19, CD34 CD45 and CD7 (). The 
uncompensated list mode fcs data files of bone marrow samples (100.000 stained cells) of 9 
AML patients and 6 individuals where no haematological malignancy could be detected in the 
BM, were used in this study. The flowcytometric analyses were performed on a FACSCanto II 
(Becton Dickinson). 
Lipopolysaccharide (LPS) challenge 
In the LPS challenge dataset there are 16 individuals: 8 healthy controls and 8 that have 
undertaken the LPS challenge. Flow Cytometry measurements were performed during an 
endotoxin trial (NCT01374711; www.clinicaltrials.gov). Details regarding the Flow Cytometry 
experiments that provided the data to illustrate the method are described in the Online 
Supplement I; source data can be accessed through www.flowrepository.org ID: FR-FCM-
ZZEE. This dataset has been extensively analysed in two earlier publications. 
Asthma 
The asthma dataset contains 24 asthma patients and 10 healthy controls aged 18-75 were 
recruited at the respiratory outpatient clinics of the Churchill Oxford University Hospital, UK. 
The study received ethical approval, and written informed consent was obtained. After inclusion 
patients filled out symptom questionnaires, sputum induction was performed, blood was taken, 
and patients underwent FeNO measurement and lung functional testing. All patients were 
receiving appropriate asthma treatment at the time of blood withdrawal. Blood cells were 
stained with a panel of 8 antibodies including CD3, CD4, CD8, CD14, CD16, CRTH2 (CD294), 
CD123 and CD193. After staining, red blood cells were lysed using a FACS Lysing solution 
(Becton Dickinson). Cells were measured on a LSR Fortessa flow cytometer (Becton 
Dickinson). 
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Four levels 
The leukocyte map, together with the prediction scores quantitatively connect all four 
information levels within MFC data. The associations between the co-expressions of different 
markers can be evaluated from the Base model loadings 𝐏base (level 1). The cells for which 
these related markers are most prominently over or underrepresented can be observed from the 
interpretation of 𝐖𝐭𝐨𝐩. From the latter, co-varying bins in the histograms 𝐇𝑖𝑔can aggregate in 
regions, which may correspond to cell populations (level 2). The degree to which an individual 
respond to the entire contrast 𝐖𝐭𝐨𝐩 can be found by superimposing the histogram 𝐇𝑖𝑔 (Level 
3). Whether the haematological map in fact represents a specific clinical phenotype can be 
determined from the classification (i.e. sensitivity and selectivity) of these scores (Level 4). 
Principal Component Analysis (PCA) as top model 
Instead of a classification, the Top model can also be an ordination to explore the heterogeneity 
in a more unsupervised fashion; the model in equation 7 can then be replaced by a PCA model 
that provides descriptive rather than predictive scores 𝐓top,PCA . The loadings of these 
components are then however less intuitively interpretable, because they are not directly related 
to a classification between groups. However, it is possible to define a line in the PC space and 
to project the loadings onto this line, in order to see the difference between control and case 
clusters or completely different observed clusters. This is quite tedious work as you have to 
subjectively define the line and for every line you get a different map. 
Quantitative analysis of the variability between the histograms in a Top PCA model shows that 
the major variability across the histograms occurs between those of controls and of challenged 
individuals, as seen in Figure s8. Secondly, the variability in surface marker expression across 
control individuals is larger than that between case individuals. Thirdly, three control 
individuals deviate strongly from the other five control individuals as well as from the 
challenged individuals; a similar yet less-pronounced heterogeneity is observed between two 
clusters of challenged individuals. 
The Top PCA however lacks in two aspects: Firstly, the separation is based on maximum 
variability between all individuals; the distinction between challenged individuals and controls 
can only be observed if the immune response is considerably larger than the variability in 
surface marker expression between individuals. Secondly, if the Top PCA shows a distinction 
between scores of challenged individuals and controls, the response can only be characterized 
through a linear combination between two Principal Components, as seen in Figure s9 and s10. 
Figure s11 shows the Top PCA model for the asthma dataset and shows some grouping between 
the individuals but no distinction between the asthma and controls. Figure s12 shows a great 
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distinction between the top PCA scores of controls and AML patients, however, no clear 
objective line can be defined to separate all the controls from the all AML patients. 
 
Figure s8: Top PCA score plot. Each red round represents a control and each blue cross a 
LPS-responding individual. Four cluster can be found and are shown with a black convex hull. 
The red-blue line is the direction from mean of the two control clusters, depicted in red, to the 
mean of the two LPS-responding clusters, depicted in blue. The magenta-cyan line is in the 
direction from mean of the top control and top LPS-responding clusters, depicted in magenta, 
to the mean of the bottom control and bottom LPS-responding clusters, depicted in cyan. 
 
Figure s9: Shows the linear combination of loadings from the top PCA model seen in Figure 
s8. This is based on the red-blue line, observed in Figure s8, in the direction from mean of the 
two control clusters, depicted in red, to the mean of the two LPS-responding clusters, depicted 
in blue. The loadings of the Base model are plotted on top as black vectors and indicate how 
each surface marker contributes to the cell variability in a specific direction within the model. 
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Figure s10: Shows the linear combination of loadings from the top PCA model seen in Figure 
s8. This is based on the magenta-cyan line, observed in Figure s8, in the direction from mean 
of the top control and top LPS-responding clusters, depicted in magenta, to the mean of the 
bottom control and bottom LPS-responding clusters, depicted in cyan. The loadings of the Base 
model are plotted on top as black vectors and indicate how each surface marker contributes to 
the cell variability in a specific direction within the model. 
 
 
Figure s11: Top PCA score plot. Each red round represents a control, each cyan triangle 
represents a mild asthma patient and each blue cross a severe asthma patient. Three clusters 
can be found and are shown with a black convex hull. 
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Figure s12: Top PCA score plot of AML data. Each red round represents a control and each 
blue cross an AML patient. 
Multidimensional smoothed histograms; illustrated with the HIV vaccine trial network 
data 
Acknowledgement for Paul Eilers, who helped with the multidimensional histogramming. 
Introduction 
The DAMACY algorithm was also tested on HIV vaccine trial network data (HVTN) of the 
FLOWCAP II challenge. However, the algorithm only performed with a classification accuracy 
of 91%. In order to improve the accuracy the base model was built with 3 PCs. The 
histogram/smoothing algorithm described by Eilers and Goeman was adapted in order to create 
multidimensional histograms.[2] 
 
HIV vaccine trial network data (HVTN)-In this experiment 48 individuals were given an 
experimental HIV vaccine. After 10 months, samples were collected and each sample was 
divided over five vials. In two vials T-cells were challenged with two antigens (ENV-1-PTEG 
and GAG-1-PTEG). The FLOWCAP II challenge was to discriminate between those two 
antigens. In another vial an antigen was added, which is known to produce a cytokine response 
(positive control). The remaining two vials were used as a negative control and nothing was 
added. The data consists of 5×48 flow cytometry measurements and was gated for only single, 
live lymphocytes. The following variables were measured in each tube: area and height of 
forward scatter, area of sideward scatter and 8 surface markers; CD4, ViViD, TNFa, IL4, IFNg, 
CD8, CD3, IL2 and each sample contained 40,000-350,000 cells. 
 
HVTN adapted methods 
The centring and scaling was based on the data of the negative control tubes. The models were 
built on the training set provided by the FLOWCAP II challenge. A 3-D histogram was built 
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and the number of bins per dimension was 63, so the total number of bins was close to the 
number of 2-D histograms, i.e. 250 thousand bins. Smoothing was performed by first unfolding 
the histogram 𝐇𝑖𝑔 in one dimension to matrix 𝐂𝑖𝑔  with size (𝐹𝑘 × 𝐹
𝐾𝑏𝑎𝑠𝑒−1 ) and apply 
smoothing function seen in equation s5, refold back to original dimension of histogram 𝐇𝑖𝑔 and 
repeat for the other dimensions until smoothing was applied into every dimension. 
(s5) (𝐈 + 𝟐 λ𝐃𝟏
𝐓𝐃𝟏 + λ
2𝐃𝟐
𝐓𝐃𝟐) Ĥ𝑖𝑔 = 𝐇𝑖𝑔 
with 𝐈 being the identity matrix, for matrix 𝐃1 holds that 𝐃1𝐇 = ∆𝐇 and for matrix 𝐃2 holds 
that 𝐃2𝐇 = ∆
2𝐇, λ is the smoothing factor, this equation results in smoothed histogram Ĥ𝑖𝒈 of 
size (∏ 𝐹
𝐾𝑏𝑎𝑠𝑒
𝑘𝑏𝑎𝑠𝑒=1
). 
HVTN results 
The HVTN dataset only performed with 91 % accuracy when histograms of the first two PCs 
were used. At least three PCs were needed to get an accuracy of 100 %. By choosing 3 PCs, 45 
% of the total variance is being explained by the PCA model (PC1= 21 %, PC2=13% and 
PC3=11 %). 
 
After vectorization of the 3-dimensional histograms an OPLS-DA model was built as illustrated 
in Figure s13. At the left side, the prediction of each sample can be seen. At the right side, three 
plots show, which area is important for the GAG (blue area) and which is important for the 
ENV (red area). Only two dimensions can be plotted against each other, therefore each point 
plotted contains the information of the bins in the other dimension. 
 
Figure s13: On the left are the individual prediction scores and on the right is the 
immunological cell map. If the other dimension only contains negative values the bin is colored 
blue. If the other dimension only contains positive values, the bin is colored red. If the other 
dimension contains both negative and positive values, the bin is colored purple. 
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The training set consists of almost 38 million cells, this is probably why three PCs were needed 
to adequately describe the data and to discriminate between GAG and ENV. The HVTN dataset 
showed the best results for the first three PCs. Other combinations of two or three principal 
components would lead to a lower accuracy. The HVTN dataset scored a 100% accuracy, which 
was comparable with other methods. The DAMACY algorithm works with more PCs, however, 
the resolutions drops as the number of bins per dimension is lower. Moreover, not a single map 
is obtained, where the PCs are plotted against each other, but multiple maps for each 
combination of PCs used. Nevertheless, the DAMACY maps show the marker expression, 
which other multivariate methods fail to show or need to create a separate figure for each 
marker. 
Analysis of LPS data with ViSNE 
ViSNE analysis was performed on the LPS data using the Matlab GUI cyt. The data was 
subsampled to contain 1,875 cells in each sample, so the total amount was 30,000 as was 
optimal according to Amir et. al.[3] First the analysis was performed using the preprocessing 
in the GUI and the result can be seen in Figure s14. In the lower left corner are mostly cell 
corresponding the LPS responders and correspond to CD62L-CD16+CD69+CD11b+ cells, 
which were also found by DAMACY. However, it seems that all cells per individual are cluster 
together. In the second analysis we performed ViSNE based on our way of preprocessing. In 
Figure s15 can be seen that no longer cells are clustered together per individual. The same cell 
cluster of LPS individuals can be found here in the lower right corner. A new cell cluster 
appears, which contain CD32- cells, but they seem to both present in controls and in LPS. 
 
Figure s14: ViSNE analysis performed using the preprocessing built in cyt. In the upper left 
panel are the cells colored red for controls and cyan for LPS. The cells of other panels are 
colored based on their logarithmic marker intensity. 
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Figure s15: ViSNE analysis performed using the preprocessing built in cyt. In the upper left 
panel are the cells colored red for controls and cyan for LPS. The cells of other panels are 
colored based on their logarithmic marker intensity. 
Analysis of LPS data with Citrus 
Citrus analysis was performed on the LPS data using the R GUI.[4] The data was subsampled 
to contain 1,875 cells in each sample, so the total amount was 30,000. First the analysis was 
performed using the pre-processing of the R GUI. The model misclassified 1 sample and the 
discriminating clusters can be seen in Figure s16. Cluster 29983 and 29992 explain the 
CD62L+CD16- cells and cluster 29998 the CD62L-CD16+CD11c+CD69+CD11b+ cells. 
These cells were also found by DAMACY, as seen in Figure s2 and s3. In the second analysis 
our preprocessing strategy was applied and lead to a perfect classification, however only the 
CD62L+CD16- population was found. 
 
Figure s16: The histograms per marker of the most discriminating clusters. 
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Figure s17: The histograms per marker of the most discriminating clusters. 
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Multicolour flow cytometry (MFC) is used to measure multiple cellular markers at the single-
cell level. Cellular marker may be coloured with different panels of fluorescently-labelled 
antibodies, either aimed at cell identification or for detection of activated cells in pre-defined, 
‘gated’ specific cell subsets. However, the number of markers per measurement is 
technologically limited, which requires every panel to be analysed in a separate aliquot 
measurement. Combined analyses of these dedicated panels may enhance predictive ability of 
these measurements and can enrich the interpretation of the immunological information. We 
introduce here a fusion method for MFC data, based on DAMACY (Discriminant Analysis of 
Multi-Aspect Cytometry data), that may also combine information from complementary panels. 
We show how this approach both leads to enhanced predictions and to interpretation compared 
to analyses of the separate measurements. We illustrate this method on two datasets: the 
response of neutrophils evoked by systemic endotoxin challenge and the activated immune 
status of obese versus lean individuals in innate cells, T and B cells. The data fusion approach 
was able to detect cells that on themselves do not describe a difference in clinical phenotype 
but in combination with other cells do play a role. 
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Introduction 
Multicolour flow cytometry (MFC) is a powerful analytical platform that is used to measure 
multiple cellular markers at the single-cell level. Samples may contain a very large number of 
cells (>10,000). Certain cells or cellular activation states with specific combinations of cellular 
marker expressions may be discriminative for an immune response. However, the number of 
cellular markers per MFC measurement is technologically limited, because of the spectral 
overlap between the fluorescent dyes This limitation may reduce the cellular diversity found 
within a sample, as several studies reveal that simultaneously combining more markers leads to 
a more detailed view of the immune system in which more cell variability may be discerned.1 
 
Ideally you want to measure the complete cellular heterogeneity with single cell Omics2. Cells 
with specific marker expression that are not predictive by themselves may support predictions 
based on other cells, through the covariance between the cell presence. Subsequently, the 
multivariate data analysis method should only highlight all the relevant cellular variability for 
the studied clinical phenotype. A single cell (sub)type may not describe the whole system and 
the complete cellular variability may mask the important variability for the studied clinical 
phenotype. Moreover, the approach should ideally be data driven to find not only the cells that 
you are looking for as in hypothesis driven research, but also new yet unknown cell (sub)types 
for the studied clinical phenotype. 
To increase the number of measured parameters beyond the technical limitations of a given 
MFC setup, additional markers could be measured in multiple aliquot measurement of different 
panels. Methods exist to integrate the non-measured marker variability in all measured aliquots 
on basis of overlapping markers. However, this implies that all panels characterize mainly the 
same cells. However, experimental research is often aimed at investigating different cell types 
and their activation sate. These complementary cell types may interact upon an immunological 
response, which is the specific biomedical information of interest. Measuring different cell 
types on the same sample is often achieved by using distinct panels for each blood aliquot. For 
this reason, we focus in this article on methods that describe the cell characteristics within a 
panel and use these descriptions of each panel together to classify immune responses from 
controls. 
Existing methods use one of the following three approaches. The first approach is to cluster the 
cells using for example kmeans or manual sequential bivariate gating and to create a distribution 
of each sample over these clusters.3 The second way is to extract important features from each 
marker in each panel, such as mean, standard deviation and skewness, for example admire-lvq.4 
The drawback of the first and second way is that the quantitative single-cell marker expression 
is lost. Interpretation of the data is then limited. The third approach creates 2D histograms of 
each pair of markers. Interpretation is possible in the third way, but tedious as there are many 
pairwise combinations of markers.5 
One of our recently developed methods called DAMACY visualizes the over- and 
underrepresented cells in an immune response measured in a case-control experiment.6 The 
method first creates a multidimensional histogram for each sample within a low-dimensional 
Principal Component space. These histograms are then quantitatively compared in a second 
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step between individuals using the discriminant analysis method Orthogonal Partial Least 
Squares Discriminant Analysis (OPLS-DA). OPLS-DA translates the histograms into a ‘cell 
map’ in which the multivariate marker expression can be associated with differential expression 
of cells, which are represented as a contrast. The main advantage is that the original marker co-
expressions may still be observed from this cell map and can be associated to the specifically 
differentially expressed cells and to the diagnosis of the specific sample in which the cell is 
found. 
The DAMACY original implementation focused on single panel experiments. However, the 
second step of quantitative comparison of different histograms allows with relatively small 
adjustments to integrate the data from multiple panels measured on the same samples.6 We 
extend the discriminative step of DAMACY with a fusion of data from different measured 
aliquots to discern groups of samples based on the covariance between cell populations they 
express within each panel, , and the relationships between the cell populations within different 
panels. This may enhance predictive ability compared to analysis of single panel because of the 
‘multivariate advantage’7, the former group of cells are then essential constituents in the 
mechanisms that allow diagnosis but would be otherwise overlooked in a model fitted on all 
cells within a single aliquot. This data fusion approach may thereby also enhance the 
interpretation of the diagnosis, by associating a larger variability of cells to the immune 
response. This method of data fusion will bring flow cytometry considerable closer to a single-
cell omics, where the full complement of cells may be included in a diagnosis and associated 
mechanistic interpretation. 
  
62 
 
Results 
We demonstrate fusion with DAMACY using two case studies. The first dataset on the in vivo 
effect of lipopolysaccharide (LPS) on gated blood neutrophils and consists of three different 
measured aliquots. The second dataset, to study the effect of obesity on the immune system 
measuring two different aliquots, where we could define three distinct subsets: T cells, B cells 
and innate cells, see methods. 
Lipopolysaccharide challenge 
Intravenous administration of lipopolysaccharide (endotoxin) elicits an immune response that 
mimics systemic inflammatory response syndrome in humans (SIRS). Upon an LPS challenge, 
three neutrophil subsets are found in the peripheral blood, which can be characterized by 
different expressions of CD16 and CD62L, together with the co-expression of other surface 
markers. All three panels contain the marker CD16 and CD62L and a set of different markers 
to study co-expression of markers in an inflammatory response. 
The aliquots separately have a decent prediction accuracy of 98-100%. The fusion model 
performs with 100% cross-validated accuracy, as shown in Table 1. The predictions of 
individual fused samples are shown in the left panel of Figure 1, which indicates a relative 
severity of the LPS response among all modelled samples, higher meaning more severe. The 
three right panels show which areas, in the PCA spaces of the different measured aliquots that 
contain cells that are predictors for LPS (blue) or control (red). The second panel shows mature 
neutrophils (CD62L+CD16+) associated with control individuals and immature neutrophils 
(CD62L+CD16−) and CD62L−CD16+ neutrophils both associated with LPS responders. Also, 
in the first and third aliquot these immature CD62Llow neutrophils can be found. The immature 
neutrophils have dim expressions of most markers but do have a relatively high expression of 
CD64. The mature neutrophils present in the control samples show a higher (co)-expression of 
CD181, CD182, CD88 and TLR-4. The LPS-associated mature neutrophils have a higher (co)-
expression of PDL-1, CBRM1/5, LAIR-1, CD32, CD49d, CD11b and CD66b. Another small 
subpopulation associated with control individuals can also be found within aliquot 2 and 3, but 
masked due to the VIP, see supplementary Figure 1. This subpopulation has a similar expression 
as the LPS-associated mature neutrophils, but has a higher expression in CD11b, CD11c, CD32, 
CD35, CD49d, CD66b and CD182. In some individuals this subpopulation is more present in 
control measurement while in other individuals more present in the response, which would 
explain the lower prediction specificity in the second and third aliquot. 
Table 1: Cross-validated performance of the models on each dataset and the fusion of all three 
datasets. 
 Accuracy Sensitivity Specificity 
Aliquot 1 100% 100% 99% 
Aliquot 2 97% 98% 97% 
Aliquot 3 97% 100% 94% 
Fusion 99% 100% 99% 
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Figure 1: Fusion model of all the LPS aliquot after variable selection. The left panel shows in 
blue the LPS responder individuals and in red the controls. If the predicted value is above the 
threshold, the individuals are classified as LPS responder. The three right panels show the 
weights of the model of respectively aliquot 1,2 and 3. Positive weights are colored blue and 
belong to cells more represented in LPS responders, negative weights are colored red and 
belong to cells more present in controls. 
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Effect of obesity on the immune system 
In this study we wanted to see the difference in circulating immune cells between obese and 
lean individuals, based on the markers we measured in multiple aliquots. Discriminant models 
were built separately for each aliquot as shown in Table 3. The model built on the innate cells 
and on the T cells is well able to discriminate obese from lean individuals (75% and 79%), 
compared to the model built on the B cells which had a lower prediction accuracy of 71%. The 
fusion model does improve in classification (1.5%) and does show weights for the B cell data. 
The innate cells show a large increase compared to a model made on B and T cells, which 
suggests that these cells describe unique variance to predict obesity compared to the B and T 
dataset. The B cell only had a minor contribution, although in combination with T cells and 
innate cells they do support the discrimination between obese and lean individuals. 
To further evaluate the importance of the weights of the fusion model, we used Variable 
Importance on Projection (VIP) to select those cellular subsets important for discriminating 
between lean and obese individuals (VIP > 1). Based on this quantitative criterion we found ten 
relevant cell populations for discriminating lean versus obese, shown in Figure 2 and 
summarised in Table 4. The marker expressions of these cells observed in the histograms 
(loadings) are confirmed by gating the areas in Figure 2 and plotting the single-marker 
histograms, see supplementary materials. Obese individuals have more activated B cells (high 
in CD25 and CD45RO expression), more activated CD4+ T cells (high in CD25, CD45RO and 
CD127expression), more activated NK, classical monocytes and non-classical monocytes 
(higher in CD11b, CD11c and CX3CR1 expression) compared to lean individuals who have 
more B cells and T cells high in CD38 expression, more non-activated NK cells, classical 
monocytes (lower in CD11b, CD11c and CX3CR1 expression). Lean individuals also have 
more cells that have a low to absent expression of the measured markers, which may be 
plasmacytoid dendritic cell (pDCs, characterized by a low expression of CD11b and CD11c). 
As seen by the blue and red contours some cell populations are not discriminating between 
obese and lean individuals which include: CD38−IgD+ B cells, B cells with very high CD38 
expression, CD8+CD4− cells, (non)-activated intermediate monocytes and non-activated non-
classical monocytes as well as a cell population which is negative for all markers. 
Table 2: Performance of the DAMACY models on each dataset and the fusion of all three 
datasets. Accuracy depicts the percentage of correctly classified samples in the cross 
validation, sensitivity the obese samples and specificity the control samples. The p-value is the 
relative amount of higher prediction accuracies found after permutation. The %increase shows 
how much the accuracy would increase if that dataset is included in the data fusion model 
compared to a fusion model with only the two other datasets 
Dataset Accuracy Sensitivity Specificity p-value %increase 
B cells 71% 80% 59% <12/1000 1.5% 
T cells 79% 86% 70% <1/1000 4.5% 
Innate 75% 75% 75% <9/1000 11.8% 
Data Fusion 80% 82% 78% <2/1000  
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Figure 2: Fusion model after variable selection. The left panel shows with blue crosses the 
obese individuals and with red circles the controls. If the predicted value is above the threshold, 
the individuals are classified as obese. The three right panels are the weights of the model of 
respectively the B cell, T cell and monocyte dataset. Areas colored blue belong to cells more 
present in obese and areas colored red belong to cells more present in lean individuals. The 
blue contours show where on average 80% of the cells of the obese individuals lie and the red 
contours of the lean individuals. 
Table 3: Cell populations found in Figure 2. The expression of the markers are summarized in 
5 different levels going from lowest to highest: −, dim, dim+, +, ++. 
Dataset Letter Cell type Marker expression More present in 
B cells A B cells CD38++CD45RO−CD25−CD127− Lean 
B cells B B cells CD38+CD45RO+CD25+CD19++CD12
7dim 
Obese 
T cells C CD4+CD8
− 
CD38+CD45RO−CD25−CD28+CD3+
+ 
Lean 
T cells D CD4+CD8
− 
CD38−CD45RO+CD25+CD127+CD28
++CD3+ 
Obese 
Innate E NK cells CD56+CD16+CD14−HLADR−CD11bd
im 
CD11cdimCX3CR1dim 
Lean 
Innate F NK cells CD56++CD16++CD14−HLADR−CD1
1bdim+ 
CD11cdim+CX3CR1dim+ 
Obese 
Innate G Classical 
monocytes 
CD56−CD16−CD14+HLADR+CD11b
+ 
CD11cdim+CX3CR1dim 
Lean 
Innate H Activated 
classical 
monocytes 
CD56−CD16−CD14+HLADR++CD11
b++ 
CD11c+CX3CR1+ 
Obese 
Innate I Activated 
non-
classical 
monocytes 
CD56−CD16++CD14dimHLADR++CD
11bdim+ 
CD11c++CX3CR1++ 
Obese 
Innate J pDCs? CD11cdimCD11bdim+, rest negative Lean 
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Comparison with other methods 
Table 5 shows the performance of different methods on discrimination between lean and obese 
individuals. The combination of describing the cellular distribution with self-organizing maps 
(SOM) and support vector machines (SVM) as classifier is even slightly better than the fusion 
with DAMACY. However, interpretation of the model results is considerably more challenging, 
as SOM + SVM resulted in three times 100 nodes which almost all seem to be important for 
the discrimination, as seen in Figure 3. Citrus circumvents the interpretation issue of having too 
many nodes by putting a lasso regularization on the regression coefficients which results in only 
a few nodes important for the discrimination. However, in the double cross validation the 
combination of SOM + Lasso regularized logistic regression did not seem to perform well in 
terms of accuracy but did have a significant model according the p-value. This is probably 
because the number of variables (nodes) for classification is drastic reduced and cannot capture 
the heterogeneity of both classes. Furthermore, the combination of OPLS-DA and SOM did not 
perform well, but OPLS-DA did perform in the DAMACY algorithm. The histogram bins close 
to each other are highly correlated because of the smoothing step and OPLS may take advantage 
of these correlations. The DAMACY base model did not perform well with SVM as classifier, 
which is probably overfitting with the many correlated variables (bins) and this also caused a 
problem with lasso regularized logistic regression which could not converge. Admire-LVQ did 
not perform well, which may be caused by the feature extraction of every single marker which 
misses the multivariate advantage, as it cannot find activated NK cells 
(CD11bdimCD56+CD16+) but does find a high kurtosis of CD127 in T cells of obese 
individuals. To conclude, both fusion with DAMACY and SOM + SVM perform well in terms 
of prediction accuracy, however, fusion with DAMACY has easier interpretation as seen in 
Figure 2 and Table 4 but may miss information which is present in the complicated Figure 3 of 
SOM + SVM. 
Table 4: Performance of the different methods on all three datasets of the lean versus obese 
model 
 Accuracy Sensitivity Specificity p-value 
Fusion with DAMACY 80% 82% 78% <2/1000 
SOM15 + SVM18 81% 66% 94% <1/1000 
DAMACY base6 + SVM18 77% 83% 71% <1/1000 
Admire-LVQ4 73% 75% 71% <13/1000 
SOM 15+ Lasso regularized logistic 
regression18 
73% 73% 74% <3/1000 
SOM15 + OPLS-DA19 71% 66% 77% <14/1000 
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Figure 3: Self-organizing map of respectively dataset B cells, T cells and innate cells. The 
relative marker expression of a node is depicted as a pie chart. Blue shade behind the node 
contain more cells in obese individuals and the red shade contain less as predicted with SVM. 
 
Discussion 
The data fusion extension of DAMACY shows an increase in predictive and interpretative 
capability compared to separate analyses of different measured aliquot. The analysis of the LPS 
dataset did not have an increase in prediction but showed in aliquot 2 that the marker CD64 
resulted in a clear separation between two LPS-associated neutrophils whereas the other two 
aliquots showed a continuum. The fusion guaranteed that the found cellular signature is 
significant across all measured aliquots and was less influenced by a non-discriminating cell 
subtype in aliquot 2 and 3. In the obesity versus lean dataset we do see a significant 
improvement in prediction, although some individuals are still misclassified. The 
misclassification may be because those individuals are either not affected by obesity in the same 
way as the other individuals or their immune system is affected by something else than obesity. 
Interestingly, B cells on their own were marginal significant different between obese and lean 
people but do enhance the prediction in combination with specific T cells or innate cells. 
Variable Importance on Projection (VIP) provide a quantitative identifier for cells that are 
important for the prediction. The VIP is calculated based on the weights of the final (O)-PLS 
model. Another way is to apply sparsity at the same time as building the model as is used in the 
lasso regularized logistic regression. However, this may not be sufficient to model the 
comprehensive biological change in the clinical phenotypes. The combination of fusing the 
histograms of the PCA models of the different measured aliquots with applying VIP may give 
a better view on all relevant components of the immune response you could find with the 
markers that are measured. The better view is caused by showing a map for each aliquot with 
only the relevant cells highlighted for either the control or the case and on top the original 
marker contribution as loadings of the PCA model. 
Previous hypothesis driven analysis of the lean versus obese dataset with sequential 2-D gating 
in combination with univariate testing8 found the same findings as the DAMACY analysis, i.e. 
a higher CD11b expression on classical monocytes, a higher CX3CR1 expression on non-
classical monocytes and relatively higher amount of NK cells in obese people. Moreover, the 
hypothesis driven analysis also found a higher CD11b expression on intermediate monocytes, 
which were not found discriminative in the DAMACY because they were not highlighted after 
68 
 
VIP correction in the DAMACY analysis: the full data did not contain sufficient power to 
indicate these cells as significant contributors to prediction. The hypothesis driven analysis 
failed to find any significant changes in the B and T cells, which may be because the cells are 
not significant different between lean and obese on their own, such as the CD25+CD45RO+ B 
cells (p-value 0.0555), but only in combination with other cells. Another reason could be that 
the specific subset was not tested such as the increased amount of CD25−CD45RO– B cells (p-
value .0024) CD4+CD38−CD45RO+CD25+CD127+ T cells (p-value 8.3e-4) and the 
decreased amount of CD4+CD38+CD45RO−CD25−CD127− T cells (p-value 0.0011) in obese 
individuals. For this reason, to study yet unknown relations between cells, a data driven 
approach is better suited as it will find all specific cells that are significant more or less in the 
studied clinical phenotype compared to hypothesis driven research which will only find the 
significant specific cells that are tested. 
Multivariate analysis methods observe the expression of all markers on all cells for every 
patient. Importance of cells within the model is then determined by (1) their marker expression 
related to an immune response under study or (2) co-occurrence with other cells. ‘Standard 
multivariate methods’, including SVM, SOM, PCA, PLS, provide a readout of the relative 
importance of every cell in the model. This leads to a data-dense representation (see e.g. figure 
3) from which the dedicated immunological information may be challenging to interpret. 
Sparse methods, like lasso regularized logistic regression as used in citrus, have been developed 
to specifically provide descriptive models for an immune response that involve as few different 
cell types as possible. The resulting minimal set of cells will be much easier to interpret than 
results from the ‘standard methods’, but it will not contain the comprehensive set of cells 
involved in the response. Immune responses may consist of highly specific mechanisms but 
may also involve generic mechanisms such as normal inflammatory markers that may be 
induced for many more different immune responses; both aspects are redundant in their 
involvement with the response. Sparse models do not distinguish between the specificity of 
such patterns in a binary comparison, such that strongly responding but highly generic cells 
may be discovered as most characteristic for a studied response. Secondly, and most 
characteristic in our study is that the sparsity criterion may select different redundant cells for 
different realisations within the double cross validation. 
The desired set from a comprehensive cell characterization would be only the relevant 
comprehensive subset for the response. DAMACY, specifically involving OPLS as top model 
is among the described methods the most appropriate for this. The method is data-driven, thus 
may also find the unexplored relations between (sub)types of cells and the studied response. 
OPLS removes the orthogonal information and together with VIP only shows relevant cellular 
variability. Finally, complementary cell data may be merged in a multiblock sense and may be 
extended also to clinical or other omics data. The set of cells resulting from DAMACY may 
then be seen as all cells of which the involvement may be significantly identified. This may be 
compared to the objective of metabolomics that (1) aims to measure all small organic 
metabolites and then (2) tries to find all chemical species that are involved in a studied 
biological process. Analogously, the cell set resulting from DAMACY will be optimally 
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informative for further immunological studies on the variability of and mechanisms underlying 
the studied response. 
Conclusion 
The data fusion extension of the DAMACY method can be used to effectively discriminate 
clinical phenotypes for flow cytometry data with multiple aliquot measurements of different 
panels. The method will use correlations between cell subtypes and give a cell map for each 
aliquot with only the relevant cells highlighted for discriminating between the clinical 
phenotypes. The original marker (co)-expression is plotted on top of the map as vectors. In this 
way you can easily see which cells are important for the clinical phenotypes and their (co)-
expression. The data fusion method will perform equally well or better than the best DAMACY 
model on a single aliquot as statistically tested with double cross validation and permutation 
testing. 
  
70 
 
Materials and Methods 
Data 
Subjects in both the LPS challenge study and obese versus lean study gave peripheral blood. 
All data were obtained by using standardized protocols. The LPS challenge study and sample 
collection were approved by the medical ethics committee of Radboud University Medical 
Center (RadboudUMC), the Netherlands and these participants gave their written informed 
consent. The study protocol of the obese versus lean data was approved by the Medical Ethical 
Committee Jessa hospital, Hasselt, and Hasselt University, Belgium, in accordance with the 
Declaration of Helsinki, and all subjects gave their written informed consent before 
participating in the study. 
LPS data 
In total 16 individuals were measure before and after 180 minutes of administration of LPS. 
Three aliquots containing the following markers were measured: 
Aliquot 1: CD182, CD181, CD62L, CD66b, PDL-1, LAIR-1, CBRM1/5, CD11b, CD54, 
CD16; 
Aliquot 2: CD35, TLR-4, CD62L, CD11c, CD49d, CD32, CBRM1/5, CD11b, CD64, CD16; 
Aliquot 3: CD88, CD181, CD62L, CD66b, CD49d, CD182, CD11b, CD16 
The data was gated on neutrophils using forward, sideward scatter and CD16 expression using 
standard protocol. 
Obesity versus lean data8 
In total 31 individuals were measured, 13 lean with Body mass index (BMI) in the range 
between 20.83 and 25.62 and 16 obese with BMI between 30.47 and 49.27. Two aliquots 
containing the following markers were measured: 
Aliquot 1: CD38, CD4, CD45RO, CD127, CD28/IgD, CD25, CD8/CD19, CD3 
Aliquot 2: CXRCR1, CD14, CD56, CD11c, CD16, HLA-DR, CD3/CD19/CD66b 
Aliquot 1 contains specific antibodies for B cells and T cells on the same fluorophore and was 
split to simplify interpretation of the analysis by gating the data for B cells (CD19+CD3−) and 
T cells (CD3+), the gated data contained the following markers: 
B cells: CD38, CD45RO, CD127, IgD, CD25, CD19 
T cells: CD38, CD4, CD45RO, CD128, CD28, CD25, CD8, CD3 
Aliquot 2 was gated on innate cells by removing all cell positive for markers CD3, CD19, 
CD66b 
Experimental method 
In this paper we compare the fusion of the histograms in DAMACY with the prediction with 
extracted features in Admire-LVQ4 and with the approach where we first cluster the data using 
self-organizing maps (SOM) and subsequently apply classifiers such as OPLS-DA, support 
vector machine (SVM) and lasso regularized logistic regression. We choose SOM, because it 
is proven to be a very effective clustering method in both describing the data and in terms of 
speed9,10, which is needed to effectively cross validate the algorithms. SVM was proven to be 
a success in the Flowcap 2 challenge5 and the lasso regularized logistic regression is successful 
in Citrus11. We compare both the prediction performance as the interpretation of the data 
visualization. 
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Cross validation and permutation 
The data was split into a training and test set using fivefold cross validation and fifty iterations. 
The data was thus stratified randomly split into five parts and four of the five parts were used 
to train each model on and the left-out part was used to assess the model performance, this was 
repeated such that all parts were once used to assess the model performance. The stratified 
random splitting into five parts was repeated fifty times.12 The composition of the training and 
test sets were stored and reused to assess the performance of each method, resulting into a fairer 
comparison between the methods. Orthogonal Partial Least Squares (OPLS) had an inner leave 
one out cross validation to determine the number of orthogonal latent variables and lasso 
regularized logistic regression had an inner tenfold cross validation to determine lambda.13 
Permutation testing was applied to see if the models built predict an actual effect or random 
effect. The labels were randomly permuted a thousand times and models were built to classify 
the random effects. In OPLS the same number of orthogonal latent variables were used as the 
model and in lasso the same lambda, so that an inner cross validation loop was not needed. A 
p-value can be calculated by counting the number of times the accuracy of a random effect is 
equal or higher than the accuracy of the studied effect and dividing by the total number of 
permutations, which is in our case 1000, see equation 1.13 
Equation 1 
𝑝 <
∑(𝑎𝑐𝑐𝑢𝑟𝑎𝑐𝑦𝑝𝑒𝑟𝑚𝑢𝑡𝑎𝑡𝑒𝑑 ≥ 𝑎𝑐𝑐𝑢𝑟𝑎𝑐𝑦𝑚𝑜𝑑𝑒𝑙) + 1
1000
 
 
Pre-processing of the data 
The data of each aliquot measurement was transformed using the hyperbolic inverse sine with 
cofactor 150. In the case of obese versus lean, the data was transformed with median centering 
using the median marker expression of all the lean individuals from the training set and 
subsequently scaled by dividing every marker with the standard deviation of that marker of all 
the lean individuals from the training set. In the case of the LPS dataset, each measurement was 
centered and scaled using the median and standard deviation of each individual of both the 
measurements before and after LPS. 
Adaption of DAMACY 
After pre-processing, a Principal Component Analysis (PCA) model was built on the 
concatenated training data and all individuals were projected into the principal component 
space. A 2-D histogram was calculated on the PCA scores of each aliquot as described in the 
original DAMACY paper6 and summarized in supplementary material. Each histogram of each 
aliquot is smoothed and normalized to unit sum of all bins. Then, the unfolded histograms of 
each aliquot were concatenated into one large matrix, see equation 2. 
Equation 2 
𝐇 = [
𝐇1,1,1 ⋯ 𝐇1,𝐹2,1  ⋯ 𝐇1,𝐹2,𝑀
⋮ ⋱ ⋮ ⋱ ⋮
𝐇𝐼,1,1 ⋯  𝐇𝐼,𝐹2,1 ⋯ 𝐇𝐼,𝐹2,𝑀
] 
Where 𝐇𝑖𝑓𝑚  is a bin 𝑓  in the unfolded histogram 𝑚  of individual 𝑖 =  1… 𝐼 , 𝐼  is the total 
number of individuals, 𝑓 =  1…𝐹2 , 𝐹  is the total number of bins in one dimension of the 
histogram, default value used is 𝐹 = 500, but in this article 100 bins were used, because the 
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number of cells per sample was relatively low (<10,000) and the histogram of aliquot 𝑚 =
 1…𝑀, 𝑀 is the total number of different measured aliquots. 
The large matrix 𝐇 was mean centered using the mean of the training set. An orthogonal partial 
least squares discriminant analysis (OPLS-DA) model was built using the training data of 𝐇 
and the logical dummy vector with length 𝐼∗ , where 𝐼∗  is the number of individuals in the 
training data. Finally, a prediction score ?̂? is calculated for each individual in the test set. The 
whole algorithm was repeated until every iteration of the training set matrix was used. This 
leads to fifty values of ?̂? for each individual. The mean value was plotted as the mean prediction 
score. Then a final model is built on all samples giving the weight vector 𝒘𝑡𝑜𝑝 which can be 
refolded into an (𝐹 × 𝐹 × 𝑀)  matrix 𝐖𝐭𝐨𝐩 , when the number of principal components is 
𝑲𝐛𝐚𝐬𝐞 = 2 in the base model. This corresponds to the original 𝑀 histograms 𝐇𝒊𝒎, forming a 
leukocyte map for each aliquot, see Figure 1 and 2. This map shows which histogram bins, 
hence which cells, are over- or underrepresented in either group and can be interpreted together 
with the mean predictive scores of ?̂?. Each single cell increases the individual score positively 
or negatively, when it ends up in a positively or negatively weighted bin in the leukocyte map. 
After the building the OPLS-DA model, the variable importance in projection (VIP)14 may be 
calculated for each bin weight, using equation 3. Weights (Histogram bins) that had a VIP lower 
than one were set to zero. The weights with a VIP higher than one are the histogram bins that 
contribute significantly to the model. 
Equation 3 
VIP =  √𝐹∗ × 𝒘𝑡𝑜𝑝
2  
Self-organizing maps 
The self-organizing maps (SOM) were built on the training data of each aliquot with Matlab 
toolbox for SOM.15 Using the same default setting as flowSOM9, such as Euclidian distance, 
grid size 10 by 10 nodes and using the batch training algorithm with the number of steps 10 
times the number of cells in the training set. Finally, the number of cells per node was calculated 
for all samples using the nearest neighbor, resulting in a large matrix with  
size 𝐼 × 100𝑀, where 𝐼 is the total number of individuals and 𝑀 is the number of aliquots. 
Classifiers on self-organizing map nodes 
Three classifiers were tested on the large matrix: support vector machines (SVM) as used in 
flowpeakSVM3,5, lasso regularized logistic regression used in Citrus11 and orthogonal partial 
least squares discriminant analysis (OPLS-DA) in DAMACY6. With SVM we used a linear 
kernel and a box constraint of one. As visualization we used the regression coefficients of SVM 
and the regression coefficients with lambda with the minimum deviance in the inner cross 
validation loop of lasso regularized logistic regression and the weights of the OPLS-DA model 
with the number of orthogonal variables which gave the minimum error in the inner cross 
validation loop. We built a minimum spanning tree of each SOM using the kamada and kawai 
algorithm16 as used in flowSOM9 and SPADE17, we colored each node according to regression 
coefficient or weight or mean marker expression. 
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Figure 1: Fusion model of all the LPS aliquot after variable selection. The left panel shows in 
blue the LPS responder individuals and in red the controls. If the predicted value is above the 
threshold, the individuals are classified as LPS responder. The three right panels show the 
weights of the model of respectively aliquot 1,2 and 3. Positive weights are colored blue and 
belong to cells more represented in LPS responders, negative weights are colored red and 
belong to cells more present in controls. 
 
Supplementary Figure 1: Fusion model of all the LPS aliquot. The left panel shows in blue the 
LPS responder individuals and in red the controls. If the predicted value is above the threshold, 
the individuals are classified as LPS responder. The three right panels are the weights of the 
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model of respectively aliquot 1,2 and 3. Positive weights are colored blue and belong to cells 
more present in LPS responders, negative weights are colored red and belong to cells more 
present in controls. 
Supplementary Table 1: Performance of the different methods on all three aliquots of the LPS 
dataset 
 Accuracy Sensitivity Specificity 
Fusion with DAMACY 99% 100% 99% 
SOM15 + SVM18 99% 100% 99% 
DAMACY base6 + SVM18 98% 98% 99% 
SOM 15+ Lasso regularized logistic regression18 93% 92% 95% 
SOM15 + OPLS-DA19 100% 100% 100% 
 
 
Supplementary Figure 2: Self-organizing map of the LPS dataset. The relative marker 
expression of a node is depicted as a pie chart. Blue shade behind the node contain more cells 
in obese individuals and the red shade contain less as predicted with SVM. 
 
Supplementary Figure 3: Self-organizing map of the LPS dataset. The relative marker 
expression of a node is depicted as a pie chart. Blue shade behind the node contain more cells 
in obese individuals and the red shade contain less as predicted with OPLS. 
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Supplementary Figure 4: Self-organizing map of the LPS dataset. The relative marker 
expression of a node is depicted as a pie chart. Blue shade behind the node contain more cells 
in obese individuals and the red shade contain less as predicted with Lasso. 
 
Supplementary Figure 5: DAMACY base model with SVM as classifier. The three panels are 
the weights of the model of respectively the aliquot measurements of the LPS dataset. Areas 
colored blue belong to cells more present in LPS responders and areas colored contain cells 
less present in LPS responders. 
 
Figure 2: Fusion model after variable selection. The left panel shows with blue crosses the 
obese individuals and with red circles the controls. If the predicted value is above the threshold, 
the individuals are classified as obese. The three right panels are the weights of the model of 
respectively the B cell, T cell and monocyte dataset. Areas colored blue belong to cells more 
present in obese and areas colored red belong to cells more present in lean individuals. The 
blue contours show where on average 80% of the cells of the obese individuals lie and the red 
contours of the lean individuals. 
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Figure 3: Self-organizing map of respectively dataset B cells, T cells and innate cells. The 
relative marker expression of a node is depicted as a pie chart. Blue shade behind the node 
contain more cells in obese individuals and the red shade contain less as predicted with SVM. 
 
Supplementary Figure 6: Self-organizing map of respectively dataset B cells, T cells and innate 
cells. The relative marker expression of a node is depicted as a pie chart. Blue shade behind 
the node contain more cells in obese individuals and the red shade contain less as predicted 
with OPLS-DA. 
 
Supplementary Figure 7: Self-organizing map of respectively dataset B cells, T cells and innate 
cells. The relative marker expression of a node is depicted as a pie chart. Blue shade behind 
the node contain more cells in obese individuals and the red shade contain less as predicted 
with lasso regularized logistic regression. 
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Supplementary Figure 8: DAMACY base model with SVM as classifier. The three panels are 
the weights of the model of respectively the aliquot measurements of the B cell, T cell and 
monocyte dataset. Areas colored blue belong to cells more present in obese individuals and 
areas colored contain less cells. 
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Algorithm 
Below you find the complete algorithm of Discriminant Analysis of Multi Aspect flow 
Cytometry data (DAMACY): 
1) Import the data and arrange it as matrix 𝐗  = [
𝐗11
⋮
𝐗𝐼𝐺
]  of size  (∑ 𝑁𝑖𝐺
𝐼𝐺
𝑖𝑔=11
×  𝐽)  for 
analysis by DAMACY, where 𝑁𝑖𝑔  is the number of cells per individual  𝑖𝑔 =
11, … 𝐼1, … 1𝐺 , … 𝐼𝐺; 𝑔 = 1,… . . 𝐺 indicates the pre-defined groups of individuals with 
𝑔 = 1 representing the control group and 𝑔 = 2 the patient/challenged group, with 𝑗 =
1, … , 𝐽 indicates the surface markers; The data of each individual can analogously be 
denoted as 𝐗𝑖𝑔 = [
𝐱1𝑖𝑔
𝑇
⋮
𝐱𝑁𝑖𝑔
𝑇
] of size (𝑁𝑖𝑔 ×  𝐽) and the data of each class as 𝐗𝑔 = [
𝐗1𝑔
⋮
𝐗𝐼𝑔
] of 
size (∑ 𝑁𝑖𝑔
𝐼𝑔
𝑖𝑔=1𝑔
×  𝐽). 
2) Use arcsinh with cofactor 150 to transform the data: 𝐗log = 𝑎𝑟𝑐𝑠𝑖𝑛ℎ(𝐗/150) 
3) Separate the data into test and training set using 5-fold stratified cross validation with 
50 repetitions. 
4) Separate the training data in a training set and a calibration set using leave one of each 
group out validation for small datasets or use 7 cross-validation for larger datasets (>50 
individuals per group). 
5) Mean centre the data using supplementary equation s1, s2 or s3. Note: only use training 
data to calculate mean of multiple individuals. 
6) Scale the data using supplementary equation s4, s5 or s6. Note: only use training data 
to calculate standard deviation of multiple individuals. 
7) Perform simultaneous component analysis (SCA) on training data using supplementary 
equation s7. 
8) Project the test data onto the SCA model using supplementary equation s7C. 
9) Define binsize using supplementary equation s8. 
10) Create histograms 𝐇  of size ( ∑ 𝐼𝑔
𝐺
𝑔=1  × ∏ 𝐹
𝐾𝑏𝑎𝑠𝑒
𝑘𝑏𝑎𝑠𝑒=1
), with 𝑘𝑏𝑎𝑠𝑒 = 1,… , 𝐾𝑏𝑎𝑠𝑒 
indicating the components used in the base model, 𝑓 = 1,… , 𝐹  indicating the bins 
within the histograms, by counting the number of cells per bin per individual and 
normalize it using supplementary equation s9. 
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11) Smooth the histogram using supplementary equation s10, with 𝐈  being the identity 
matrix, for matrix 𝐃1 holds that 𝐃1𝐇 = ∆𝐇 and for matrix 𝐃2 holds that 𝐃2𝐇 = ∆
2𝐇, 
λ is the smoothing factor, this equation results in smoothed histogram Ĥ𝒊  of size 
(∏ 𝐹
𝐾𝑏𝑎𝑠𝑒
𝑘𝑏𝑎𝑠𝑒=1
) 
12) Repeat step 1-11 with all other measured aliquots and refold the smoothed histograms 
Ĥ into matrix 𝐇 with dimensions(𝐼 ×  𝐹𝐾base 𝑀), which results in equation 2. 
13) Remove the columns (bins) in matrix 𝐇 with small variance (< 10−6), resulting in 
matrix 𝐇∗ with dimensions(𝐼 ×  𝐹∗). with 𝐹∗ being the bins with sufficient variance. 
14) Perform Orthogonal Partial Least Squares – Discriminant Analysis (OPLS-DA) on train 
data with supplementary equation s11 
15) Predict the test data with ŷ = (𝐂test
∗ − 𝐂test
∗ 𝐖𝐨𝐏𝐨
𝐓)𝐰top𝐩top
𝐓 𝐪 
16) Go back to step 4 until you have a prediction for every individual in the training set for 
every model based on the different settings of parameters such as way of pre-processing, 
principle components used in the base model, number of bins, smoothing factor and 
number of orthogonal latent variables in the OPLS-DA top model. 
17) Based on the prediction of calibration set select the optimal parameters. 
18) Go back to step 3 until you have a prediction for every individual using the optimal 
parameters. 
19) Perform OPLS-DA on complete data with equation 7 
20) Calculate the VIP using equation 3 and set all 𝐰top with VIP < 1 to 0. 
21) Refold weight vector 𝐰top into an (𝑀 × 𝐹 × 𝐹) matrix 𝐖𝐭𝐨𝐩, when the components 
𝐾base = 2 in the base model. 
22) Plot matrix 𝐖𝐭𝐨𝐩 with red intensity for negative weights and blue intensity for positive 
weights. 
Equations used in the algorithm: 
(s1) A 
 
B 
𝐦𝑖𝑔
T = 
∑ 𝐗log𝑖𝑔
𝑁𝑖𝑔
𝑛=1
 
𝑁𝑖𝑔
 
𝐦T =
∑ ∑ 𝐦𝑖𝑔
T𝑰𝑔
𝑖𝑔=𝟏
𝐺
𝑔=1
∑ 𝐼𝑔
𝐺
𝑔=1
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C 𝐃mc = 𝐗log −  𝟏𝐦
T 
 
(s2) A 
 
B 
𝐦𝑖1
T = 
∑ 𝐗log𝑖1
𝑵𝑖1
𝑛=1   
𝑁𝑖1
 
𝐦1
T =
∑ 𝐦𝑖1
T𝑰𝟏
𝑖=1
𝐼1
 
 
C 𝐃mc = 𝐗log −  𝟏𝐦1
T 
 
(s3) A 
 
B 
𝐦𝑖𝑔
T = 
∑ 𝐗log𝑖𝑔
𝑵𝑖𝑔
𝑛=1   
𝑁𝑖𝑔
 
𝐃mc𝑖𝑔 = 𝐗log𝑖𝑔 − 𝟏𝑖𝑔𝐦𝑖𝑔
T  
 
(s4) 
 
A 
𝐬𝐓 = √
∑ ∑ 𝑣𝑎𝑟 (𝐃𝐦𝐜𝑖𝑔)
𝐼𝑔
𝑖=1
𝐺
𝑔=1
∑ 𝐼𝑔
𝐺
𝑔=1
 
 B 𝐒 =  𝐝𝐢𝐚𝐠(𝐬𝐓) 
 C  𝐗𝐜𝐬 = 𝐃𝐦𝐜𝐒
−𝟏 
 
(s5) 
 
A 
𝐬1
𝐓 = √
∑ 𝑣𝑎𝑟 (𝐃𝐦𝐜𝑖1)
𝐼1
𝑖=1
𝐼1
 
 B 𝐒1 =  𝐝𝐢𝐚𝐠(𝐬1
𝐓) 
 C  𝐗𝐜𝐬 = 𝐃𝐦𝐜𝐒1
−𝟏 
 
(s6) 
 
A 𝐒𝒊𝒈 =  𝐝𝐢𝐚𝐠 (𝐬𝑖𝑔
𝐓 ) 
 B  𝐗𝐜𝐬𝒊𝒈 = 𝐃𝐦𝐜𝑖𝑔𝐒𝑖𝑔
−𝟏 
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(s7) A 
 𝐗𝐜𝐬𝐧 = [
𝐗𝟏𝟏𝐍𝟏𝟏
−𝟏/𝟐 
⋮
𝐗𝑰𝑮𝐍𝑰𝑮
−𝟏/𝟐
] 
 B 𝐗𝐜𝐬𝐧 = 𝐓𝐛𝐚𝐬𝐞∗𝐏𝐛𝐚𝐬𝐞∗
𝐓 + 𝐄 
 C 𝐓𝐛𝐚𝐬𝐞 = 𝐗𝐜𝐬𝐏𝐛𝐚𝐬𝐞∗ 
 
(s8)  
𝛿𝑘 = 
𝐩𝐞𝐫𝐜𝐞𝐧𝐭𝐢𝐥𝐞𝟗𝟗. 𝟗𝟓(𝐭𝑘) − 𝐩𝐞𝐫𝐜𝐞𝐧𝐭𝐢𝐥𝐞𝟎. 𝟎𝟓(𝐭𝑘)
𝐹
 
(s9)  𝐇𝑖 = 𝐇𝑖/𝐍𝑖 
(s10)  (𝐈 + 𝟐 λ𝐃𝟏
𝐓𝐃𝟏 + λ
2𝐃𝟐
𝐓𝐃𝟐) Ĥ𝑖 = 𝐇𝑖 
(2)  
𝐇 = [
𝐇1,1,1 ⋯ 𝐇1,𝐹2,1  ⋯ 𝐇1,𝐹2,𝑀
⋮ ⋱ ⋮ ⋱ ⋮
𝐇𝐼,1,1 ⋯  𝐇𝐼,𝐹2,1 ⋯ 𝐇𝐼,𝐹2,𝑀
] 
(s11)  𝐇∗ = 𝐭top𝐩top
𝐓 + 𝐓𝐨𝐏𝐨
𝐓  + 𝐄OPLS 
(3)  
VIP =  √𝐹∗ × 𝒘𝑡𝑜𝑝
2  
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Single marker histograms of B cell dataset 
Below, you can see the Figures of the single marker histogram of the gated data in area A (red) 
and B (blue) as seen in Figure 2, the rest of the cells are plotted in black. 
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Single marker histograms of T cell dataset 
Below, you can see the Figures of the single marker histogram of the gated data in area C (red) 
and D (blue) as seen in Figure 2, the rest of the cells are plotted in black. 
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Single marker histograms of innate cell 
dataset 
Below, you can see the Figures of the single 
marker histogram of the gated data in area 
E (green), F (yellow), G (magenta), H 
(cyan), I (blue) and J (red) as seen in Figure 
2, the rest of the cells are plotted in black.
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Abstract 
Flow cytometry is a powerful analytical technology to simultaneously measure multiple 
markers per single cell. Ten thousands to millions of single cells can be measured per sample 
and each sample may contain a different number of cells. All samples may be bundled together, 
leading to a ‘multi-set’ structure. Many multivariate methods have been developed for flow 
cytometry data but none of them considers this structure in their quantitative handling of the 
data. The conventional pre-processing used by existing methods provides models mainly 
influenced by the samples with more cells, while such a model should provide a balanced view 
of the biomedical information within all measurements. We propose an alternative ‘multi-set’ 
preprocessing that corrects for the difference in number of cells measured, balancing the relative 
importance of each multi-cell sample in the data while using all data collected from these 
expensive analyses. Moreover, one case example shows how multi-set pre-processing may 
benefit removal of undesired sample-to-sample variability and another where class-based multi-
set pre-processing enhances the studied response upon comparison to the control reference 
samples. Our results show that adjusting data analysis algorithms to consider this multi-set 
structure may greatly benefit immunological insight and classification performance of Flow 
Cytometry data. For this reason, when performing multivariate data analysis, it is advisable to 
adapt the method to the multi-set structure and screen for multiple pre-processing options to 
obtain both robust results and be able to get the most out of the data analysis method chosen. 
 
Background 
Multicolour flow cytometry (MFC) is a powerful technique for quantitative detection of cellular 
marker expression at the single-cell level. MFC technology has become routine for biological 
studies and clinical diagnoses. In immunology, the main applications of MFC span the 
identification and quantification of (rare) cell subpopulations, monitoring of disease and its 
treatment and studying dynamic cellular processes such as cell differentiation.[1-3] 
Increasingly, applications involve automated comparison of larger numbers of samples, in 
which large numbers of cells are typically collected in every sample. Furthermore, many 
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contemporary experiments quantitatively compare a ’case’ (or responder) groups of samples 
against a ‘control’ (or healthy) sample group, in which expressions of identical cellular markers 
may be measured on the cells within all samples. 
Fig 1 shows the possible arrangements of the MFC data by considering three different levels. 
(1) Single matrices, which hold the cell set measured per sample; comprehensive analysis of 
different samples require that the same cellular markers are measured across all samples. (2) 
Single matrices may then be concatenated column (or variable)-wise leading to a ‘multi-set’ 
structure where each set contains the cells of one sample. Each sample might be either a control 
or a responder and the information of the respective group is displayed in the level (3) of the 
multi-set structure. Different indexes are used for control and for the responder groups that 
might correspond to different diseases or subtypes of the same disease. In some cases, samples 
are paired, which means that the same person is followed over time and analysed before and 
during an immune response. In this case the index i is not unique (3a); while for unpaired 
samples, each set is indicated by different 𝑖 (3b). 
 
 
Figure 1: (1) Single data matrices representing measurement per sample, (2) When same 
variables are measured data can be arranged in a multi-set structure by linking the single 
matrices column-wise, (3a) Control/Responder differentiation of the multi-set structure, with 
paired data, (3b) Control/Responder differentiation of the multi-set structure, with unpaired 
data 
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Several data analysis methods have been developed to quantitatively explore the cell 
composition of MFC samples [4]. To our knowledge, none of these methods quantitatively 
accounts for the multi-set structure of MFC data either in the pre-processing or in the analysis 
step. This may lead to a suboptimal overview and interpretability of the cell variability across 
all samples, instead reflecting non-biologically relevant inter-group or inter-sample variability. 
The problem especially occurs when different number of cells are measured between samples 
and/or baseline shifts are present between the samples due to e.g. technical variation. 
Multivariate analysis methods such as Citrus [5] and FlowSOM [6], concatenate the MFC 
sample measurements in a single big matrix, without retaining the information about the 
different sets, prior to the analysis. 
Both methods then comprise mean-center and scaling based on such concatenated samples. If 
the various samples strongly differ in the number of cells measured, the calculated mean and 
standard deviation would be affected by this difference and, as result, the model will mainly 
describe the cellular marker variability of the samples with the most cells. Instead, a model 
where each sample is equally contributing to is desirable to avoid misleading results which may 
not reflect phenotypical heterogeneity. In other algorithms, such as SPADE [7] and viSNE [8], 
problems related to difference in number of cells measured may be avoided by downsampling 
the data to a fixed and equal number of cells per sample. Here the downsampling is imposed by 
computational limits of these methods and it causes loss of valuable data, which might be 
essential in several high-impact application of MFC, e.g. minimal residual disease detection. 
Taking the multi-set structure of MFC data into account would be beneficial for the multivariate 
analysis methods because all cells may be used for the analysis by retaining all the biologically 
relevant information and by assuring that each sample contributes equally even when 
differences in event number are present. Additionally, retaining the multi-set structure allows 
the analyser to use information about case/control not only during the analysis step (as done in 
Citrus) but also in the pre-processing. 
The multi-set-structure has already been an integral part of the methods DAMACY [9] and 
ECLIPSE [10]. However, until now we have not yet presented a detailed study to elaborate on 
this aspect of these methods. Both DAMACY and ECLIPSE consider the multi-set structure 
during the pre-processing steps and when building the models to compare samples. 
Here we offer a detailed description of the multi-set pre-processing adopted by DAMACY and 
ECLIPSE and we show how, in principle, this can be beneficial for the analysis done with other 
existing algorithms. Simulated data may illustrate how larger number of cells in one sample 
may bias the overall mean and standard deviation towards this sample if the data are 
concatenated, when the multi-set pre-processing is not applied. The multi-set pre-processing 
corrects for this by averaging the mean and the (square root) of the variance between samples, 
providing a more reliable representation of variability in the original marker expressions within 
the separate samples. Additionally, we describe how the multi-set structure allows for extra pre-
processing options. Each combination of the different pre-processing types may be chosen 
accordingly to the problem under study or even to correct for artefacts present in the data. We 
may pre-process the data per sample, to correct for unwanted technical variability between the 
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samples. This helps to systematically remove variability unrelated to the studied immunological 
problem. Pre-processing the whole data based on only the data of the control group is also 
possible. This may enhance the deviation of immune response-specific marker variability from 
control reference marker expressions and lead to a better discrimination and diagnosis accuracy. 
Also algorithms such as viSNE and SPADE, which are distance based methods and do not 
explicitly use the mean, may benefit from the multi-set pre-processing. It may alter the relative 
differences between cells in different samples, thereby removing unwanted variation and 
essentially improving the information content of the models. 
In this paper we first describe the different multi-set pre-processing options and we illustrate 
their effects with a simple simulated data set (see Method). Subsequently, various simulated 
data of increased complexity are used to schematically show how difference in sample size may 
affect the estimation of the mean prior the analysis and this can lead to suboptimal 
representation of the results in a multi-dimensional space. Multi-set preprocessing strategy is 
then compared against conventional pre-processing with a real life data set characterized by 
sample-to-sample variability by using various existing algorithms such as flowSOM, viSNE 
and Citrus. Finally, a more thorough investigation of the effect of all possible pre-processing 
options on discrimination accuracy for case-control studies is illustrated by applying DAMACY 
to discriminate between obese and lean individuals. 
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Method 
Data 
LPS study data 
MFC data of the “Lipopolysaccharide study” were part of an endotoxin trial 
(NCT01374711; www.clinicaltrials.gov), in which male healthy donors were challenged with 
intravenous administration of Lipopolysaccharide (LPS). The LPS dataset comprises gated 
neutrophils from 16 samples: 8 ‘control’ (or reference) samples who did not receive LPS, and 
8 different ‘response’ samples who were administered with LPS. For the responders, whole 
blood was collected 180 minutes post LPS administration. Seven surface markers were 
measured on the neutrophils in samples of both classes: CD62L, CD11b, CD11c, CD64, CD32, 
CD69, and CD16. The samples size range between 6 thousand to 40 thousands cells. Further 
details regarding the Flow Cytometry experiments that generated the data can be found in a 
previous publication.[11] 
 
Obese data 
The obese data comprises 29 samples: 13 lean samples with Body mass index (BMI) in the 
range between 20.83 and 25.62 and 16 obese samples with BMI between 30.47 and 49.27.[12] 
The following markers were measured: CXRCR1, CD14, CD56, CD11c, CD16, HLA-DR, 
CD3/CD19/CD66b. The data was gated on innate cells by removing all cell positive for markers 
CD3, CD19, CD66b. The samples have 2 thousand to 24 thousand cells left after gating. 
 
Simulated data 
Simulated dataset A was constructed to illustrate the effect of the different pre-processing 
strategies. It consisted of two normal distributions, representing different cell populations (Fig 
2). A ‘control’ population (red rounds) was drawn from a normal distribution with mean μcontrol 
= [4,0] and standard deviation σcontrol= [0.5, 2] and a ‘responder’ population (blue crosses) from 
a normal distribution with mean μresponse = [4,4] and standard deviation σresponse = [2, 0.5]. The 
responder population shows a different shape and it is shifted compared to the control 
population. 
Simulated datasets B, C and D were created to illustrate the influence of different sample sizes 
in the estimation of the mean and how this would affect representation of the pre-processed 
data. All the simulations were characterized by three samples having increasingly complexity 
in number of variables and cell populations. In simulated dataset B, the three samples comprised 
two variables and were characterized by a single population. The event size of the samples was 
initially the same: 10.000 events each. The event size of one sample was then increased to 
100.000, 250.000, 500.000 events, while maintaining the size of both other samples invariant. 
In dataset C another combination of three samples was successively created by adding a third 
variable and a mutual exclusive positive expression of only one of the three markers on the 
different samples. A more complex dataset D was finally introduced to mimic a more realistic 
immunological scenario with 6 variables and presence of small subsets in some of the samples. 
For the latter two simulations, the event size of one sample was enlarged to 500.000 compared 
to the other two samples that maintained the same size of 10.000 events. The effect of pre-
processing on such constructed higher dimensional data was investigating by applying the 
dimensionality reduction method Simultaneous Component Analysis (SCA). 
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Data pre-processing 
Transformation 
Data pre-processing is a crucial aspect of multivariate data analysis [13] to remove variability 
in the data that is unrelated to the problem under study, while retaining the experimentally 
relevant information. In Flow Cytometry, such irrelevant variability might result from 
instrumental artefacts due to misalignment of the laser source, baseline drift, laser power 
variability, interference of fluorescent labels, or uninformative noise coming from low intensity 
signals. Time delays between sample collection and measurements can also bring variability 
that is not related to the problem under study. Especially granulocytes should either be 
measured fresh and as fast as possible, or measured after using advanced freezing techniques 
to minimize such nonspecific activation. [14,15] 
Different data pre-processing steps may be applied to guarantee that the fluorescence intensities 
are as little as possible influenced by factors other than the quantitative levels of protein 
expression on the cells. 
MFC raw data can be arranged in the matrix X =  [
X1
⋮
X𝐼
] of size ∑ 𝑁𝑖𝑔x 𝐽
𝐼
1 , where 𝑁𝑖𝑔  is the 
number of cells of the  𝑖𝑔
th sample, with 𝑔 = 0  used for the control group and 𝑔 ≥ 1  for 
responder groups and 𝐽 corresponds to the markers measured, 1… 𝑗 … 𝐽. The first step of the 
pre-processing consists of transforming 𝐗 with log (Eq. 1a) or hyperbolic inverse sine (arcsinh) 
function (Eq. 1b).[16] 
𝐗log = log10(𝐗) (1a) 
𝐗log = log(
X
c
+ √(
X
c
+ 1)2) 
 
(1b) 
These transformations perform a non-linear conversion of the data and they are generally 
applied to correct for heteroscedasticity and to change skewed distributions into more 
symmetric, Gaussian distributed peaks. In MFC, this type of transformation has been very 
useful in coping with the wide dynamic range of photon emissions between fluorophores and 
thus in providing informative and proper displays of MFC data. A log transformation may be 
still used on datasets exported with only positive data values, arcsinh transformation has been 
introduced to accommodate for the negative values in MFC data that may result from the 
background subtractions performed by newer digital MFC technology, or by compensation [17] 
to correct for spectral overlap between different fluorophores. We used arcsinh transformation 
with a default cofactor c value of 150 and used visual inspection of the data to preclude the 
emergence of any ‘split peaks’ upon transformation.[18] 
Multi-set centering and scaling 
Arcsinh and log transformation can be considered as a ‘pseudo scaling’ transformation that 
ameliorates magnitude differences in the fluorescence emissions per fluorophore between 
different markers. However, full removal of such differences requires variable scaling and mean 
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centering after transformation.[19] Mean (or median) centering subtracts the column mean (or 
median) from every element in the column. This removes marker expression (or offsets) 
consistently present across all the cells and creates a common point of reference to quantify 
variability in cellular marker expression between the cells. Centering is typically applied in 
combination with scaling, which consists in dividing each variable by a scaling factor. Scaling 
equalizes the variability of each cellular marker across the cells. This allows the variability in 
every surface marker to contribute equally to a multivariate model of the data, regardless of the 
intensity of the used fluorophore or the absolute variability in abundance of every surface 
marker. 
In the pre-processing as applied in Citrus [5] and flowSOM [6] analyses, all the data files are 
bundle together in a big data matrix and, after transformation, centering is performed according 
to equation 2: 
(a) 
𝐦 = 
1
𝑁
 𝟏𝑁
𝐓  𝐗log 
(2) 
(b) 𝐗𝐦 = 𝐗log − 𝟏𝑁m
T  
Where 𝐦 is the mean of the arcsinh (or log-) transformed cellular marker expression calculated 
across all the samples included in the matrix 𝐗log; 𝑁 is the number of total cells measured; 1 is 
a column vector of ones with length 𝑁. The mean-centered matrix 𝐗𝐦 is then scaled according 
to Equation 3: 
(a) 𝐬T = √𝑣𝑎𝑟(𝐗𝐦) (3) 
(b) 𝐒 =  𝐝𝐢𝐚𝐠(𝐬T )  
(c) 𝐗sc = 𝐗𝐦𝐒
T  
with 𝐒 diagonal matrix holding the standard deviation 𝐬T; 𝐗sc the resulting auto-scaled matrix. 
This ‘conventional’ pre-processing ignores the multi-set structure (Fig 1) of multi-cells flow 
cytometry data which means that the information of cells belonging to a specific sample or 
group is lost. 
Our ‘multi-set’ pre-processing specifically accommodates the multi-set- structure of flow 
cytometry data and tackles various sub-aspects: cells measured may belong to different 
samples, where these can be drawn from different experimental cohorts (such as control and 
responder) and different numbers of cells can be measured per sample. Several strategies for 
centering and scaling [19] are therefore available which may lead to different views and 
information: to centre/scale using the mean/standard deviation calculated on all the samples, on 
the control samples or per sample. 
The different pre-processing strategies were tested on simulated data A which consisted of two 
normal distributions, representing different cell populations (Fig S1, Online Supplementary 
Material I). 
In Fig 2 the effect of three different types of centering on this dataset is displayed, without any 
scaling: centering over the whole dataset, based on group-level, and per sample (Fig 2A-B-C). 
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Figure 2: 2D scatter plot of the simulated data after applying different types of centering on 
both control (red) and responder (blue) populations. Left (A): data are centered using the mean 
calculated on the whole dataset and correcting for differences in # cells measured per sample; 
Center (B): data are centered using the mean estimated for the control samples and correcting 
for differences in # cells measured per control; Right (C): data are mean center per sample. 
Centering over the whole dataset employs the data from both the responder and control groups. 
This centering operation requires a correction for the possibly different number of cells 
measured per sample, to avoid the sample with most cells dominating the calculated mean. This 
is done to equally weighting each sample in the calculation of the overall mean, according to 
Eq. 4: 
(a) 
𝐦𝑖𝑔 = 
1
𝑁𝑖𝑔
 𝟏𝑁𝑖𝑖𝑔
𝐓  𝐗log,𝑖𝑔 
(4) 
(b) 
𝐦 =
∑ ∑ 𝐦𝑖𝑔
𝑰𝒈
𝒊𝒈=𝟏
𝑮
𝒈=𝟏
∑ 𝐼𝑔
𝐺
𝑔=1
 
 
(c) 𝐗𝐦 = 𝐗log − 𝟏𝑁𝑖𝑔𝐦
T  
 
Here, the average marker expression 𝐗𝐦 based on all the samples m is calculated by dividing 
the sample-specific mean 𝐦𝑖𝑔, estimated per each sample 𝑖 of group 𝑔, over the total number 
of samples 𝐼𝑔. Centering over the whole dataset (Eq. 4c) translates the means of both groups 
around the axis coordinate origin (mcontrol = 0,-2; mresponse = 0,2), as displayed in Fig 3a. 
Centering can be performed based on group (control)-level, which means the control group is 
used as point of reference. Centering based on controls is given by equation: 
(a) 
𝐦0 = 
∑  
𝐼0
10
𝐦𝑖0
𝐼0
 
(5) 
(b) 𝐗m0 = 𝐗log − 𝟏𝑁𝑖𝑔m0
T  
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Also in this case, a correction for different numbers of cells per sample is performed by using 
the mean of each 𝑖0–th control sample 𝐦𝑖0to calculate the weighted control class mean 𝐦0, 
where 𝐼0 represents the number of control samples. The resulting 𝐗m0, of size 𝑁𝑖0x 𝐽, represents 
the multi-set matrix centered using the class mean of the log-transformed surface marker 
intensities of the control group. Centring based on the control samples (Eq. 5b) will remove the 
shift of the control cells of which variability is used as reference. This emphasizes the deviation 
of responder cell variability (mresponse= 0,2) from the control reference (mcontrol = 0,0), as shown 
in Fig 3b. 
Centering per multi-cell set, i.e. per MFC sample, is calculated as follows: 
(a) 
𝐦𝑖𝑔 = 
1
𝑁𝑖𝑔
 𝟏𝑁𝑖𝑖𝑔
𝐓  𝐗log,𝑖𝑔 
(6) 
(b) 𝐗𝐦𝑖𝑔 = 𝐗log,𝑖𝑔 − 𝟏𝑁𝑖𝑔m𝑖𝑔
T   
Where 𝐦𝑖𝑔 is the mean calculated for the cellular markers measurements of the 𝑖𝑔–th sample, 
𝑖𝑔 = 1𝑔, … , IG , hold in the matrix 𝐗log,𝑖𝑔 of size 𝑁𝑖𝑔x 𝐽; 𝑁𝑖𝑔 corresponds to the number of cells 
of the 𝑖𝑔–th sample; 1 is a column vector of ones with length 𝑁𝑖𝑔. 
Centering per sample (or per individual) (Eq. 6b) removes the shift per sample in both groups 
(mcontrol = mresponse = 0,0), as shown in Fig 3c. This strategy may be used to correct for technical 
sample-specific offsets due to e.g. changes and/or misalignment of laser intensity, sample 
handling etc. that are unrelated to the biomedical information within the MFC dataset. 
Additionally to centering, scaling is performed. As for centering, the same alternatives are 
available also for the scaling step. Below, we discuss and show the formulas of the different 
scaling options performed on the sample mean centered data matrix 𝐗𝐦𝑖𝑔  (Eq. 4). Each formula 
can be easily adapted to the other types of centering. Similar conclusions about the effect of 
scaling can be drawn and they are summarized in Fig 3. 
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Figure 3: 2D scatter plot of the pre-processed simulated data for each pre-processing 
combination. Red rounds represent a ‘control’ population and the blue triangles represent a 
‘responder’ population. The columns contain the different scaling options (from left to right): 
scaling based on complete data, scaling based on the control samples and scaling per sample. 
The rows show the different centring options (from top to bottom): centering based on complete 
dataset, centering based on controls, centring per sample. 
Scaling over the whole dataset is performed with the following equation: 
(a) 
𝐬𝐓 = √
∑ ∑ 𝑣𝑎𝑟 (𝐗𝐦𝑖𝑔)
𝐼𝑔
𝑖=1
𝐺
𝑔=1
∑ 𝐼𝑔
𝐺
𝑔=1
 
(7) 
(b) 𝐒 =  𝐝𝐢𝐚𝐠(𝐬𝐓)  
(c)  𝐗𝐬𝐜 = 𝐗𝐦𝑖𝐒
−𝟏  
 
Where 𝐒 is a diagonal matrix of size 𝐽x 𝐽 containing the standard deviation of each surface 
marker 𝐬𝐓, calculated on all cells of all samples. Scaling based on the complete data will keep 
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the same difference in shape between control (scontrol = 0.34, 1.37) and responder (sresponse = 
1.37, 0.34) population, but the variables are now equally important (s = 1,1). 
Scaling based on the control group is given in Eq. 8: 
(a) 
𝐬0
𝐓 = √
∑ 𝑣𝑎𝑟(𝐗𝐦𝑖)
𝐼0
𝑖=0
𝐼0
 
(8) 
(b) 𝐒0 =  𝐝𝐢𝐚𝐠(𝐬0
𝐓)  
(c)  𝐗𝐬𝐜 = 𝐗𝐦𝑖𝐒0
−𝟏
  
 
With 𝐒0 of dimensions (𝐽 ×  𝐽) with the diagonal element containing the standard deviation 𝐬0
𝐓 
of each surface marker based on all cells of control samples. Scaling based on the control group 
(σ = 0.5, 2) will remove the shape of the control (new standard deviation scontrol = 1, 1) and 
emphasize the shape of the challenged population (new standard deviation sresponse = 4, 0.25). 
Scaling per sample is calculated as follows: 
(a) 
𝐬𝑖𝑔
𝐓  = √𝑣𝑎𝑟(𝐗𝐦𝑖) 
(9) 
(b) 𝐒𝑖𝑔 =  𝐝𝐢𝐚𝐠 (𝐬𝑖𝑔
𝐓  )  
(c) 𝐗sc = 𝐗𝐦𝑖 𝐒𝑖𝑔
−𝟏  
 
Where 𝐒𝑖𝑔 is diagonal matrix of size 𝐽x𝐽 holding the standard deviation of the mean-centered 
surface markers of the 𝑖𝑔–th sample. Scaling per sample makes cell population of both groups 
homogenous (scontrol = sresponse= 1, 1). 
The plots in Fig 4 show that, the method of pre-processing may greatly determine the pre-
processed data structure. Centering and scaling based on the control class will enhance the 
deviations of the responder samples from the cell variability observed in the control samples. 
Alternatively, sample centering and scaling might be a preferable option when measurements 
were influenced by differences in the (technical or practical) experimental procedure per 
sample. These operations now rid the resulting data of uninformative offsets and allow each 
surface marker to a priori contribute equally to the model fitted subsequently, considering both 
the multi-set and control/responder structure of the data. However, it should be noted that the 
last option has a considerable disadvantage. When all cells of one response sample show up or 
downregulation of one or multiple markers compared to the cells of the control samples, this 
information will be lost due to sample centering and scaling. 
 
  
100 
 
Simultaneous Component Analysis 
Chemometric dimension reduction techniques such as Principal Component Analysis (PCA) is 
a widely used method to facilitate visualization of multidimensional data, including flow 
cytometry data, while retaining most of the variability expressed in the originally measured 
variables.[20,21] A multi-set extension of PCA exists to accommodate multi-set structure 
present in the data and it is known as Simultaneous Component Analysis (SCA).[22] When 
applying the SCA decomposition, the pre-processed matrix 𝐗sc is normalized such that each 
sample contributes with the same amount of information. The normalization is done by 
blockscaling [23], which consists of dividing each sample by the square root of the 
corresponding number of cells, see Equation 10: 
(a) 
 𝐗sc = [
𝐗𝐬𝐜11𝑁11
−1/2 
⋮
𝐗sc𝐼𝐺𝑁𝐼𝐺
−1/2
] 
(10) 
SCA then decomposed the resulting matrix as follows: 
(a) 𝐗sc = 𝐓∗𝐏∗
𝐓 + 𝐄 (11) 
(b) 𝐓 = 𝐗sc𝐏∗ 
 
 
where 𝐓  of size ∑ 𝑁𝑖𝐺
𝐼𝐺
𝑖𝑔=11
×  𝐾  contains the SCA scores, 𝑘 = 1,… , 𝐾  indicates the 
dimensionality of the new low-dimensional space, 𝐏∗ of size 𝐾 ×  𝐽 containing the loadings 
and 𝐄 being the residuals. The loadings represent the contribution of each cellular marker in 
building the low dimensional space and in describing the cell variability contained in the scores 
matrix. Blockscaling is essential to estimate loadings which are not highly influenced by the 
cellular maker variability of the samples with the most samples. The relations between cell 
variability and the related expression of markers in the SCA space may be combined in a single 
biplot [24]. 
Effect of sample size, illustrated with simulated data with increasing complexity 
Two-dimensional synthetic dataset B is constructed to highlight the effect of changes in the 
number of events (cells) between samples on the calculated mean. 
The data comprises three samples coded in different colours. Each sample is represented by a 
single cell population, of which variables expression can be observed in the univariate 
histograms shown in Fig S2, Online Supplementary Material I. Fig 4 shows the change in value 
of the overall mean, calculated according to Eq. 2b, when the size of the green sample 
progressively increases. As the ratio of the event size between the green and the other two 
groups increases, the mean shifts towards the centre of mass of the most populated sample. 
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Figure 4: Contour representation of simulated data consisting of three samples (blue, red, 
green), characterized each by a single population. The numbers represent the position of the 
mean calculated on the merged data, after increasing the size of the green sample: 1. samples 
size is the same, 10.000; 2. sample size of the green sample increased to 100.000; 3. sample 
size of the green sample increased to 250.000; 4. sample size of the green sample increased to 
500.000. 
This shift of the mean may change interpretation of the data, as it greatly affects the results of 
multivariate analysis methods that combine information of the three surface markers. We 
illustrate the effects of sample sizes on pre-processing of higher dimensional simulated dataset 
by applying the widely used data reduction and visualization technique Simultaneous 
Component Analysis (SCA). 
Simulated dataset C has three samples with a single cell population. The histograms of the three 
markers expression level are shown in the Online Supplementary Material I (Fig S3). 
The three samples are characterized by the mutual exclusive positive expression of only one of 
the three markers: the blue group is positive for Blue, the red group is positive for Red and the 
green group is positive for Green. Similar to the previous simulation, we increased the original 
size of the green sample of factor 50 compared to the size of the blue and red samples. The 
resulting simulated dataset with different sample size was pre-processed using conventional 
pre-processing (Eq. 2-3) and multi-set pre-processing over the whole dataset (Eq. 4 and 7). SCA 
models were built on the resulting different simulated subsets and the effect of the analyses on 
the diverse mean-centered (and block-scaled) data is shown in Fig 5. 
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Figure 5: Biplot of SCA model. A single population for each sample, the arrows show loadings. 
A) Standard SCA model with same sample size of 10.000; B) Standard SCA model and sample 
size of the green triangles increased to 500.000; C) Block scaled SCA model and sample size 
of the green triangles increased to 500.000; D) Multi-set pre-processing over the whole dataset 
(Eq. 4 and 7) and block scaled SCA model and sample size of the green triangles increased to 
500.000. 
When the sample sizes is equal among the three samples (Panel A), the origin of the loadings 
is in the middle of the data, suggesting that the mean properly represents the average marker 
expression among the three samples. Moreover, it can be observed that the loadings point 
toward the correct cell populations on which each loading is exclusively expressed. In Panel B, 
the size of the green group was increased 50 fold and when SCA is applied to the conventionally 
mean-centered data, the Green loading is large and positive (points to the right) in the first 
principal component while the Blue/Red loading is smaller and negative (points to the left). 
Additionally, as effect of conventional centering the origin is moved in the direction of the 
green sample and this would indicate that it has an average expression of all markers. In reality, 
the green sample is low in Red and Blue, and high only in Green, as shown in the single marker 
expression histograms (Fig S4, Online Supplementary Material I). Block scaling (Equation 9a) 
applied before the SCA model does not overcome this misinterpretation, see Panel C. In fact, 
only when combining block scaling with multi-set pre-processing (Panel D), then the SCA 
model is similar to the one shown in Panel A, which means the analysis is not influenced 
anymore by the different numbers of cells within the samples. 
In simulated dataset D three additional variables (GreenBlue, GreenRed and AntiGreen) are 
added (Figure 9), where the red and the blue samples have an extra small cell population 
positive for Red and Blue variable, respectively. All three samples have a similar cell population 
which is positive for variables Green, GreenRed, GreenBlue and negative for variables Blue, 
Red and Antigreen. 
Again, the three MFC samples have the same size of 10.000 cells, here divided in 1000 cells 
and 9000 within the small and the big population, respectively, for both blue and red sample. 
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The green sample was then 50-fold increased in size in the same manner as previously. SCA 
analyses are performed and shown in Fig 6. When the three samples have the same number of 
cells measured (Panel A), the origin of the SCA model is in the similar population, overlapping 
as well with the major population of blue and red. 
In panel B the green sample has increased in size and the resulting data are conventionally 
mean-centered. When SCA is applied, the first two principal component to mainly describe the 
variance within the green group. The extra red and extra blue population overlap partly and they 
are very close to the green populations. The loadings do not correctly describe the variability 
of these two small populations. In the third analysis the block scaling helps in equally weighting 
the samples in the built SCA model (Panel C). The extra red and extra blue population are now 
well described and the loadings seem to be correctly oriented. However, the loading of 
AntiGreen variable is very small, meaning that this marker does not contribute much to the 
model and thus it is not a descriptor for the populations. A more relevant representation of the 
marker expressions, that contains the systematic variation introduced into the simulation, is 
obtained only after multi-set pre-processing over the whole dataset and block scaling (Panel D). 
The resulting SCA model is similar to the model in Panel A. Multi-set pre-processing combined 
with block scaling is essential to represent the different cell populations accurately and to reflect 
the original marker expression. 
 
Figure 6: Biplot of SCA model. A) Standard SCA model with same sample size of 10.000 for all 
3 populations; Blue crosses have both 1000 cells in the blue population and 9.000 in green 
population, red circles have both 1000 cells in the red population and 9000 in green population, 
green triangles have 10.000 cells in the green population. B-D) sample size of the green 
triangles increased to 500,000; B) Standard SCA model C) Block scaled SCA model D) Multi-
set pre-processing and block scaled SCA model 
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Effects of dedicate pre-processing on the interpretation of viSNE, SOM and Citrus models 
of real-life data: The Lipopolysaccharide study 
The Lipopolysaccharide (LPS) challenge study entails intravenous administration of systemic 
endotoxin to eight volunteers. This experiment is used to mimic acute inflammation in humans 
which is most prominent 180 minutes after LPS administration [11,25]. Neutrophils, which are 
the main effector cells in fighting infections, are largely mobilized during acute inflammation. 
Previous publications have shown that upon acute inflammation, two neutrophil subsets arise 
in the peripheral blood, which differentially express FcγRIII (CD16) and L-selectin (CD62L). 
Neutrophils under homeostasis express both CD16 and CD62L, while both arising subsets are 
CD16+CD62L- and CD16-CD62L+, with different morphological and functional features [11]. 
Both CD16 and CD62L were measured during LPS challenge as well as six other neutrophil 
markers. The challenge aimed to characterize the expression of activation markers on the 
neutrophil subsets released in peripheral blood during the LPS-induced response, compared to 
a homeostatic reference present in the control group. 
Considerable shifts of the fluorescence signals are present between the samples in both groups 
for nearly all markers, as shown in Figure S5 in the Online Supplementary Material II. Changes 
in the absolute position of the same cell population across the samples might result from both 
(not-relevant) biological and technical variation [26]. In fact, various studies have shown how 
different sample treatments may affect marker expression on neutrophils [14,15]. Additionally, 
time delay between sample collections, reagent staining and actual measurements may vary 
across the samples and this introduces an uncontrolled between-sample variation which can 
hinder an accurate data analysis and influence interpretation of the findings when the data is 
not accurately corrected for this. 
After log-transformation, all samples were concatenated and autoscaled (mean-centered + 
scaled) by the mean and standard deviation calculated across all measured cells disregarding to 
which sample they belong, according to Equations 1-2. These ‘conventional’ pre-processing 
steps are included in methods like Citrus and flowSOM. 
Conventionally pre-processed LPS data 
Self-organizing map algorithm was applied to the standard pre-processed LPS data using the 
SOM toolbox implemented in Matlab. [27] The algorithm was trained on the data using 
parameter settings as used in flowSOM [6]: grid size of 10 x 10, Euclidean distance to find 
nearest neighbor, and training length of 10 epochs. The resulting clustering done by SOM can 
be visualized as minimal spanning tree [7] in Fig 7. Nodes connected to each other are most 
similar, based on their multidimensional marker expressions. 
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Figure 7: SOM tree results obtained for the conventionally pre-processed LPS dataset, 
consisting of centering and scaling by using mean and standard deviation calculated over the 
all the samples. Panel A: Nodes of the SOM tree are colored according to the mean intensities 
of the markers for all the cells assigned to each node; Panel B: Nodes of the SOM tree are 
colored according to the number of cells belonging to the different samples. 
In Fig 7A, each node is depicted with a pie chart representing the average intensities of the 
markers for all the cells assigned to the specific node. By looking at the corresponding colors 
of the markers, no information about distinctive clusters could be extracted. Most of the nodes 
are characterized by high expression of both CD16 and CD62L, suggesting that the tree may be 
dominated by the majority of normal mature neutrophils. Few nodes on the top right and left 
branch appear to have CD16+CD62L- and CD16-CD62L+ phenotype, respectively. However, 
when coloring the pie chart according to the number of cells from each sample in the nodes (Fig 
7B), we can observe that sample-specific clustering is present. In fact, a considerable number 
of nodes consists of cells from mainly the same sample or only a few samples. This indicates 
that SOM algorithm is influenced by between-individual variability which dominates the model 
at the expenses of the subtler variability related to the homogenous LPS-induced response. 
An insight at single-cell resolution level was obtained by viSNE [8] analysis on the same 
conventionally pre-processed dataset. The analysis was done using the Matlab GUI cyt, 
downloaded from the website https://www.c2b2.columbia.edu/danapeerlab. For each sample 
we randomly selected a subset of 2000 cells, so that the total number of cells analyzed was 
32.000. The results of viSNE analysis are shown in the Online Supplementary Material II (Fig 
S6). 
Like in the SOM representation, cells of the same sample are mostly grouped together (Fig 
S6A), suggesting that the clusters found by the algorithm are sample specific. When the viSNE 
map is colored according to the control/response group (Fig S6B), cells of the control and 
response samples overlap considerably. The upper left region and the middle low area appear 
to be distinctive regions for the responder. However, not all the responder samples show cells 
in those regions. Single marker expression profiles are visualized in Fig 8. 
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Figure 8: viSNE analysis performed on the conventionally pre-processed LPS data, consisting 
of centering and scaling by using mean and standard deviation calculated over the all the 
samples. Panel A: Cells are colored based on expression of the single 7 surface markers. Panel 
B: CD62L and CD16 expression plots are zoomed; the region in the viSNE which may be 
assigned to premature neutrophils (CD16-CD62L+) is gated for further inspection. 
In the lower panel we zoomed in the viSNE map that was colored for CD62L and CD16 
expression. In particular, premature (banded nucleus) neutrophils can be detected as having a 
typical CD16-CD62L+ expression. We therefore gated the region corresponding to this 
phenotype in the viSNE map and extracted the cells within the gate. Cells contained in the gate, 
and thus associated to the premature phenotype, are mainly represented by cells from a single 
sample (Patient #5), as shown in the bar plot Fig S7 of the Online Supplementary Material II. 
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To check whether the standard pre-processing could affect the results of a discrimination model 
between the control and responder groups, we performed a Citrus analysis [5]. Citrus was 
performed on the Cytobank platform (https://www.cytobank.org/). The model identified as 
optimal by the double cross-validation procedure (cv.min in Fig S8A, Online Supplementary 
Material II) provided the highest accuracy achievable, corresponding to 25% of misclassified 
samples. Two features were identified as distinctive for the discrimination between LPS 
responders and controls by the cross-validated model. The histograms of the corresponding cell 
clusters, both more abundant in the LPS responders, are shown against the background cluster, 
which contains all the rest of the cells not included in the specified cluster (Fig S8B). 
The cells within these clusters may be identified as premature and mature neutrophils with 
CD16-CD62L+CD64+ and CD16+CD11b+CD69+CD11c+CD62L- phenotypes, respectively. 
The high cross-validation error rate of the model however suggests that the identified clusters 
might not represent all samples within the responder group similarly well. 
 
Multiset pre-processed LPS data 
Multivariate analyses were performed on the LPS data pre-processed with the multiset 
approach. The log-transformed data were mean-centered per individual and scaled over the 
control group (Eq. 6,8). This multiset pre-processing accounts for difference in terms of 
numbers of cells measured per individual sample and may correct for shifts caused by between-
sample variability. 
The results of a SOM algorithm trained on such pre-processed data are shown in Fig 9. When 
displaying the nodes with pie chart (Fig 9A), the whole tree seems to be dominated by the 
majority of normal mature neutrophils having CD16+CD62L+ expression. This was observed 
also when training the algorithm on the standard pre-processed data. Previous work has shown 
how the vast number of normal-like cells presents in the responder individuals can hamper the 
identification of response-specific cell subsets.[10] However, when the pie chart is coloured 
based on the number of cells belonging to the different samples (Fig 9B), it can be observed 
that cells from the 16 samples are distributed throughout the tree. This indicates that the multiset 
pre-processing leads to a cell clustering mostly based on marker expression variability within 
the samples, rather than between samples. 
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Figure 9: SOM tree results obtained for the multiset pre-processed LPS dataset, consisting of 
centering and scaling over the control individuals. Panel A: Nodes of the SOM tree are colored 
according to the mean intensities of the markers for all the cells assigned to each node; Panel 
B: Nodes of the SOM tree are colored according to the number of cells belonging to the different 
individuals. 
The viSNE analysis supports these observations (Fig S9, Online Supplementary Material II). 
The viSNE map, coloured per sample, shows how the cells are distributed across the map and 
no sample-specific clusters are present (Fig 9A). As expected, considerable overlap is present 
between cells from the responder (red, Fig 9B) and control groups (blue, Fig 9B). 
The map is then colored according to the seven marker expression profiles. LPS-specific cells 
CD62L-CD16+CD11b+ are well distinct in the upper left part of the map (Fig 10). Pre-mature 
neutrophils CD16-CD62L+ were also identified (lower part). As done for the previous viSNE 
analysis we gated this region and we observed that cells within the gate are from multiple 
responder individuals as shown in the bar plot Fig S10 in the Supplementary Material II. The 
viSNE analysis applied on the multiset pre-processed data thus models the LPS-induced 
response across all the responder individuals and no sample-to-sample variation seems to be 
dominant. 
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Figure 10: viSNE analysis performed on the multiset pre-processed LPS data, consisting of 
centering and scaling over the control individuals. Panel A: Cells are colored based on 
expression of the single 7 surface markers. Panel B: CD62L and CD16 expression plots are 
zoomed; the region in the viSNE which may be assigned to premature neutrophils (CD16-
CD62L+) is gated for further inspection. 
When Citrus analysis was trained on the multiset pre-processed data, a perfect classification 
was obtained as shown in the Supplementary Material II (Fig S11A). The phenotypes of the 
cell clusters associated with the four features, associated to a null cross-validation error rate, 
are shown in Fig S11B. The first three clusters are more abundant in the responder group and 
they may be associated to premature and mature neutrophils. The last cluster found more 
present in the control group compared to the responder group may be assigned to normal mature 
neutrophils having CD16+CD62L+ expression. 
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Discriminant accuracy comparison for models with various pre-processing options using 
Discriminant Analysis of Multi-Aspect Cytometry (DAMACY) 
In this section we used Discriminant Analysis of Multi-Aspect Cytometry (DAMACY)9 to 
explore the different pre-processing options mentioned in the method section. The whole 
algorithm, including the pre-processing step, was validated using leave one out validation in 
the LPS results and seven-fold cross-validation with fifty iteration in the obese dataset. This 
leads to well statically validated prediction accuracies that may be compared with each other. 
Only DAMACY was used, because the multiset preprocessing options are not yet incorporated 
in other methods and thus unable to correctly validate the results. 
LPS results 
In addition to providing enhanced insight, multiset pre-processing may also benefit the 
discriminative power between control and LPS responders. Discriminant Analysis of Multi-
Aspect Cytometry data (DAMACY)9 first describes the cellular variability in N-dimensional 
histograms based on Simultaneous Component Analysis (SCA) of the pre-processed data using 
the multiset structure. Subsequently it uses Orthogonal Partial Least Squares Discriminant 
Analysis (OPLS-DA)26 on the histograms to create a regression map. The regression map shows 
which cell (sub)populations are more or less present in LPS responders compared to control 
samples. The map can also be used to predict new samples and the prediction performance is 
calculated using double cross-validation procedure. 
Table 1: Prediction performance of the LPS data with DAMACY using different pre-processing 
strategies. The optimal strategy chosen is highlighted in bold. 
Centering Scaling Accuracy Sensitivity Specificity AUC Mean 
#OLV 
Conventional Conventional 75% 88% 63% .86 4 
Whole Whole 81% 100% 63% 1 6 
Control Whole 88% 100% 75% .94 6 
Individual Whole 100% 100% 100% 1 1 
Whole Control 88% 100% 75% .84 5 
Control Control 75% 88% 63% .83 6 
Individual Control 94% 100% 88% 1 1 
Whole Individual 50% 63% 38% .58 6 
Control Individual 25% 38% 13% .39 6 
Individual Individual 100% 100% 100% 1 0 
 
Table 1 shows the prediction performance of different pre-processing strategies using 
DAMACY. Conventionally concatenating the data and subsequently autoscaling leads to a 
prediction accuracy of 75%. Perfect prediction is acquired when multi-set individual centering 
combined with scaling over the entire set and correcting for the number of cells per sample or 
scaling per individual sample. Also the number of orthogonal latent variables (OLV) drops, 
probably because the pre-processing already removed a large part of the orthogonal 
information. Centering based on the whole set in combination with scaling per individual 
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sample leads to an unpredictable model. The data is characterized by shifts in mean due to 
technical variation of the samples, but also has a biological increase in variability in most 
markers due to the LPS induced effect. Scaling per individual without centering per individual 
only removes biological but not the technical variability, which therefore lowers prediction 
accuracy. 
Obesity versus lean data 
Different pre-processing strategies were tested with DAMACY on the obese vs lean dataset, 
using 5-fold cross validation with 50 repetitions. The prediction performance is summarized in 
Table 2. The Receiver Operating Characterics (ROC) curves of the selected pre-processing 
strategies can be visualized in the Online Supplementary Material III, Fig S13. Ideally, the ROC 
curve would go from left bottom corner via the top left corner (all obese samples correctly 
classified with no false positives) to the top right corner. Conventional pre-processing (cyan 
line in Fig S13) of the data leads already to a high prediction accuracy of 76.6%, mainly because 
the obese samples are well predicted (high sensitivity). The obese samples have more cells 
measured compared to the lean individuals and are therefore more important in the model and 
also better predicted. Centering and scaling based on the whole set considering the number of 
cells per sample (dark blue) creates a model with worse accuracy but with increased specificity. 
Centering based on the controls (lean individuals) enhanced the difference between obese and 
lean and led to a slightly better model than conventional pre-processing. Individual centering 
of the data removes the shift in marker expression found in obese individuals and results in bad 
predicting models, while individual scaling in this data improved the prediction accuracy. 
 
Fig 11 shows the DAMACY model based on optimal pre-processing, while DAMACY model 
based on conventional pre-processing and worst pre-processing are displayed in Fig S14 and 
Fig S15 of the Online Supplementary Material III, respectively. The optimal pre-processing, 
consisting of control centering and scaling per individual, shows a clear shift in obese and 
control cells in the direction of CD11b, CD11c and CX3CR1. Cells identified as classical 
monocytes are in direction of CD14 and HLA-DR and they show a split in upper blue 
highlighted and lower red highlighted area which corresponds to increasing CD11b, CD11c and 
CX3CR1 expression in cells more present in obese individuals. The same increase is also 
observed in NK cells in direction of CD16 and CD56. Moreover, a trend in blue highlighted 
areas corresponding to more cells in obese individuals from CD14 towards CD16 is observed, 
which corresponds to transition of classical, intermediate and non-classical monocytes 
(CD14−CD16+). The same information is more difficult to extract from the model based on 
conventional pre-processing, because the trend is more skewed, see Fig S14 and completely 
absent in the model based on worst pre-processing, see Fig S15. Therefore, multiset pre-
processing is beneficial for interpretation, even when it does not specifically enhance diagnostic 
potential. However a screening through all the possible options should be done in order to obtain 
the optimal results.[13] 
 
  
112 
 
Table 2: Prediction performance of the Obesity versus lean data with DAMACY using different 
pre-processing strategies. The optimal strategy chosen is highlighted in bold. 
Centering Scaling Accuracy Sensitivity Specificity AUC Mean 
#OLV 
Standard Standard 76.6% 81.9% 70.0% .860 7 
Whole Whole 75.9% 76.8% 74.5% .826 4 
Control Whole 75.6% 78.6% 72.2% .820 5 
Individual Whole 61.4% 70.1% 50.4% .637 4 
Whole Control 75.6% 78.5% 72.0% .835 5 
Control Control 76.1% 78.5% 73.1% .847 6 
Individual Control 62.1% 71.0% 51.1% .636 3 
Whole Individual 76.7% 78.1% 74.9% .831 7 
Control Individual 76.8% 78.4% 74.8% .845 7 
Individual Individual 62.7% 71.2% 52.2% .646 4 
 
 
Figure 11: DAMACY model of obese versus lean data with optimal centering based on control 
and scaling per individual. The left panel shows the average prediction score of the OPLS-DA 
model of controls as red rounds and asthma individuals as blue crosses. The right panel shows 
negative weights as red and positive weights as blue. The loadings of the Base model are plotted 
on top as black vectors and indicate how each surface marker contributes to the cell variability 
in a specific direction within the model. 
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Discussion 
The integration of the multi-set structure in the pre-processing and multivariate analysis steps 
of MFC data is essential to overcome the influences that non-informative aspects of the data. 
Here we showed that our multi-set pre-processing may be essential to extract the full biomedical 
information from MFC data consisting of samples (sets) which may belong to different groups 
(e.g. case vs control) and may be characterized by different number of cells measured. Based 
on classification accuracy, biomedical insight or both. 
Difference number of cells measured per set 
If the difference in number of cells measured between samples is not corrected, this may bias 
the analysis results and thus lead to a misleading interpretation of the findings. This happens 
because when MFC data are pre-processed (by mean centering and scaling), as conventionally 
done in most analysis methods such as Citrus and flowSOM, the calculated mean shifts towards 
the sample(s) with most cells (see simulated data results). The effect of the shift in multivariate 
analysis is shown by Simultaneous Component Analysis (SCA), which was chosen as it offers 
a representation of cells population together with marker (co)-expression in a single plot. 
Blockscaling (Eq.11) is an integral part of the SCA analysis when estimating the loadings. The 
SCA scores are then calculated by multiplying the pre-processed data with such corrected 
loadings. We showed that only when blockscaling is combined with multi-set pre-processing, 
the resulting SCA model offers the best representation of the original marker expression when 
the number of cells in one of the samples was increased (Fig 6). In other simulated data (Fig 5) 
with less correlation structure because only three variables were measured, blockscaling had a 
negligible influence but the correction provided by the multiset pre-processing improved the 
interpretation of the results. The correction provided by our multi-set pre-processing can be a 
more optimal solution to down-sample the sets that uses all collected data, as done for SPADE 
and (optionally) in viSNE, to make each sample equally contribute to the built model. 
Additionally, it will be crucial when low abundant cell populations are relevant, as their 
detection could be hampered as the mean shifts greatly to the more abundant populations. 
Measurement-to-measurement variability 
Finding biological variability in the samples which is relevant to the studied response/disease 
is one of major challenge in MFC data analysis. Our multi-set pre-processing strategy enables 
to systematically remove variability unrelated to the studied problem while retaining the 
informative biological information. Non-relevant biological or technical variation could 
provoke shifts of fluorescence signals of the same cell population among the samples, as in the 
case of the LPS dataset. When applying conventional pre-processing to the LPS data, this 
variability is not removed and remained quite dominant in the multivariate analyses performed. 
The viSNE and SOM models thus intrinsically described mainly this unwanted variability 
leading to trivial conclusions. In fact, the obtained results enabled us to identify putative 
phenotypically different cells subsets which are not realistically representing the homogenous 
immune response across all the samples. We showed how this sample-to-sample variability 
might also lead to a suboptimal discrimination accuracy in Citrus and DAMACY analysis. By 
using multi-set pre-processing was beneficial for viSNE and SOM analyses of which results 
were better representing the phenotypical variation present in the data. It also helped in 
outperforming the predictive ability of the Citrus and DAMACY discriminant models. 
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The effect of pre-processing investigated using Control vs case studies / data 
Diagnostic ability is another challenge for which MFC data analysis methods should be used. 
The multiset structure allows for pre-processing based on only the control samples to enhance 
the differences between case/responder and control, which may improve the discrimination and 
diagnostic ability. In the case of obese versus lean data standard pre-processing already 
performed very well with 76.6% accuracy, when compared to 76.8% accuracy in the optimal 
model with control centering and individual scaling. However, the optimal model enhances the 
response-specific variability in the case samples, and is therefore better able to describe the 
relationship between the markers measured. This will allow better and more robust 
interpretation of the data, as shown in the comparison between Fig 11 and Fig S14 and S15. 
The high accuracy in conventional pre-processing is mainly caused by the high sensitivity, 
probably because the obese samples had more cells measured and were thus better modeled 
compared to the control individuals. Also, pre-processing choices could be made that are 
detrimental to the predictive power, as the worst model based on individual centering and 
scaling on the whole dataset lead to a prediction accuracy of only 61.4%, which is a decrease 
of around 15% compared to conventional pre-processing. Clearly, a systematic exploration of 
all options for multiset and case-control pre-processing is essential to obtain an optimally 
predictive model.[13] 
The obese versus lean data mainly had a shift in CD11b, CD11c and CXCR1 in monocytes and 
NK cells, see Fig 21. This biological shift is removed by individual centering of the data, see 
Fig S15. However, in the case of the LPS data, control centering and individual scaling lead to 
a predictive performance of 25% compared to perfect prediction when using the optimal pre-
processing. For this reason, multiple pre-processing options should always be explored to find 
the most optimal model. The current pre-processing setup entails only a limited number of 
possible permutations, but it needs to be integrated with the other pre-processing steps for MFC, 
such as transformation and compensation. 
Conclusion 
Nowadays most of the widespread applications of MFC involve the measurements of cells from 
several patients. The same markers are measured across all the patients and this enables the 
arrangement of MFC data in a multiset structure. Here we presented how the integration of 
multiset structure in the pre-processing and analysis of MFC data led to better interpretation of 
the analysis methods the results and corrected for challenges occurring in MFC. In fact, the 
multiset pre-processing proposed corrects for difference in number of cells measured across all 
the patients. This difference should be always taken in consideration because it may be 
detrimental for the interpretation of the findings of the analysis method used, as demonstrated 
with the simulations proposed. 
In addition, the versatility of the pre-processing algorithm allows several different pre-
processing strategies. These include solutions to remove unwanted non-biological/technical 
variation between the samples and strategies to best accommodate the study research questions, 
e.g. discrimination between control and diseased/case group. 
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The multi-set pre-processing (already present in DAMACY and ECLIPSE algorithms) may be 
implemented in any multivariate data analysis methods. This may enable outperforming of 
prediction accuracy and lead to more robust results. 
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Supplementary material I 
Simulated Data 
 
Figure S 1: 2D scatter plot of simulated data A. A ‘control’ population is depicted in red, while 
‘responder’ population is visualized in blue. The responder population shows a different shape 
and it is shifted compared to the control population 
 
 
 
Figure S 2: Histograms showing the expression of the two variables included in the 2-
dimensional synthetic data. The three populations blue, red and green are displayed with 
corresponding colors and different line style. 
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Figure S 3: Histograms shown the marker expression level of the three markers created for the 
synthetic data consisting of three single-population groups blue, red and green. Each group is 
represented by the corresponding color and different line style and it is characterized by the 
exclusive (positive) expression of the marker of the corresponding color 
 
 
Figure S 4: Histograms shown the marker expression level of the six markers created for the 
synthetic data consisting of three samples colored blue, red and green. All three samples have 
a common cell population with high expression for Green, GreenRed, Greenblue and low for 
Blue and Red. The blue and red sample have an extra small population high for Blue and Red 
respectively and low for GreenRed and Greenblue respectively and both are low for Green. 
Variable AntiGreen is negative correlated to Green. 
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Supplementary Material II 
LPS data 
 
 
Figure S 5: Panel A: Histograms of the original single marker expression of control individuals. 
Different individuals are displayed in different colours; Panel B: Histograms of the original 
single marker expression of responder individuals. Different responder individuals are 
displayed in different colors. 
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Figure S 6: viSNE analysis performed on the conventionally pre-processed LPS data, consisting 
of centering and scaling by using mean and standard deviation calculated over the all the 
samples. Panel A: cells in the viSNE map are colored per different sample; Panel B: cells in 
the viSNE map are colored based on control (blue) and responder (red) group. 
 
Figure S 7: Barplot of the amount of cells per each individual present in the gated region which 
may be identified as premature neutrophils of the viSNE map. Cells contained in that region 
are mainly from the responder individual Patient #5. 
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Figure S 8: Panel A: The Figure shows the Model Cross-validation Error Rate vs the 
log(Regularization Threshold) for the classification models constructed on the standard pre-
processed LPS dataset. The green circle (cv.min) points out the model with the smallest number 
of features necessary to obtain the lowest cross-validation error; while the orange diamond 
(cv_1se) indicates the model with the smallest number of features associated to cross-validation 
error 1 std higher than the minimum error. The model with cv.min is chosen by the Citrus 
analysis and this corresponds to an error rate of around 25%; Panel B: The histograms show 
the phenotype of the cells belonging to the cluster (red) selected by the cross-validated model. 
The background histograms (blue) show the rest of the data, not included in the cluster. Cells 
from cluster 38650 are characterized by the distinctive phenotype 
CD16+CD11b+CD69+CD11c+CD62L-; cells from cluster 38655 are CD16-
CD62L+CD64+. Both clusters are more abundant in the responder group. 
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Figure S 9: viSNE analysis performed on the conventionally pre-processed LPS data, consisting 
of centering and scaling over the control individuals. Panel A: cells in the viSNE map are 
colored per different individual; Panel B: cells in the viSNE map are colored based on control 
(blue) and responder (red) group. 
 
Figure S 10: Barplot of the amount of cells per each individual present in the gated region 
CD16-CD962L+ which may be identified as premature neutrophils of the viSNE map. Cells 
contained in that region from all the responder individuals; also control individuals have small 
percentage of cells in the gated region. 
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Figure S 11: Panel A: Cross-validation error rate plot for the analysis on the multiset pre-
processed LPS dataset. Model Cross Validation Error Rate equals to 0 is obtained with 4 
stratifying features. Panel B: Histograms show the phenotypes of the four cluster identified by 
the cross-validated classification model. The first three clusters are more abundant in the 
responder group: cluster 38658 and 38666 present phenotypes that might be assigned to pre-
mature neutrophils, with CD16-CD62L+andmid; cluster 38663 might be identified as mature 
neutrophils with CD16+CD11b+CD62L-. Cluster 38668, more abundant in the control group, 
can be associated to mature neutrophils. 
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Supplementary Material III 
 
 
Figure S 12: Receiver Operating Characteristic (ROC) curve of the prediction performance on 
the discrimination of lean versus obese individuals with DAMACY using different pre-
processing strategies 
 
 
Figure S 13: DAMACY model of obese versus lean data with conventional pre-processing. The 
left panel shows the average prediction score of the OPLS-DA model of controls as red rounds 
and asthma individuals as blue crosses. The right panel shows negative weights as red and 
positive weights as blue. The loadings of the Base model are plotted on top as black vectors 
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and indicate how each surface marker contributes to the cell variability in a specific direction 
within the model. 
 
 
 
 
Figure S 14: DAMACY model of obese versus lean data with worst pre-processing, centering 
per individual and scaling based on the whole dataset. The left panel shows the average 
prediction score of the OPLS-DA model of controls as red rounds and asthma individuals as 
blue crosses. The right panel shows negative weights as red and positive weights as blue. The 
loadings of the Base model are plotted on top as black vectors and indicate how each surface 
marker contributes to the cell variability in a specific direction within the model. 
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In the next chapter: “Automated flow cytometric identification of disease-specific cells by 
the ECLIPSE algorithm” my main scientific contribution on the pre-processing and 
Simultaneous Component Analysis of the data, specifically “step 0: multiset 
preprocessing” in the supplementary and “step 1: Simultaneous Component Analysis of 
Controls” in the methods section. I furthermore contributed to writing, reviewing and 
editing the entire manuscript for publication. 
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Multicolor Flow Cytometry (MFC)-based gating allows the selection of cellular (pheno)types 
based on their unique marker expression. Current manual gating practice is highly subjective 
and may remove relevant information to preclude discovery of cell populations with specific 
co-expression of multiple markers. Only multivariate approaches can extract such aspects of 
cell variability from multi-dimensional MFC data. We describe the novel method ECLIPSE 
(Elimination of Cells Lying in Patterns Similar to Endogeneity) to identify and characterize 
aberrant cells present in individuals out of homeostasis. ECLIPSE combines dimensionality 
reduction by Simultaneous Component Analysis with Kernel Density Estimates. A Difference 
between Densities (DbD) is used to eliminate cells in responder samples that overlap in marker 
expression with cells of controls. Thereby, subsequent data analyses focus on the immune 
response-specific cells, leading to more informative and focused models. To prove the power 
of ECLIPSE, we applied the method to study two distinct datasets: the in vivo neutrophil 
response induced by systemic endotoxin challenge and in studying the heterogeneous immune-
response of asthmatics. ECLIPSE described the well-characterized common response in the 
LPS challenge insightfully, while identifying slight differences between responders. Also, 
ECLIPSE enabled characterization of the immune response associated to asthma, where the co-
expressions between all markers were used to stratify patients according to disease-specific cell 
profiles. 
Introduction 
Multicolour Flow Cytometry (MFC) is a powerful analytical technique, widely used in 
biomedicine as a diagnostic tool to evaluate and characterize health and disease.1 It enables 
quantitative detection of marker expression, among other cell characteristics, at the single-cell 
level by specific antibodies conjugated to a multitude of fluorophores. The power of MFC lies 
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in the simultaneous measurement of multiple surface or intra-cellular markers. This allows both 
a comprehensive biological and physical characterization of cells and cell populations of 
interest. Advances in technology and fluorophore chemistry have drastically increased the 
number of parameters that can be concurrently measured.2,3. Fluorescence-based flow 
cytometry allows simultaneous measurement of more than 20 markers, while the most recent 
generation of mass cytometry platforms (Cytometry-Time of Flight) can routinely run 
experiments with more than 40 parameters.4 In fact, massive amounts of data are generated in 
a single experiment, for which many different dedicated data analysis methods have been 
proposed.5 
One of the major objectives of MFC data analysis is the identification of homogenous cell types 
of interest. In the conventional MFC data analysis software, cells of interest are selected through 
a selection process called ‘gating’, based on uni- or bivariate marker expressions. Manual 
‘multiple’ gating on binary combinations of cell characteristics is by far the most widely used 
method. This is however highly subjective and resource-intensive, because expert technicians 
need to establish quantitative thresholds in several bi-dimensional plots that cannot be mutually 
compared on the single-cell level. Manual gating of a data set with seven measured cellular 
markers would already require inspection of 21 bivariate plots per individual sample. The 
number of possible combinations becomes difficult to manage with increasing numbers of 
measured markers, to the extent that the manual gating approach becomes unfeasible quite soon. 
Aside from the extensive time-consumption involved, it would place additional requirements 
in consistency of operation and expertise between operators. Moreover, this bi-dimensional 
approach is done hierarchically, by which cell populations may be overlooked like in sequential 
gating on single markers.6 
Recently, several multivariate methods have been proposed to overcome these problems. The 
viSNE method7 is commonly used as a visualization tool for high-dimensional MFC data. 
Clusters of single cells are visualized in a biaxial viSNE map, using the non-linear t-Stochastic 
Neighbour Embedding (t-SNE) algorithm for dimensionality reduction. Even though viSNE 
may be beneficial in the presence of strongly non-linear data, the use of such a non-convex 
objective algorithm brings about several drawbacks. Each run performed on the same dataset 
would result in a different map, making the maps difficult to validate. Consequentially and 
importantly, the arrangement of the cells cannot be directly and easily associated with the 
marker expression and it is not possible to project a new individual in an existing map without 
a complete new run. This highly limits the comparison of new, incoming datasets to a model 
calibrated and validated as a diagnostic instrument for single-cell analysis.  
Spanning-tree Progression Analysis of Density-Normalized Events (SPADE)8 uses hierarchical 
clustering to connect different cell subpopulations in ‘minimum spanning trees’ which 
represents their mutual relations. The cell distribution is visualized as nodes of clustered cells 
in the SPADE tree that have specific phenotypes. Unlike viSNE, a new MFC sample may be 
represented into a spanning minimum tree previously built on a dataset, by matching all the 
cells to the nodes with the most similar phenotype. However, if an extra cell population is 
present in the new sample, these cells are forced to incorrectly belong to one or more of the 
available nodes. The (high) residuals of the projection of the cells are not directly detectable. 
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Another recently developed method, Citrus9, also uses hierarchical clustering to identify 
phenotypically similar cell populations. The method is particularly used for intergroup analysis, 
for which a regularized classification model detects group-specific cell clusters for each sample. 
Both SPADE and Citrus adopt multivariate and linear approach but they fail, like viSNE, to 
show the multivariate co-expression that underlies the diversity of cell phenotypes. Co-
expression relationships among all the measured markers either remain hidden in the models or 
are limited to a visual inspection of all the single marker expression levels. 
Two alternative methods to analyse Flow Cytometry data are APS (Automatic Population 
Separator)10, and FLOOD (FLow cytometric Orthogonal Orientation for Diagnosis)11. Both 
methods employ Principal Component Analysis (PCA)12 as dimension reduction technique to 
condense the relevant biological cell marker information in a few, mostly two, dimensions. 
Although they use the same underlying principle, both methods differ considerably in important 
aspects. APS builds a PCA model on different phenotypes of disease known as reference 
groups. After that, each case is compared against each reference group13 and it is matched to 
the closest group in the PCA space. The reference groups need to be established a priori, which 
becomes challenging in absence of information about a disease and/or with a small number of 
individuals within each reference group. The solution to circumvent this disadvantage is to use 
healthy individuals as reference group and highlight the deviation of diseased individuals from 
the normal cell marker variability, as done in FLOOD. The FLOOD approach first describes 
the characteristic cell-to-cell marker variability among healthy (or control) individuals; then it 
models the cell variability present only in responding individuals within a second model, the 
response model. FLOOD provides multivariate ‘biplots’ that offer an intuitive view of the cell 
marker variability associated to a specific immune response, interpreted in terms of co-
expression between all the markers, in a representation that is analogous to that used in bivariate 
gating. However, the information within the FLOOD response model is reduced by the 
contribution of considerable numbers of ‘healthy’ (or not response-specific) cells in the analysis 
of responding individuals. 
We present ECLIPSE (Elimination of Cells Lying in Pattern Similar to Endogeneity), which 
combines Simultaneous Component Analysis (SCA), a generalization of PCA suitable for MFC 
data, and Probability Density Functions of the cell distribution in the dimension reduced space, 
to identify and eliminate the ‘healthy’ or ‘normal’ cells from the patient (or responder) data. 
Since these normal cells in the responder individuals are not the discerning factor in the disease 
response (only the change in number is), they can be removed from the MFC dataset. When 
initially healthy cells change in relative abundance or when they upregulate or downregulate 
certain markers as a response to a stimulus or a disease, these cells are considered response-
specific and are, therefore, not removed from the dataset. 
Methods 
Data 
LPS study 
MFC measurements of the ‘Lipopolysaccharide study ‘were performed on cells obtained from 
healthy individuals challenged with systemic endotoxin (LPS). 
(NCT01374711; www.clinicaltrials.gov) The LPS dataset comprises gated neutrophils from 
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eight ‘control’ individuals who did not receive LPS intravenously, and eight different 
‘response’ individuals who received LPS administration and from whom blood was collected 
180 minutes post LPS administration. Seven surface markers were measured on the neutrophils 
in samples of both classes of individuals: CD62L, CD11b, CD11c, CD64, CD32, CD69, and 
CD16. Further details regarding the Flow Cytometry experiments that generated the data can 
be found in a previous publication.11 
Asthma study 
The asthma dataset consists of a ‘response group’ of 11 patients classified as suffering from 
severe asthma (aged 22-78, x̅ = 57) and a ‘control group’ of 10 non-asthmatic individuals (aged 
25–57, x̅ = 40). Whole-blood cells were stained with the following eight fluorescent markers: 
CD3, CD4, CD8, CD14, CD16, CRTH2 (CD294), CD123, and CD193. After staining, red 
blood cells were lysed using a FACS Lysing solution (Becton Dickinson). Cells were measured 
on a LSR Fortessa flow cytometer (Becton Dickinson).14 
In both studies, the data were compensated before the analysis to limit the spectral ‘spill over’ 
between the markers. This assures that conclusions drawn on marker co-expressions were 
mainly due to biological correlation rather than spectral overlap. 
Details about the pre-processing procedure to transform the data can be found in the Online 
Supplementary Material I. 
ECLIPSE algorithm 
The MFC data were arranged in a multiset structure illustrated in the Supplementary Material 
I. This arrangement is relevant throughout the quantitative analysis of Flow Cytometry data and 
each following step of ECLIPSE therefore takes this distinctive structure by design, while 
retaining the information of each single individual sample. In fact, the ECLIPSE method, 
through the whole algorithm, takes into account the fact that cells in MFC data may come from 
different individuals. Difference in terms of the number of cells measured per individual is 
preventively addressed in the pre-processing (extensively described in Step 0: Data pre-
processing, in Online Supplementary Material I), so that each individual equally contributes to 
the models, disregarding the size of each set. The ECLIPSE algorithm is described step by step 
and the FlowChart of the methodology is shown in Figure 1. 
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Figure 1: Flowchart of the ECLIPSE algorithm. In light blue are highlighted the pre-processing 
steps (0a: pre-processing on the raw MFC data, 0b: pre-processing on the raw MFC data, after 
removal of normal cells); in red the probability densities distribution estimations (2A: estimate 
of control PDF, 2B: estimate of responder PDF, from the projection of responder-group cells); 
in grey the results of the corresponding previous steps. 
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Step 1: Simultaneous Component Analysis on control individuals 
Chemometric dimension reduction techniques such as Principal Component Analysis (PCA) 
reduce the multidimensional information into a few dimensions to facilitate the information-
rich representation of, in this case, flow cytometry data6. PCA is an unsupervised technique for 
the multivariate explorative analysis that operates dimension reduction of multidimensional 
data. The idea underlying PCA is to contract the information present in the original variables in 
a lower-dimensional space that best fits the data, with the aim of retaining all the relevant 
information and removing minor, non-systematic sources of variability. PCA operates a 
projection of the original data onto a new, reduced space where each dimension is a linear 
combination of the original variables. The new dimensions, called Principal Components 
(PCs), capture as much variability in all immunological features among all measured MFC 
events as possible. They are mutually orthogonal and the first Principal Component explains 
most of the original variance and the successive principal components explain then the highest 
percentage of remaining variance.12 
PCA has been widely used to reduce the dimensionality of Multicolour flow cytometry 
data10,15,16. Because these earlier methods disregard the MFC multiset structure (described in 
Figure S1 of the Online Supplementary Material I), application of such methods may lead to 
individuals with large numbers of cells dominating the resulting model. Multiset extensions of 
PCA, such as described here, consider these differences, in a way that each individual will 
contribute equally to the constructed model. Secondly, PCA on both control and responder 
individuals simultaneously may mix normal and response-related cell variability in the resulting 
PCA model. Both aspects need to be addressed in a comprehensive modelling approach. 
From the multiset structure, we consider the control individuals and we build a Control Model, 
which describes the cellular markers’ variability within all the control class individuals. This 
variability is not of primary interest for describing the immune response; it may therefore serve 
as a benchmark, where the complement to the cell variability in immunologically perturbed 
samples or responder individuals is more likely response-related. The availability of identical 
loading vectors across all control individuals explicitly models the similarities between all 
control individuals and allows direct comparison between the distinctive scores for each control 
individual. The Simultaneous Component Analysis with equal patterns (SCA-P) imposes the 
constraint of identical loading vectors.17 
The pre-processed MFC data are arranged in the matrix 𝐗sc0 from Equation S5 (Supplementary 
Material I, Data pre-processing) of size 𝑁𝑖𝑔x 𝐽 , where 𝑁𝑖𝑔 is the number of cells of the 𝑖𝑔–th 
individual, 𝑖𝑔 = 1𝑔, … , IG , with 𝑔 = 0 for the control and 𝑔 ≥ 1 for the responder groups; 𝐽 
corresponds to the markers measured,1… 𝑗 … 𝐽. Before applying the SCA decomposition, 𝐗sc0 
is normalized such that each individual contributes with the same amount of information, 
regardless of the number of cells measured per set (Eq. 1). The resulting matrix 𝐗sc0∗  is then 
decomposed according Equations 2a-b-c: 
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𝐗sc0∗ =
[
 
 
 
 𝐗𝒔c𝟏𝟎
𝐍𝟏𝟎
−
𝟏
𝟐 
⋮
𝐗𝒔c𝑰𝟎
𝐍𝑰𝟎
−
𝟏
𝟐
]
 
 
 
 
              Eq.1 
(a) 𝐗sc0∗= 𝐓0∗𝐏0
T + 𝐄0∗        Eq.2 
(b) 𝐓𝟎 = 𝐗sc0  𝐏0
T 
(c) 𝐄0= 𝐗sc0 −  𝐓0𝐏0
T 
where the matrix of the scores 𝐓0, of size ∑ 𝑁𝑖𝑔x 𝑅𝐶  
𝐼0
𝑖0
, with 𝑅C dimensionality of the new low-
dimensional space, holds the coordinates of the 𝑖𝑔–th control individual in the new space; 𝐏𝟎 
the 𝐽 x 𝑅C  matrix of loadings, common to all the control individuals; 𝐄0  of size 
∑ 𝑁𝑖𝑔x 𝐽 
𝐼0
10
contains the residuals of the 𝑖𝑔 control individuals, with 𝑖𝑔 = 10, … , 𝐼0. 
The scores 𝐓0 represent the major variability across cells in all cellular markers simultaneously. 
This is however an inherently simplified representation. The residuals matrix 𝐄0 contains the 
cell variability that remains unmodeled by loadings P0. These residuals may be diagnostic for 
outlying or abnormal cells, where cells with high residuals are poorly described by the Control 
loadings. This abnormality is quantified in the Sum Prediction Error (SPE) in Equation 3: 
𝐒𝐏𝐄𝑖0 = sum(𝐄𝑖0𝐄𝑖0
T)         Eq. 3 
Where 𝐄𝑖0contains the residuals for the 𝑖0–th individual. The statistics for all the 𝐼0 control 
individual might be collected in the cumulative 𝐒𝐏𝐄0=[
𝐒𝐏𝐄𝟏𝟎
⋮
𝐒𝐏𝐄𝐼𝟎
] of size ∑ 𝑁𝑖0x 1
𝐼
1 . A confidence 
limit corresponding to the (1- α) percentile may be evaluated for the statistics SPE𝑖0of each 
individual as the value exceeded by α% of the cells. These individual values with α=0.05 can 
be collected in the vector SPE00.05=[
𝑆𝑃𝐸𝟏00.05
⋮
𝑆𝑃𝐸𝐼00.05
] of size 𝐼0 ×  1. The total confidence limit, is 
calculated as the mean of the individuals 𝑆𝑃𝐸𝒊00.05and it is used as reference to establish the 
degree of “normal condition” of the cells. 
Step 2: Probability density estimation of cell variability with KDE 
The Control Model may be represented in a multivariate biplot. This two-dimensional 
representation, obtained by plotting two principal components and superimposing these onto 
the loadings, allows simultaneous visualisation of the ∑ 𝑁𝑖𝑔  
𝐼0
10
observations and the J variables 
and therefore how these associate. 
In the resulting space, the single cell coordinates of an individual are represented as single 
points. To enable interpretation of the distribution of the cells and the presence of distinctive 
cell subpopulations we approximate this distribution from the measured single cells by 
multidimensional density estimation. The probability density function (PDF) may be used to 
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describe the probability that a cellular marker expression assumes a certain value in a D-
dimensional space, which can be established by Kernel Density Estimation.18,19 
This estimate does not require a priori assumptions about the shape of the underlying 
distribution of the expressions, such as Mixture Modeling20. The density estimation results from 
the sum of the individual contributions of the estimated function centered at each sample 
position. In our case the sample position is represented by the scores’ coordinates in the 𝑅C- 
dimensional PCA space for each cells belonging to the 𝑖𝑔–th individual. 
Step 2A, in the Flowchart Figure 1, estimates the PDF of the control cell scores with KDE. 
Equation 4 contains the formula for the KDE for each cell score belonging to the 𝑖0–th control 
individual: 
𝑓𝑖0
̂(𝑡, h) =
1
𝑁𝑖0ℎ
∑ 𝐾 (
𝐭T−𝐭𝑛𝑖0
T
ℎ
)
𝑁0
10
       Eq. 4 
where 𝐭𝐓is a vector holding the location where the function is being evaluated, expressed in 
score coordinates in the PCA space; 𝐭𝑛𝑖𝑔
T contains the location of the 𝑖-th cell score belonging to 
the control individual 𝑖0–th; 𝑁𝑖0 is the total number of cells; 𝐾 the kernel function centered at 
the cell score location and ℎ the width of the such kernel function, that works as smoothing 
parameter. 
We used Gaussian function as kernel functions 𝐾. Several studies have shown, however, that 
this choice of 𝐾 does not strongly determine the estimate21. The kernel bandwidth ℎ in Equation 
4 determines the model outcome to a much larger extent. Figure S2 in the Online Supplementary 
Material I, illustrates the effects of the bandwidth choice on the estimate of a normal 
distribution. Large bandwidths will mask finer structures of the data that may be biologically 
relevant. Too-small bandwidths may result in spiky density estimates that may be challenging 
to interpret. Finding the bandwidth where the estimate best approximates the true distribution 
is therefore imperative. Various methods for optimal bandwidth selection have been proposed 
in literature22,23. The method proposed by Botev et al. based on the Fast Gauss Transform 
performs best in estimating simulated distributions24,25. This relatively fast and accurate method 
was particularly better in representing multimodal distributions of the cellular marker 
expressions that are characteristic of multiple cell populations. A specific advantage of using 
the aforementioned method to fit the KDE lies in the fact that it automatically evaluates the 
optimal bandwidth of Gaussian kernel functions 𝐾 . The KDE formulation (Eq. 4) already 
includes a normalization over the number of cells per individual 𝑁𝑖0, facilitating quantitative 
comparison between estimates of different individuals within the control class. The KDEs for 
each individual may be pooled into a KDE0 of all control individuals by summing up the 
individual KDEs and subsequent normalization to unit probability. 
Step 3: Projection of responder individuals onto the Control Model 
The Control Model created in Step 1 explains the cellular marker variability of the control 
individuals. Step 3 consists of orthogonal projection of the cells of the responder individuals 
into the control space. Assuming the value for the case group ≠ 0 ∧  𝑔 = 1 , the orthogonal 
projection is provided by the equation: 
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𝐓1 = 𝐗sc1𝐏𝟎          Eq. 5 
𝐄1 = 𝐗sc1 − 𝐓1𝐏0
T         Eq. 6 
Where Eq. 5 is further equivalent: 
[
𝐓𝟏𝟏
⋮
𝐓𝐼𝟏
] =  [
𝑿sc𝟏𝟏
⋮
𝑿sc𝑰𝟏
] 𝐏0         Eq. 7 
𝐓1 ( ∑ 𝑁𝑖𝑔x 𝑅𝐶) 
𝐼1
𝑖𝑔=11
is the matrix of the scores for all the 𝑖1–th responder individuals, projected 
in the Control Space using the orthogonal loadings 𝐏0  (Eq. 1) from controls and 𝐄1 
( ∑ 𝑁𝑖𝑔x 𝐽) 
𝐼1
11
refers to the matrix containing the residuals of the projection. Cells with high 
residual are outliers in the Control Model and considered abnormal or response-specific. Such 
cells can be detected by evaluating the Sum Prediction Error (SPE) of the projections using Eq. 
3, against the confidence limit for the control calculated as mean of the 𝑆𝑃𝐸𝒊00.05of the 𝑖0–th 
control individuals. Cells of which the SPE exceeds this limit are considered ‘non-normal’ in 
their marker expression, as it does not overlap with the variability within the Control model 
density estimate. These non-normal cells are specifically interesting for the immune response 
and therefore excluded from the Control Space and they will be reintroduced in the model just 
after the ECLIPSE filter provided by Step 4, Flowchart Figure 1). 
We estimate the Probability Density Function for the scores of the remaining cells of the 
responder individual with KDE using Eq. 4 (Step 2B of the Flowchart, Figure 1). In addition to 
the amenable representation of the cell scores distributions in a 2D-space, the PDF estimations 
might allow a direct and easy comparison of cell distribution drawn from different populations. 
Step 4: Difference between Densities 
We may now match the KDE of each responding individual against the cumulative control 
kernel estimate, resulting in a Difference between Densities (DbD) for each responder 
individual26. This step is the core of the ECLIPSE algorithm, with the DbD as an automated 
filter to exclude those cells with a marker expression that is also found in control individuals. 
Cells are binned onto the DbD ; bins with a positive value contain cells with a higher chance to 
be found in control individuals. This isolates the cells that are more likely to be found in 
responders than in control individuals, and therefore likely response-specific together with 
those cells with a SPE that exceeds the limit observed in the control individuals isolated in Step 
3. 
Step 5: ECLIPSE model 
As a result from previous steps the new matrix 𝐗E1 contains the raw signals of the response 
specific cells while retaining the information of the individuals, which means that the multiset 
structure is maintained. The resulting matrix needs to be pre-processed following the recipe 
chosen in Step 0. After log or arcsinh transformation, 𝐗E1is autoscaled using the mean and the 
standard deviation of each responder individual (i.e. individual centering), according to Eq. S2b 
and S3c, in the Online Supplementary Material I. The autoscaled matrix 𝐗E1is normalized over 
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the number of cells of each individual, following Eq. 1, and then decomposed through 
Simultaneous Component Analysis, according to Eq. 8: 
(a) 𝐗E1∗ = 𝐓E1∗  𝐏E1
T + 𝐄E1∗  
(b) 𝐓E1= 𝐗E1∗  𝐏E1
T  
(c) 𝐄E1= 𝐗E1 − 𝐓E1  𝐏E1
T         Eq. 8 
where the matrix of scores 𝐓E1  has size ∑ 𝑁𝐸,𝑖𝑔x 𝑅𝐸  
𝐼1
11
, with ∑ 𝑁𝐸,𝑖𝑔
𝐼1
11
the total number of 
activated or responding in the responder individuals, and 𝑅E the number of dimensions of the 
new ECLIPSE space in which the majority of the original variability is explained; 𝐏E1the 𝐽 x 𝑅E 
matrix holding the loadings, common to all the responder individuals; 𝐄E1 of size ∑ 𝑁𝐸,𝑖𝑔x 𝑅E
𝐼1
11
 
contains the residuals for the ECLIPSE space. 
The ECLIPSE model, built on the activated cells within the responder individuals, allows the 
investigation of the cellular marker variability introduced by the immune response to the 
disease. This variability is indeed modelled through SCA, which makes it directly comparable 
across of the responder individuals with the common matrix of loadings 𝐏E1 . The loadings 
contained in 𝐏E1 exclusively describe relations and correlations among cellular markers 
exhibited by cells that produced or activated in the immune response. These relations are the 
ones important for the understanding of the pathogenesis and progress of the disease under 
study. No information about the normal cells is left in this model, because the elimination Step 
4 excludes cells with marker expressions similar to those observed in the control individuals. 
Stratified ECLIPSE model 
The ECLIPSE model may be very insightful to reveal similar cell distribution patterns across 
different individuals. This information can then be used to subsequently stratify individuals 
based on their ECLIPSE scores into responder subgroups. This can be very useful to study 
immune responses involving subtypes that are either known or unknown, with cell variability 
both unlike each other and unlike that in the control individuals. Such stratification could be 
done by visual inspection of the score distributions of 𝐓E1, perhaps including prior knowledge, 
but here we propose to cluster the scores of different individuals with an automated algorithm. 
Cells of each individual are binned into the ECLIPSE space; pairwise distances are calculated 
between bins across all the responders. The obtained distance matrix is then a measure of 
(dis)similarity of the score distributions between the individuals. Responders that present cells 
in the same bins (small distances), express similar cell populations and are therefore allocated 
to the same cluster. When multiple individuals cluster closely together and away from other 
individuals, they can be modelled by an ECLIPSE (partial) cluster-specific model dedicated to 
those individuals to better focus upon their specific cell variability in marker expression of 
likely response-specific cells. 
Quantitative Validation of the ECLIPSE approach 
Steps 1 and 5 (Flowchart Figure 1) involve a dimension reduction to condense the cellular 
marker variability within the control individuals (Step 1) and the responder cells (Step 5) 
respectively into fewer representative dimensions. The number of significant principal 
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components needed for this should be estimated with a bootstrapping procedure to result in a 
stable model solution27,28. 
The cells within each individual 𝐗𝑖𝑔 from the multiset structure are bootstrapped and SCA is 
applied to each new resulting multiset matrix; the stability of the angle between the loading 
subspaces of the bootstrapped samples should be high to indicate that the SCA components 
describe relevant and systematic information rather than cells occurring in only one or a few 
individuals. 
Results 
We illustrate ECLIPSE with two case studies. The first investigates the immune response in 
individuals that intravenously received endotoxin Lipopolysaccharide (LPS) as a model of 
systemic inflammatory response syndrome (SIRS).29 
In the second study, the immune response in peripheral blood of severe asthma patients is 
examined. Asthma is a chronic and heterogeneous disease, consisting of several disease 
phenotypes with distinct etiologies and underlying immune responses. Distinguishing these is 
essential for efficient medical treatment of the relevant phenotypes in the asthma patients.30 
The running time for both the LPS data (281505 events) and the asthma study data (2157326 
events) did not exceed 2 minutes when computing the analyses on a laptop with 2.7 GHz, i7-
7500U processor, 8GB of memory. 
Lipopolysaccharide challenge 
Intravenous administration of LPS in humans induces the rise of neutrophil subpopulations in 
the peripheral blood that are normally absent. This is most prominent 180 minutes after LPS 
administration. The two neutrophil subpopulations that are induced after LPS challenge can be 
distinguished based on their expression of CD16 and CD62L. One of the populations is 
CD62LdimCD16bright and the second population is CD62LbrightCD16dim. Next to these markers it 
has been shown that co-expression of multiple other surface markers characterize these 
neutrophil subpopulations.11,31. 
After log-transformation, the data were mean-centred per individual and scaled over the control 
group, according to Equations S2b and S5b, respectively. Supplementary Material I contains 
more detailed information on the data pre-processing. A control individual identified as outlier 
from previous analysis11 was excluded from the ECLIPSE modelling. 
The bootstrapping procedure indicated that two components for the Control Model describe the 
variation of the marker expression in a stable model of the Control individuals. These 
components together explain 45% of variability in marker expression across cells from control 
individuals, ranging between 42-53% per individual. This indicates that the model provides a 
balanced representation of all seven control individuals. Although this percentage might appear 
nominally low because the majority of marker variability remains unexplained, statistical model 
validation shows that models with additional components are more unstable and therefore 
inappropriate as generic filters for ‘normal’ cells. 
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Figure 2: Panel a Scores plot of control cells of all the control individuals in the Control 
Space, plus 3D-contour of the PDF of the control scores estimated with KDE; Panel b Scores 
plot of all the responder cells projected in the Control Space, plus 3D-contour of the PDF of 
the responder scores estimated with KDE. 
 
Figure 2 shows the Control score distributions of cells in control individuals (a, in blue) and of 
the responder individuals (b, in red) projected onto the control model. Dots represent single 
cells within the dimension-reduced space. The third dimension is the ‘Kernel density estimation 
(KDE) intensity’, i.e. the local density estimate at each cell score position. Locations with 
higher KDE intensities are more densely populated by cells. The inhomogeneous estimate in B 
indicates a distribution of cells with a continuum variation of fluorescent signal intensities, i.e. 
surface marker expressions, compared to the control individuals. 
The biplot (Figure 3a-b) shows the scores distribution of the cells, as a 2D-density 
representation, together with the surface marker loadings. This plot shows how the continuum 
a
o
 
b
o
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of the cell scores associates with the co-expression of the different surface markers. The 
homogeneous neutrophil population in the control individuals (Figure 3a) varies mostly in 
expression of CD11b, CD11c and partially CD16, where cells on the right side of the 
distribution co-express these markers above-average and more than cells on the left side. The 
large loadings of CD32, CD62L and CD69, in the vertical direction, indicate that the expression 
of these markers varies considerably among the neutrophils, along the second component. 
The responder cells projected into the Control Model (Figure 3b) vary in a characteristic ‘bean-
like’ shape, showing neutrophil subpopulations towards the markers CD16/CD11b/CD11c 
from one side and CD32/CD62L/CD69 from the other, that emerge upon LPS response. 
However, responder individuals contain a considerable fraction of cells with cell surface marker 
expressions identical to the cells within samples from non-responding Control individuals. 
These cells are less-interesting for the immune response characterization and would 
considerably affect any quantitative models of cells variability in responder individuals, at the 
expense of the rarer cells associated with the LPS induced immune response 
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Figure 3: Panel a, Biplot representation of PDF of the control scores, estimated with KDE; 
Panel b, Biplot representation of the PDF of the responder scores, estimated with KDE. The 
loadings of the SCA Control Model are plotted as vectors: their length indicates the 
contribution of each marker to the cell-to-cell variability; the mutual directions suggest a 
positive (same direction) or negative (opposite direction) co-expression. An angle of 90 
between the direction of the vectors indicates no co-expression. 
We therefore selected those cells that deviate from the normal cell surface marker variability in 
the space defined by the first two PCs of the Control model. These abnormal cells are selected 
in two independent steps. 
First, cells with high Sum Prediction Error (SPE), analogous to Equation 3, are worth further 
investigation. The Control Model cannot explain these cells well: they exceed the limit 
established for the Control Model, and are therefore designated as ‘abnormal’. The percentage 
a
o
b
o
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of these abnormal cells ranges between 12-21% for the different responder individuals—
considerably and consistently higher than the 5% of cells in control individuals. 
Secondly, cells with model residuals similar to those in the control individuals may be further 
filtered by quantitative comparison of the kernel density estimates of each Responder against 
that of the control group. The resulting responder-specific Difference between Densities (DbD) 
for a typical responder is shown in Figure 4. Regions with negative intensity contain cells with 
a higher chance to be found in a responder than in the control individuals on the basis of their 
Control Model score. These cells are therefore potentially response-related. Those cells lying 
in regions with positive intensity may be found with higher probability in control than in 
responder individuals and are therefore excluded from subsequent analyses. 
 
Figure 4: KDE of the scores distribution of a typical LPS-responder (ID #9) is subtracted from 
the cumulative KDE of the control scores distribution. The negative intensity (red) indicates 
the location where cells over-produced in the responder are more likely to be present; the 
positive intensity (blue) indicates the location where healthy cells are more likely to be present. 
The white area between the red and blue areas corresponds to a value of KDE=0, which can 
indicate bins with no cells or equal intensity of control and responder estimates. The axes report 
the variance of ID#9 explained by the respective PCs (Control Model). 
A dedicated new SCA model was modeled on those cells that were either identified based on 
SPE or DbD as response-related, to specifically fit the variability in marker expression of these 
LPS-induced cells. 
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Figure 5: Panel a, ECLIPSE model built on all the responding cells from the responder 
individuals. The cells generally attributed to the control group have been eliminated from the 
analysis, and the SCA space has been recomputed. The loadings show the LPS-response 
specific surface marker expression for all cells. Gates a (magenta) and b (yellow) encircle the 
two most densely populated areas; Panel b, Histograms of the surface marker expression of the 
cells lying in the two different gates. The distributions are displayed with the colour of the 
corresponding gate (magenta for gate a, yellow for gate b); the blue distribution corresponds 
to the cells not included in the specified gate. 
 
The ECLIPSE Model computed on the response-related cells that were identified before (Figure 
5) shows how two groups of neutrophils arise in the LPS-induced immune response. 
The loadings, superimposed on the space, indicate how the surface markers in both groups of 
cells differ in expression. CD62L is more strongly expressed in gate a, and CD69, CD16, 
CD11c, and CD11b are more intensively co-expressed on the cells in gate b. Although CD32 
varies much in expression across response-related cells, its intensity does not significantly differ 
between both cell groups. 
The population with higher expression of CD62L and lower expression of CD16, in gate a, 
corresponds to the premature neutrophils (cells with a banded nucleus) and the cells with higher 
expression of CD16 are mature neutrophils, which were both identified in earlier studies.31 
Single-marker expression profiles of the cells present in both gates are shown as histograms in 
Figure 5b, against a background containing the cells that are not included in the specified gate. 
The background contains both cells of the responders as well as cells of controls outside of the 
depicted gate. This is analogous to the histogram representation used in Citrus. A differential 
expression of the marker CD62L, indicated also by the direction of the loading, is present in 
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gate b. This suggests the presence of two sub-clusters within the gate: a cluster which is 
CD62Lbright and a CD62Ldim cluster. These sub-clusters might occur due to variability between 
the different responder individuals. The density estimates of the ECLIPSE cell scores of two 
different responders (Figure S3, Online Supplementary Material II) confirm that there is 
heterogeneity in the surface marker expressions of the cells specifically induced by LPS. The 
variability in the continuum of surface marker expressions for all the responders are shown in 
the Table S2 of the Supplementary Material II. All responder individuals react with increases 
in premature neutrophils three hours after LPS was administered, while the presence and 
expression profiles of the mature neutrophils vary between individuals. In some cases, these 
cells consist of two subpopulations. The diversity in responses to the administered LPS is 
enhanced after the elimination of normal cells. Especially when the number of response-specific 
cells is limited or when the response is heterogeneous, these normal cells will considerably 
affect quantitative models of the responder individuals, at the expense of the rarer cells 
associated to the immune response. As proof of concept, we performed a simultaneous 
component analysis on the original cells of the responder individuals and compared the model 
against the SCA Control Model and the SCA ECLIPSE Model, defined previously. The angle 
between the subspaces spanned by the loadings of each model, built with the first two Principal 
Components, is used as metric of dissimilarity. A procedure similar to the procedure as 
described by Liu and al27 gives the distribution of the angles between the subspaces. The smaller 
angle distribution in Figure S4 (Online Supplementary Material II) confirms that a model built 
on all cells of the responders grasps a variability in surface marker expression similar to that of 
the control individuals. The larger angle difference between the ECLIPSE SCA model and 
Control or Response SCA model shows that the elimination step is essential to capture the 
surface marker expressions specifically related to the response. 
To compare the ECLIPSE results with other multivariate methods, we performed viSNE and 
Citrus analyses on the same dataset. The cell phenotypes found by the three methods can be 
compared. From this, we can conclude that the cell phenotypes, highlighted in the ECLIPSE 
space, are similar to the ones found by the Citrus and viSNE analyses in Supplementary 
Material III. We performed Citrus and viSNE analyses on three differently pre-processed LPS 
datasets: the arcsinh transformed (cofactor) LPS data, the LPS dataset pre-processed as used in 
ECLIPSE (log transformation, mean-centering per individuals, scaling over controls) and the 
LPS dataset after removal of normal cells by ECLIPSE. When trained on the arcsinh trasformed 
LPS data, the two most relevant clusters for the classification detected by Citrus may be 
identified as premature and mature neutrophils (Figure S6). In contrast to the ECLIPSE results, 
the Citrus cluster of mature neutrophils only consists of CD62L low cells. The cross-validation 
error rate of the model around 7% (Figure S5) however suggests that the identified clusters 
might not be specific for all the individuals within the control or responder groups. 
Contrary to the arcsinh transformed data, the multi-set data pre-processed according to 
Equations S2b and S5b led to a perfect classification with Citrus (Figure S7). The similar pre-
processing also allows a more direct comparison between both methods. In this case, Citrus 
recognized two clusters in the LPS data that are more abundant in the control group, with 
phenotypes that may be assigned to normal mature neutrophils, with CD16+CD62L+CD64- 
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and CD16+CD62L+CD64dim phenotypes, respectively (Figure S8). Only a single cluster, 
identified as a premature neutrophil population (based on CD16dim marker expression), was 
found to be distinctive for the response group. 
In the third analysis, which was performed on the LPS data after removal of normal cells, only 
a cluster of premature neutrophils was detected (Figure S10). The premature neutrophil 
population, which was more abundant in the response group, suffices for a correct classification 
(Figure S9). In this analysis, there were no clusters of normal mature neutrophils identified as 
most discriminant ones. 
When performing the viSNE analysis on the arcsinh transformed (cofactor 5) LPS data, no clear 
subpopulations were found. The viSNE map shows single cells with distinctive expression of 
CD11b, CD11c, CD16, CD32 and CD62L, and the other markers in lesser extend (FigureS11). 
Additionally, it seems that cells of the same individual are grouped together, suggesting that 
the cell distribution found by the algorithm are individual-specific. This grouping is removed 
when viSNE is performed on the pre-processed data. In the resulting map the cells are indeed 
evenly distributed across the space and no donor-specific clusters are present (Figure S13). 
When the analysis was performed on the data after removal of normal cells, roughly three 
distinctive cell phenotypes were found based on CD16/CD62L expression: CD16-CD62L+, 
CD16+CD62L- and CD16+CD62L+ cells (Figure S14). The expressions of the other markers 
within these three cell populations are more easily interpreted after ECLIPSE-based filtering. 
Removing the normal cells results in a less crowded viSNE map, which helps identifying the 
cells of interest and focusing on more subtle differences between and within these cell 
populations. 
Asthma-specific immune responses 
Asthma is a chronic inflammatory respiratory disease that affects the airways. Symptoms range 
from wheezing and coughing to bronchospasms and dyspnoea. Symptom severity differs 
among patients, with some barely experiencing problems in daily life, and others having 
frequent exacerbations, requiring hospitalization30. We show here how ECLIPSE may be used 
to model the asthma-specific immune response associated to differential expression of immune 
markers on white blood cells (WBCs). 
After arcsinh transformation (cofactor 5), the data were mean-centred and scaled over the 
controls according to Equations S2b and S5b (Supplementary Material I contains more detailed 
information on the data pre-processing), respectively. 
As a result of the validation step, we used a two-component Control Model for this, the PCs of 
which explain 33% and 21%, respectively, of the variability in surface marker expression of 
the 10 control individuals. Figure 6a-b shows the scores and the resulting kernel estimates of 
control individuals and patients. 
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Figure 6: Panel a Scores plot of control cells of all the control individuals in the Control 
Space, plus 3D-contour of the PDF of the control scores estimated with KDE; Panel b Scores 
plot of all the responder cells projected in the Control Space, plus 3D-contour of the PDF of 
the responder scores estimated with KDE. The kernel estimates display PDFs with multiple 
maxima; this suggests that multiple cell-subpopulations are present in the data. 
 
The large number of cells and the considerable differences in expression between the cells make 
the score distributions of patients and controls complex and difficult to interpret, although they 
are visually distinguishable. The complexity is due to the considerably larger heterogeneity in 
surface marker expression that can be expected in the full WBC compartment, compared to the 
gated neutrophils of LPS. In addition, the effects on the immune system due to asthma may be 
more subtle than the systemic response to LPS. Transcending the single-cell level into the 
kernel probability density estimates, shows how the multiple cell populations result in 
multimodal kernel estimates, both in the control and patient group. The high maxima in the 
b
o
a
o
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center of both control space plots correspond to the neutrophils, the largest constituent of all 
white blood cells. In addition to the changes in the neutrophils upon asthma immune response, 
comparing both KDEs already shows that the response involves several other WBC sub-
populations as well. 
The DbD plot (Figure 7) shows which cell populations are over- or underrepresent in patients 
with severe asthma, when compared to non-asthmatic controls. The DbD plot displays several 
negative regions (red) with a higher chance of cells with a surface marker co-expression typical 
of patients; cells in positive areas (blue) are more probable to be found in control samples. 
 
 
Figure 7: Density plot of Difference between Densities: the negative intensity (red) shows the 
locations where a larger fraction of cells scores for patients than for control individuals; 
positive intensities (blue) contain cells with larger fractions of normal cells. White areas either 
contain no cells or have similar fractions in both groups of individuals. The axes report the 
variance explained by the SCA Control Model for the control individuals, on which the DbD is 
calculated. Loadings of the SCA Control Model are represented as vectors: loadings with 
similar directions indicate positive co-expression (like for CD16, CRTH2 and CD193, CD4) 
and with opposite directions indicate negative (like for CD3 and CD16) co-expression of both 
surface markers. Orthogonal vectors indicate surface markers that express independently, 
e.g.CD8 and CD123. 
 
Cells within negative regions, together with the cells with high residuals are then selected for 
further analysis within a response-specific ECLIPSE model. The original compensated data of 
these cells, after arcsinh transformation (cofactor 5), are mean-centered and scaled across all 
the individuals (Eq. S2-S3, Online Supplementary Material I). The ECLIPSE algorithm models 
the variability of all the cells particularly found in the patients, as shown in Figure 8. 
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Figure 8: General ECLIPSE model built on all non-normal cells of the 11 asthma patients. A 
density estimation of the cell scores distribution is shown, where density is quantified from low 
(blue) to high intensity (red). Multiple cell sub-populations with different intensities can be 
observed, mainly differing in the co-expressions of CD193, CD14, CD123, CRTH2 (along the 
horizontal axis), and by simultaneous positive co-expression of CD4, CD3 with a negative co-
expression of CD16 (on the vertical axis). Both axes report the variance explained by each 
component of the two PCs in the SCA model for all the patients. The loading vectors greatly 
differ from the loadings of the Control Model because they explain the variability of only the 
not-normal cells. 
From this ECLIPSE model, scores of each individual asthma patient in the ECLIPSE space can 
be individually extracted and inspected (Table S3, Supplementary Material II, which shows the 
scores in the general models for all patients). The output of this general ECLIPSE model may 
be used as input for a clustering analysis, to stratify individuals in an automated and 
reproducible fashion. Hierarchical clustering by average linkage to the distance of the kernel 
estimates provides a dendrogram of the patients, visualized in Figure 9 (left panel), which shows 
clear subgrouping of this small cohort of asthma patients. Asthma patients may be grouped into 
three or four clusters, specifically three containing multiple patients (blue, green and red) and 
one single responder in a separate cluster (black). 
Figure 9, right panel, shows the scores in the ECLIPSE general model of two patients grouped 
in different clusters (green and red) and thus reveals differences in the cell populations present. 
However, the variance in marker expression of the individual patients was not always well 
described by the general ECLIPSE model: only 28% of the total variance of responder ID #67 
was explained in this way. To investigate the cell variability in surface marker expression that 
is relevant for a specific cluster, we built four partial cluster-specific ECLIPSE models, on each 
separate cluster of individuals (Figure 10). As expected for a heterogeneous immune response, 
the length and the orientation of the loadings are different between the 4 models. 
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Figure 9: Dendrogram (left panel) of the asthma patients, obtained by average linkage to the distances between 
the Kernel Density estimates of their ECLIPSE scores. Four different patient clusters are coloured as different 
dendrogram leaves. The figures on the right panel show the density cells scores distribution of two representative 
individuals (#67 and #66) from different patient clusters.  
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Figure 10: Partial cluster-specific ECLIPSE response models. a Density estimation of cell 
scores distribution of patients #63 and 67 grouped in the green cluster; b Density estimation of 
cell scores distribution of patients #49 and 68 grouped in the blue cluster; c Density estimation 
of cell scores distribution of patients #65, 30, 46, 66, 78 and 29 grouped in the red cluster; d 
Density estimation of cell scores distribution of patient #48 (black individual). Both axes report 
the variance explained in total for the patients of each group by the respective PCs of the partial 
cluster-specific ECLIPSE Models. The 4 models are qualitatively comparable in terms of 
percentage of variance explained. However, great difference in the loadings indicates that the 
type of variation accounted by each model is non-identical: each patient cluster is defined by a 
different and characteristic combination of cell populations. 
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Figure 11: Partial cluster-specific ECLIPSE model built on the variability of the not-normal 
cells of individual #63 and #67 (green cluster in Figure 8). Density estimates of cell score 
distributions of both patients are shown. The intensity of the estimates is indicated with the 
colour bar on the right, from low (blue) to high intensity (red). The most densely populated 
regions are highlighted with coloured gates. 
The most densely populated regions of the partial ECLISPE models can be automatically gated; 
the results for the partial ECLISPE model of individuals #63 and #67 from the green cluster are 
shown in Figure 11. One of the cell populations (gated in green) is identified as CD8+ T cells, 
due to its co-expression of markers CD3 and CD8. The partial ECLISPE models built on the 
other clusters do not show a predominant CD3+CD8+ T-cell population, in the first two PCs 
(Figure 10). On the contrary, in the partial models of the blue and the red clusters CD3+CD4+ 
T-cells had a more important contribution to the variance, as indicated by the long loadings in 
these models and shown in the Online Supplementary Material IV for the cells of the red 
clusters. Another characteristic population that we observed in multiple patient clusters most 
likely were basophils, as indicated by a relatively high expression of CD123, CD193 and 
CRTH2 (Figure 11, magenta gate). These latter cells were discriminatory only in some 
phenotypes of asthma. The mechanism behind the variation in recruitment of cellular 
populations to the peripheral blood in severe asthma patients will be examined in future studies 
and goes beyond the scope of this article. 
For comparison, we performed Citrus and viSNE on the asthma dataset (Online Supplementary 
Material III) 
The considerable heterogeneity associated with the asthma study results in a reduced 
classification accuracy in the Citrus analysis. In fact, the highest achieved accuracy 
corresponded to 25% of misclassified samples (Figure S15). This is obtained with a model 
which identifies the four most discriminant cell clusters. Two of these clusters were distinctive 
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for the control group, with CD16+CD123dimCD8dim and CD3−CD14− expression levels and 
CD4+ T cell phenotype (CD3+CD4+), respectively. The over-representation of these cells in 
the control individuals, against the asthma group, was highlighted also by the Difference 
between Densities plot (Figure 7). The blue regions here show, among other cell populations, 
the presence of CD4+ T cells and CD16+CD3− cell, which are more likely to be found in the 
control individuals. After the removal of normal cells, however, we could observe the presence 
of CD4+ T cells also in the partial ECLIPSE model of red and blue clusters (Figure 10b, c). 
The patients belonging to these clusters, identified by ECLIPSE, might have CD4+ T cells with 
a differential markers expression compared to the controls, which is emphasized by the 
difference in the angles of the loadings in the more focused models. Both other clusters 
identified by Citrus were more represented in the asthmatic patients (Figure S17). In this case, 
it was harder to identify clear phenotypes, mainly because of very heterogeneous expression 
patterns. In fact, multiple peaks per marker suggested the presence of multiple cell subtypes 
within a same cluster. Unfortunately, we were unable to identify which cell types are present in 
this cluster, since the information about the co-expression of markers is lacking in the Citrus 
results. 
The viSNE map obtained by the analysis of the asthma data showed substantial overlap of cells 
between the control and the asthmatic patients (Figure S18). Most overlapping regions are 
associated to CD4+ T cells; CD8+ T cells; CD16+ cells, which might be identified as 
neutrophils; and CD14+ cells, which might be identified as monocytes. We compared the map 
showing only the individuals #63 and #67 (Figure S19) to the ECLIPSE partial model of Figure 
11. The phenotypical marker pattern observed is similar to the cell phenotypes shown in the 
ECLIPSE partial model. The CD16+ cells might be identified as neutrophils; 
CD123+CD193+CRTH2 cells as basophils; while CD3+CD8+ cells and CD3+CD4+ cells 
might be assigned to CD8+ T cells and CD4+ T cells, respectively. 
Discussion 
The ECLIPSE methodology allows comprehensive exploration of multi-dimensional MFC data 
specifically for cells that respond upon disease or other perturbations of cellular systems that 
may be analyzed by flow cytometry. The vast number of cells in responders that are 
indistinguishable, ‘normal’, from cells present in healthy individuals hampers such an analysis. 
The methodology demonstrated removes such cells, accurately taking into account the multiset 
and multivariate features of MFC data. Rather than making the selection of cell subsets based 
on the expression of marker pairwise combinations (as for manual gating), ECLIPSE performs 
an automated gating of response-specific cells based on continuous and multivariate variability 
in surface marker expression compared to the multivariate variability of healthy cells in a 
control group. This then results in a comprehensive overview and a quantifiable indication of 
the immune response in terms of specific expression and/or co-expression of cellular markers. 
Using ECLIPSE for flow cytometry data analysis will result in more precise and elaborate 
knowledge about the cells specific for the studied host response, in a fast and un-biased manner. 
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ECLIPSE will be useful in MFC analyses of cells activated upon response, such as in the LPS 
study. It will also facilitate the analysis of whole blood in individuals with responses of 
unknown etiology. The latter is illustrated by the analysis of the asthma patients, revealing 
heterogeneity in their response to the disease. 
In the LPS analysis, we showed how ECLIPSE was able to increase resolution and 
interpretability of the endotoxin–induced immune response based on the relationships among 
all the markers, due to removal of ‘normal’ cells. In particular, the general ECLIPSE model 
shows expression (above the average) of the markers CD62L and CD16 for the LPS-induced 
immune response associated cells in the responder individuals. The same biplot representation 
indicated a co-expression of markers CD11c, CD11b, CD69 for the cells that highly express 
CD16. In this way, the algorithm offered a closer look at such a minority of cells, defining their 
characteristics in terms of phenotypic markers. 
Additionally, visualizing individual responder cell distributions provided the exploration of the 
personalized response to the LPS and focus on diversity among responders. Small differences 
in the continuum of surface marker expressions may suggest variability in the time of reaction 
to the endotoxin among the different individuals. 
The asthma study shows how ECLIPSE may be used as a flexible method to characterize 
heterogeneity of poorly understood diseases among individual patients. In such analysis, a 
general ECLIPSE model was shown to be insufficient in reproducing the heterogeneous 
response across all individuals. However, quantitative comparison of cell distributions between 
individuals in the general ECLIPSE model allows stratification into different groups, which can 
be further analyzed by partial ECLIPSE models. This allows dedicated interpretation of the cell 
variability associated to the response within each cluster of individuals, allowing a detailed 
group- or individual-based interpretation of differences in diseases profiles. The applicability 
and added value of such profiles in clinical decision-making should be examined in a 
prospective study. An individual personal response model that is exclusively based on the 
activated cells, may provide an optimal view of a unique profile in the individual patient. 
The advantage of increased resolution in individually expressed cell (sub-)populations however 
comes with the drawback that personal models cannot be compared between individuals as they 
lack common ground in the model scores and loadings, such that individual and general 
ECLIPSE models should always be interpreted simultaneously. Full interpretation of the 
different immune responses across the entire patient cohort therefore requires systematic 
exploration firstly in the common ECLIPSE model; the findings from this can then be explored 
in the clustered patient profiles to allow detailed stratification of patients in future studies. 
ECLIPSE compared to classification by Citrus 
The quantitative objectives of ECLIPSE, Citrus and viSNE are distinctive for each method, 
which makes the results derived from their models inherently slightly different and the 
comparison between the methods not always as straight-forward. In the case of a binary 
classification problem, Citrus aims to find the differences between an assumed homogeneous 
control group and a similarly homogeneous group of diseased samples. ECLIPSE equally 
assumes a homogenous control group, but allows for heterogeneity in the cell variability 
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between diseased samples; it can even explicitly model this heterogeneity in the partial or 
individual model. This also implies that ECLIPSE does not provide classification accuracies 
and other metrics that can be directly compared to those of Citrus. Both methods can, however, 
be compared by the cell subpopulation marker profiles that are distinctive between phenotypes 
(Online Supplement Material III). In the case of the LPS dataset, the phenotypes identified by 
Citrus were highly comparable to the marker profiles of the cell populations found in the 
ECLIPSE space (Figure 4). Citrus additionally identified clusters distinctive for the control 
group, corresponding to mature neutrophils. In fact, Citrus focuses on finding features that are 
most predictive for the classification endpoint (e.g. controls vs responders). Therefore, also cell 
populations that are more abundant or specific for a control group may be found to be best 
predictors. These cells are not considered of primary interest when studying an immune 
response by the current implementation of ECLIPSE. 
We show here that filtering of the ‘normal’ cells with the ECLIPSE-based filter method, 
positively affects discrimination between control and responder samples, as indicated by the 
lower error rate also in Citrus. On top of that, removal of normal cells resulted in a considerably 
lower number of features necessary for the optimal Citrus classification. However, this also 
provides a fundamental distinction between Citrus and ECLIPSE: the former aims to find an as 
low as possible number of features to classify samples, and shows the cell clusters distinctive 
for the control or response group with the marker expressions in histograms. ECLIPSE provides 
a comprehensive set of single cells that contributes to the distinction of control and responder 
samples. Features that are considered redundant by Citrus, because they do not improve the 
prediction, may be needed to describe patient-specific aspects of the response. The only 
distinctive phenotype found for the LPS responders by Citrus consisted of pre-mature 
neutrophils (as shown in Figure S10), while our ECLIPSE analysis, additionally to the presence 
of pre-mature neutrophils, showed a diversity in mature neutrophils associated to a personalized 
response across the responders. 
These results indicate that Citrus is less-well suited for identifying differences between 
individuals belonging to the same response group and it will fail in identifying putative 
personalized cell subsets which are not representative of the whole cohort but only of few 
samples. This explains why Citrus did not provide satisfying classification accuracies for a 
heterogeneous disease as asthma, as it failed to classify 25-30% of the samples correctly. 
Although some specific marker profiles were found for the asthma group, such high cross-
validation error rate indicates that the identified clusters are not consistent across the entire 
patient cohort. Therefore, they do not offer an exact overview of the variability present in the 
asthmatic patients. 
Moreover, the clusters which are either predictive for the asthma group or the control group, 
were not easy to interpret. This is due to the way the Citrus results are visualized. When multiple 
cell populations are present within one cluster, the single marker histograms do not give 
information about the co-expression per cell population. 
154 
 
The limits of Citrus in handling heterogeneous dataset was also shown, when it was applied to 
the synthetic flow cytometry-like data of cell populations characterized by differences in terms 
of abundance and expression levels of different markers (included in Online Supplementary 
Material V). Here, Citrus could only identify cell populations with different relative abundance 
in the controls compared to the response group; however, it disregarded the relevant individual 
response-specific cell populations. ECLIPSE is better suited for exploration of the within-group 
differences, as it reviews individual patient variability. Additionally, we showed how ECLIPSE 
was able to detect a small cell population, which was only present in one individual. Moreover, 
removal of normal cells was necessary to correctly model the variability of all the responder 
cells, as was shown by the orientation of the loadings in the ECLIPSE model (Figure S38). 
ECLIPSE compared to cell visualization by viSNE 
Both viSNE and ECLIPSE methodologies reduce the multi-dimensional flow cytometry data 
into fewer, commonly two, dimensions. In both cases, this provides a 2D-map that retains only 
part of the variability in the measured data. However, viSNE provides no information about the 
variability that remains unexplained by the analysis, while in ECLIPSE, the percentage of 
unexplained variance is displayed and, if needed, this variance may be described by additional 
PCs without altering the already fitted part of the model. Due to the different algorithm used 
for the dimensionality reduction, in principle, no heuristic parameter can be used for the 
quantitative comparison of the two methods. However, the Differences between the cell 
variability expressed in the ECLIPSE space and in the viSNE maps may be qualitatively 
compared and interpreted. 
The viSNE analyses performed on the two studied datasets showed a big overlap of the 
responder cells with the control regions, as expected for both studies. Such overlap, however, 
can hamper the identification of cell populations specific for the response. Secondly, in viSNE, 
we cannot affirm whether these normal-like cells are overrepresented compared to the controls 
and thus interesting to describe the immune response. The Difference between Densities (DbD, 
step 4), performed by ECLIPSE, takes into account both situations that might occur because of 
immune response: deviation from normal cell marker variability and higher relative abundance 
of normal immune cells. 
An inherent drawback of viSNE is the need to downsample the original data, due to limit in 
computational power. Populations that are more abundant will be retained in the subsampled 
data at the expenses of rarer cells. In such situations, the ECLISPE-based filtering of normal 
cells (which is a more specialized way of subsampling), focusing on the cells associated to the 
perturbation of the immune system, is more beneficial. We have shown how a less crowded 
viSNE map with more intuitive interpretation of responder-specific information can be 
constructed when combined with a responder-specific filter provided by ECLIPSE. An example 
of such a viSNE map for the LPS study is compared with the analysis run on the complete 
dataset (Online Supplementary Material III). Phenotypical patterns distinctive for the cells 
found in the challenged individuals are better appreciated. In fact, viSNE performed on the 
ECLIPSE subsampled data reveals three distinctive populations, which are mostly 
differentiated by CD16 and CD62L marker expressions. Another advantage of ECLIPSE is that 
the co-expression among the markers is displayed in one single biplot, while in viSNE the 
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single-cell representation cannot be directly linked to the co-expression of the markers 
measured. 
Multiset pre-processing 
Another advantageous hallmark of the ECLIPSE algorithm, next to the removal of normal cells, 
is the distinctive multiset pre-processing strategy. As described in the Online Supplementary 
Material I, the novel pre-processing strategy adopted by the algorithm is able to account for 
differences in terms of number of cells measured per individual, such that each individual 
equally contributes to the model. Unwanted variation present between the individuals is also 
taken care of by the pre-processing steps, which helps to systematically remove variability 
unrelated to the problem while retaining relevant biological information. We have also shown 
in Figure S14 (Online Supplementary Material III) how the elimination of individual variability 
done by ECLIPSE was beneficial for analysis with the viSNE algorithm, which might have 
been affected by sample-to-sample variability. Such multiset pre-processing was also beneficial 
to outperform the predictive ability of the discriminant model obtained with Citrus (Figure S7). 
Multivariate advantage 
The results obtained with the two different studies, show how the multivariate advantage may 
be used to unravel the correlations among all the measured surface markers and to distinguish 
cell subsets from one another. Other methods like SPADE and viSNE lack this view of mutual 
correlation among surface markers; any information on surface marker co-expression can only 
be obtained from a post hoc model interpretation, analyzing multiple single marker heatmap 
plots. The SCA loadings of ECLIPSE provide a direct compass-like representation of the 
surface marker co-expression on specific subsets of cells that may be much easier interpreted 
in terms of surface marker co-expression than, for example, viSNE maps. A direct interpretation 
of marker co-expression, compared to the qualitative evaluation necessary for non-linear 
models such as viSNE, justifies the use of linear SCA. Non-linear relationships are, anyway, 
still visible in the ECLIPSE model. In fact, the LPS-specific variability appears in the ECLIPSE 
space as a ’bean-like’ continuum (Figure 2) across co-expression of both CD16 and CD62L. 
Although FLOOD offers an explicit view of the correlations among surface markers through a 
similar biplot representation, this method lacks the filter aspect (removal of ‘normal’ cells) of 
ECLIPSE. This makes the FLOOD loadings considerably less informative than those from 
ECLIPSE, because the former also describe ‘normal’ cells to a large extent, which dilutes their 
response-specific information. This demonstrates the direct benefit of ECLIPSE for the 
comprehensive and specific interpretation of the immune response across a range of 
responders/patients. In addition, the use of Difference between Densities instead of the convex 
hull used in FLOOD, for determining the boundaries of the filter to gate out ‘normal’ cell brings 
several advantages. While the control data cannot be described using only a single convex 
shape, the Difference between Densities gating step can easily discern different populations. In 
addition, the DbD is able to take into account not only deviation from the normal cell surface 
variability but also changes in the fraction of normal cells, that might increase due to the 
immune response. 
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Conclusion 
ECLIPSE provides a filter for ‘normal’ cells present in individuals out of homeostasis, based 
on the multivariate co-expression among all the cellular markers measured. As a result, the 
algorithm allows the identification of detailed cellular information particularly present in 
response individuals (e.g. patients) completely independent of prior expertise knowledge, but 
through automatic and data-driven cell gating. ECLIPSE is specifically valuable for the 
identification of unbiased cellular information present in flow cytometry data of individuals 
with a condition of unknown etiology. The ECLIPSE method provides a higher resolution on 
response-specific cells that might be hidden among an overwhelming preponderance of normal 
cells. In future application of the ECLIPSE algorithm, we may expect that ECLIPSE could 
benefit researchers and clinicians handling intricate data, such as data containing rare cell 
subsets that only occur in diseased samples. 
In addition, the versatility of the algorithm may allow the integration of the multidimensional 
ECLIPSE filter into other multivariate MFC data analysis methods, in order to enable a better 
visualization and an outperforming prediction accuracy. 
Software and Data availability 
ECLIPSE is implemented in MATLAB®R2016b and the script is available for download at the 
https://github.com/RoelBouman/ECLIPSE. 
The data sets used in the ECLIPSE analyses are available at 
https://www.ru.nl/science/analyticalchemistry/research/data-analytical-chemistry/ 
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Supplementary Material I 
Multi-set control/response structure and pre-processing of Multicolour Flow Cytometry Data 
 
Multi-set control/response structure 
MFC data quantify the presence of fluorescently labelled cell properties, such as surface marker 
expressions, of a large number of single cells. These cells are collected per individual sample 
and the number of collected cells may vary considerably between cell ‘sets’. Experiments often 
compare a ’Case’ (or responder) group to samples obtained from ‘Control’ individuals. The 
Control individuals present surface marker expression on their cells typical for individuals that 
do not display the response of interest, while the individuals in the ‘responder’ group present 
cell populations with surface marker expressions characteristic of the immune response studied. 
Figure S1 shows the possible arrangements of the MFC data by considering three different 
levels. (1) Single matrices, which hold the cell set measured per individual; comprehensive and 
comparative analysis of different samples require that the same surface markers are measured 
across all individuals. (2) Single matrices are concatenated column-wise leading to X =  [
X1
⋮
X𝐼
] of 
size ∑ 𝑁𝑖x 𝐽 
𝐼
1 , where 𝑁𝑖  is the number of cells of the 𝑖
th individual and 𝐽 corresponds to the 
markers measured, 1… 𝑗 … 𝐽. This resulting matrix 𝐗 therefore consists of a ‘multiset’, where 
each set contains the cells of one individual; each row within each set represents measurement 
of one single cell. Each individual might be either a control or a responder, the information of 
the respective group is displayed in the level (3) of the multiset structure with the matrix 𝐗𝑖𝑔 
size 𝑁𝑖𝑔x 𝐽. 
The index 𝑔 = 0 for the control and 𝑔 ≥ 1 for the responder groups that might correspond to 
different diseases or subtypes of the same disease. If all responder individuals are drawn from 
a population with the same disease, then 𝑔 will assume values 0 and 1, for the control group 
and responder group, respectively. In some cases, experiments are paired, which means that the 
same person is followed and analysed before and after an immune response. 
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Figure S1: (1) Single data matrices representing measurement per individual, (2) Multiset data 
arrangement obtained by linking the matrices column-wise, (3a) Control/Responder 
differentiation of the multiset structure, with paired data, (3b) Control/Responder 
differentiation of the multiset structure, with paired data 
 
In this case the index 𝑖, representing the individuals, is not unique (3a). However, the two Flow 
Cytometry case studies we consider in this paper both consist of unpaired individuals, indicated 
by different 𝑖 (as in 3b). 
Step 0: Data pre-processing 
Data pre-processing is a very important aspect of chemometric data analysis.1 It aims to remove 
variability in the data that is unrelated to the problem under study, while retaining the 
experimentally relevant information. In Flow Cytometry, such irrelevant variability might 
derive from instrumental artefacts due to misalignment of the laser source, baseline drift, laser 
power variability, interference of fluorescent labels, or uninformative noise coming from low 
intensity signals. Removing such irrelevant variability in a quantitative and reproducible way 
facilitates the quest for relevant biomedical information and guarantees that the fluorescents 
intensities are measures of level of protein expression on the cells. 
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The first step of the pre-processing consists of transforming matrix 𝐗 using log (or arcsinh) 
function. In MFC, this type of transformation is essential to cope with the broad dynamic range 
of emissions between fluorophores. The data matrix may contain negative values, due to 
background subtraction or to the compensation of overlap between emission spectra of different 
fluorophores2. These require a more dedicated transformation, such as the arcsinh scaling 
described by Finak et al.3. Multivariate analysis of the cell variability then requires centering 
and scaling of the log or otherwise-transformed matrix 𝐗log = log10(𝐗) Eq. S1. Mean (or 
median) centering subtracts the column mean (or median) from every element in the column, 
which removes surface marker expression consistently present across all cells, resulting in the 
variability in surface marker expressions across the cells. Scaling equalizes the variability of 
each surface marker across the cells, to allow them to contribute equally to a multivariate model 
of the data, regardless of the intensity of the used fluorophore or the absolute variability in 
abundance of every surface marker. 
Both centering and scaling need to take into account the multi-set structure of the MFC data 
(Fig. 1). Several strategies for centering and scaling may accommodate this structure and the 
quantitative comparison between case and responder individuals4. 
One strategy is centering and scaling the variables per set, i.e. per individual. 
(a) 𝐦𝑖𝑔 = 
1
𝑁𝑖𝑔
 𝟏𝑁𝑖𝑖𝑔
𝐓  𝐗log,𝑖𝑔        Eq. S2 
(b) 𝐗𝐦𝑖 = 𝐗log,𝑖𝑔 − 𝟏𝑁𝑖𝑔m𝑖𝑔
T  
Where 𝐦𝑖𝑔  is the mean calculated for the surface markers measurements of the 𝑖𝑔 –th 
individual, 𝑖𝑔 = 1𝑔, … , IG  , hold in the matrix 𝐗log,𝑖𝑔  of size 𝑁𝑖𝑔x 𝐽 ; 𝑁𝑖𝑔  corresponds to the 
number of cells of the 𝑖𝑔–th individual; 1 is a column vector of ones with length 𝑁𝑖𝑔 . The 
resulting mean centered matrix 𝐗m,𝑖𝑔 is thus scaled using as weight the inverse of 𝐒𝑖𝑔 , diagonal 
matrix of size 𝐽x 𝐽 holding the standard deviation of the mean-centered surface markers of the 
𝑖𝑔–th individual, calculated as follows: 
(a) 𝐬𝑖𝑔
𝐓  = √𝑣𝑎𝑟(𝐗𝐦𝑖  ) 
(b) 𝐒𝑖𝑔 =  𝐝𝐢𝐚𝐠 (𝐬𝑖𝑔
𝐓  )        Eq. S3 
(c) 𝐗sc = 𝐗m,𝑖𝑔 𝐒𝑖𝑔
−𝟏 
Centering (Eq. S2b) and scaling (Eq. S3c) per individual may correct technical individual-
specific offsets due to e.g. changes and/or misalignment of laser intensity, sample handling etc. 
that do not contribute to the biomedical information within the MFC dataset5. 
Next to pre-processing per individual, there are other pre-processing options, based on the class-
level (control or response) or the whole dataset. Considering a single class, specifically the 
‘control group’ (𝑔 = 0), as a reference for ‘normal’ cell variability may highlight those cells 
that are specific to a response in the other class(es). Centering and scaling based on the control 
individuals selectively emphasizes deviations from the ‘normal’ cell variability observed in the 
case individuals, when means and the standard deviations used in Equations. S2 and S3 are 
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calculated across the control individuals. This requires correcting for the considerably different 
numbers of cells per analysed individual, in order to avoid the individual with most cells 
dominating the calculated means and standard deviations. This correction is accomplished by 
pooling the means of each set into a weighted class mean, according to Eq. S4. 
(a) 𝐦0 = 
∑  
𝐼0
10
𝐦𝑖0
𝐼0
 
(b) 𝐗m0 = 𝐗log − 𝟏𝑁𝑖𝑔m0
T       Eq. S4 
where 𝐦𝑖0is the mean of the log-transformed surface marker intensities of the 𝑖0–th control 
individual, calculated according to Eq. S2a, with 𝑔 = 0 ; 𝐼0  is the total number of control 
individuals. 𝐗m0, of size of size 𝑁𝑖𝑔x 𝐽, represents the multiset matrix centered using the class 
mean of the log-transformed surface marker intensities of the control class. 
Also the cumulative control standard deviation may be calculated by Eq. S5: 
(a) 𝐬0
𝐓  = √
∑  𝑣𝑎𝑟(𝐗𝐦,𝑖0)
𝐼0
10
𝐼0
 
(b) 𝐗sc0 = 𝐒0
−𝟏(𝐗m0)         Eq. S5 
with 𝐗m,𝑖0 the mean-centered individual control matrix, estimated according Eq. S2b, with 𝑔 =
0; 𝐒0
−𝟏  the diagonal matrix holding the standard deviation 𝐬0
𝐓 weighted for the number of 
control individuals 𝐼0; 𝐗sc0 the multiset matrix resulting from the auto-scaling performed with 
the weighted mean and standard deviation across the control individuals. From 𝐗sc0 we can 
extrapolate the pre-processed matrix of the control and responder sets, expressed in Eq. S6 and 
Eq. S7, respectively: 
𝐗sc0 = [
𝑿sc𝟏𝟎
⋮
𝑿sc𝑰𝟎
]          Eq. S6 
𝐗sc1 = [
𝑿sc𝟏𝟏
⋮
𝑿sc𝑰𝟏
]          Eq. S7 
Among the different options, centering and scaling based on the control class (Eqs. S4b, S5b), 
will enhance the deviation of the responder individuals from the cell variability observed in the 
control individuals. Alternatively, individual centering and scaling (Eqs. S2b, S3b) might be a 
preferable option when there are considerable shifts in the observed surface marker expressions 
of cells between different samples. These operations now rid the resulting data of uninformative 
offsets and allow each surface marker to a priori contribute equally to the model fitted 
subsequently, taking into account both the multiset and control/responder structure of the data. 
However it should be noted that the last option has a disadvantage. When all cells of one 
response individual show up or downregulation of one or multiple markers compared to the 
cells of the control individuals, this information will be lost due to individual centering. 
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Figure S2: The effect of Kernel bandwidth (h in Equation 4, main article) on the estimate of a 
(normal) distribution. In yellow: a histogram of 1000 samples from a Unimodal Gaussian 
distribution with mean 4 and standard deviation 1. In green: an under smoothed estimate using 
a small bandwidth. In red: an over smoothed estimate using a large bandwidth. In light-blue 
an estimate using a near optimal bandwidth. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
165 
 
Supplementary Material II 
 
Additional results of ECLIPSE on the LPS dataset 
As an example of the heterogeneity between responders, the ECLIPSE results obtained from 
Individuals #14 and #16 are shown in Figure S3. Two groups of neutrophils, mainly separated 
along the first component, can be observed in both individuals. However, in Individual #14 the 
two populations are not as well distinguished from each other as in Individual #16. Cells with 
a continuum in surface marker expressions connects the two populations at the upper part. In 
addition, Individual #14 presents a quite heterogeneous distribution within the mature 
neutrophils that can be encircled by two different gates. The percentages of the cells included 
in the gates for Individual #14 and #16 are reported in Table S1. Individual #16 displays two 
already well distinguishable homogenous populations. This indicates a difference in response 
between the two individuals, which for instance could suggest that the immune system of 
Individual #16 responded faster to the LPS stimulus when compared to the other individual. 
 
Figure S3: Visualization of two responder individuals in the ECLIPSE model, built after 
eliminating the normal cells. The variance explained by the general model for each individual 
is displayed on the axis. The individuals present different distribution of the responding cells 
that can be selected by different gates, based on the higher density estimation. The histograms 
show the marker expression of the cells within the different gate; the distribution are displayed 
with the colour of the corresponding gate. Percentage of the cells, normalized on the original 
total amount of cells, is visualized in Table 1. 
Table S3: Percentages of the total cells of responder individuals #14 and #16 in the gates 
displayed in Fig. S3. 
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Figure S4: Box plot of the angle distributions between the sub-spaces defined by loadings of 
different SCA models. The first comparison shows that the Control SCA and Responder SCA 
models are the most similar as shown by the smaller angle than those obtained by the 
comparison of each of the models to the ECLISPE SCA model. 
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Table S2: ECLIPSE plots of the LPS response group per individual. 
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Additional results of ECLIPSE on the asthma dataset 
 
Table S3: Density plots of all the asthma patients in the ECLIPSE model Space 
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Supplementary Material III 
 
Citrus and viSNE analyses on the LPS and asthma study dataset 
Results of Citrus on LPS data 
Citrus6 uses hierarchical clustering to identify phenotypically similar cell populations. 
Descriptive cell cluster-specific features are calculated on per-individual basis. These features 
can include, for example, the proportion of cells in the identified cluster for each individual. 
For intergroup analysis, the method employs a regularized classification model to detect the 
group-specific cell clusters for each sample. 
By definition, a regularized model selects subsets of features of the data to achieve the best 
prediction, avoiding overfitting. The constant regularization threshold regulates the number of 
features used for the classification. A series of models with increasing complexity, i.e. with 
increased number of selected features, is built by varying this threshold. The fit of each model 
is estimated through cross-validation. A plot of the Model cross-validation Error Rate versus 
Regularization Threshold enables investigators to assess the quality of the results of the 
classification and the fit of the model chosen by Citrus analysis. An optimal model has low 
cross-validation error rate, which corresponds to a low percentage of misclassified samples. 
When the error remains constant within a range of increasing number of features, the 
regularized threshold associated to the fewest number of features is chosen in order to select 
the most informative features that differ between the two groups. 
Citrus was applied to the LPS dataset using the R GUI. The regression classification model was 
trained on the data using the default pre-processing of the GUI, which implies arcsinh transform 
with cofactor 5. The accuracy of the classification models constructed is shown in Figure S5. 
 
Figure S5: The figure shows the Model Cross-validation Error Rate vs the log(Regularization 
Threshold) for the classification models constructed on the arcsinh-transformed LPS dataset. 
The number of the features, used to build the model, associated to the different regularized 
thresholds is shown on the top of the plot. The green circle (cv.min) points out the model with 
the smallest number of features necessary to obtain the lowest cross-validation error; while the 
orange diamond (cv_1se) indicates the model with the smallest number of features associated 
to cross-validation error 1 std higher than the minimum error. The model with cv.min is chosen 
by the Citrus analysis and this corresponds to an error rate of around 7%. 
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The model, identified as optimal by the cross-validation procedure (cv.min in Figure S5), 
incorrectly classifies around 7% of the samples. Two cell clusters were selected as the most 
discriminating ones between LPS responders and controls by the cross-validated model. The 
histograms of these clusters, both more abundant in the LPS responder, are shown against the 
background cluster, which contains all the rest of the cells not included in the specified cluster 
(Figure S6). 
 
Figure S6: The histograms show the phenotype of the cells belonging to the cluster (red) 
selected by the cross-validated model. The background histograms (blue) show the rest of the 
data, not included in the cluster. Cells from cluster 14985 are characterized by the distinctive 
phenotype CD16-and+CD62L+CD64+; cells from cluster 14989 are 
CD16+CD11b+CD69+CD11c+CD62L-. Both clusters are more abundant in the responder 
group. 
Cluster 14989 has a distinctive phenotype, existing of CD16+CD11b+CD69+CD11c+CD62L− 
cells. Two CD32 populations are present in this cluster: CD32− and CD32+. In contrast, cells 
from cluster 14985 express high levels of CD64 and CD62L, while they have a dim expression 
of CD16. The cells present in the two cluster might be identified as activated mature and partly 
immature (CD16dim) neutrophils, respectively. Using the ECLISPE method we also identified 
two LPS-specific cell clusters in the ECLIPSE space generated when plotting PC1 and PC2, 
Figure 4. To be able to compare these results, we applied Citrus on the pre-processed data as 
used in the ECLIPSE analysis. Subsequently, we applied Citrus on the LPS response-specific 
cells after ECLIPSE cell elimination. 
First, Citrus was applied on the data pre-processed with the ECLISPE algorithm, as described 
in Pre-processing section. In this analysis, all the cells were included. The cross-validated error 
rates of the obtained models are displayed in Figure S7. 
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Figure S7: Cross-validation error rate plot for LPS dataset transformed with the ECLIPSE pre-
processing procedure: arcsinh transformation, individual mean center and control scaling. 
Model Cross Validation Error Rate equals to 0 is obtained with 3 stratifying features. 
A perfect classification is achieved with a model which uses three distinctive features. This 
model is chosen as optimal by the Citrus Analysis. The most discriminant three clusters 
identified by the model are shown in Figure S8. Cluster 14956 and 14993 represent phenotypes 
that might be assigned to mature neutrophils, with CD16+CD62L+ and 
CD16+CD62L+CD32−, respectively. These clusters are found more abundant in the control 
group, compared to the responder group for which cluster 14990 is more present. This last 
cluster, with CD16−CD69− and CD62L+ can be assigned as immature neutrophils. 
 
Figure S8: Histograms show the phenotypes of the three cluster identified by the cross-
validated classification model. Cluster 14956 and 14993 present phenotypes that might be 
assigned to mature neutrophils, with CD16+CD62L+and−. The cluster 14990, more abundant 
in the responder group, is identified as premature neutrophils with CD16−CD69− and 
CD62L+. 
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Finally, we applied Citrus to the LPS dataset, after the elimination of normal cells, provided by 
ECLIPSE. The model chosen by the Citrus analysis offers a perfect classification of the 
individuals in the two groups, as shown in the cross-validation error rate plot (Figure S9). In 
this case, however, the discriminating model requires a lower number of informative features. 
In fact, only one feature is necessary to correctly classify the samples. This feature corresponds 
to the abundance of cluster 14994 in the responder group. The phenotype of this cluster (Figure 
S10) indicates that the most discriminant population is represented by cells 
CD16−CD11b−CD62L+CD69−CD11c−/dim, which might correspond to gate a in Figure 4 of 
ECLIPSE, defined as immature neutrophils. In contrast to the previous analyses, there are no 
clusters of mature neutrophils identified as most discriminant ones between the groups. 
The results obtained by the three analysis show how individual mean-centering and control 
scaling has a positive effect in the predictive ability of the Citrus algorithm. The ECLIPSE 
algorithm, at the current stage, is not developed to be used as a classification model. It is more 
suited for explorative research, finding cell populations that arise upon an immune response. 
These results can give further insight in the mechanism behind the immune response studied. 
Due to the different purposes of the models, a direct comparison of the prediction accuracy of 
the two methods is not possible. However, the last analysis, performed on the data after removal 
of normal cells, brings a further improvement of the classification model in terms of complexity. 
This shows the power of the subsampling provided by ECLIPSE, since in principle the 
ECLIPSE subsampling may be beneficial for discriminant classification methods as Citrus. 
 
Figure S9: Cross-validation error rate vs Regularization threshold plot for LPS dataset 
transformed with the ECLIPSE pre-processing procedure (arcsinh transformation, individual 
mean center and control scaling), after elimination of normal cells. Model Cross Validation 
Error Rate null is obtained with 1 stratifying feature. 
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Figure S10: Histograms of the phenotypes of the most discriminant cluster, more abundant in 
the responder group. Cells in the cluster are CD16−CD11b−CD62L+CD69−CD11c−/dim. 
Results of viSNE on LPS data 
viSNE7 analysis was applied to the LPS dataset using the Matlab GUI cyt (downloadable from 
the website https://www.c2b2.columbia.edu/danapeerlab/html/cyt.html). In order to obtain a 
better visualization of single-cell resolution, we run all the analyses on a subset of the LPS 
dataset. Each individual was subsampled to 2000 cells, so that the total amount of cells was 
30,000. The analysis was first performed using the default transformation present in the GUI, 
consisting of arcsinh transformation with cofactor 5. The results are shown in Figure S11. The 
upper left panel (Figure S11a) show the cells in the viSNE map coloured per individual. It seems 
that cells of the same individual are grouped together, suggesting that the cluster found by the 
algorithm are individual specific. The viSNE map in the upper right panel (Figure S11b) shows 
cells coloured per control/response group: a considerable overlap of cells between control and 
response individuals is observed. Distinctive region for the responders seems to be the upper 
left region and the right area. However, not all the response individuals show cells in those 
regions. 
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Figure S11: viSNE analysis performed on the LPS data pre-processed with the default arcsinh 
transformation present in the cyt gui. 11a: cells in the viSNE map are coloured per different 
individual; 11b: cells from the responder individuals, in the viSNE map, are coloured based on 
control (blue) and responder (red) group. 11c: cells are coloured based on expression of the 
single 7 markers. 
Figure S12 shows the constructed viSNE map only for the responder individual ID14, for whom 
we show the ECLIPSE model in the Supplementary material II (Figure S3, upper panel). LPS-
specific cells CD62L−CD16+CD11b+ (upper right) and CD62L+andCD16− (upper left) can 
be observed. These cell populations were clearly distinct also in the ECLIPSE space. 
A big overlap is present with the control region. However, in viSNE, we cannot affirm whether 
these normal-like cells are overrepresented compared to the controls and thus interesting to 
describe the immune response. The Difference between Densities (DbD, step 4), performed by 
ECLIPSE, takes into account both situation that might occur because of immune response: 
deviation from normal cell marker variability and overproduction of normal immune cells. 
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Figure S12: Cells from the responder individual with ID14 shown on the viSNE map built on 
all the control and responder individuals. The panels show the marker expression of the 
measured marker. 
 
Secondly, we performed viSNE on the LPS data pre-processed by the ECLIPSE algorithm; the 
results can be observed in Figure S13. The viSNE map, coloured per individual, shows how the 
cells are distributed across the map and no donor-specific clusters are present. In fact, the 
multiset pre-processing specifically adopted for the LPS study by ECLIPSE (as described in 
the Pre-processing section of Supplementary Material I, Equations S2b and S5b), helps to 
remove the individual variability of the control individuals. In this case, the individual control 
variability is biologically not that relevant and introduces noise into the results. It might 
originate from instrumental variability, for instance. 
180 
 
 
Figure S13: viSNE analysis performed on the LPS data mean-centered and scaled according 
to the ECLIPSE algorithm. 13a: cells in the viSNE map are coloured per different individual; 
13b: cells in the viSNE map are coloured based on control (blue) and responder (red) group. 
13c: cells from the responder individuals, in the viSNE map, are coloured based on expression 
of the single 7 markers. 
Finally we applied viSNE to the LPS data pre-processed by ECLIPSE, but after removal of 
normal cells from the responder individuals, performed by the ECLIPSE algorithm. The results 
are shown in Figure S14. It is clear how the cells from control individuals (blue, Figure S14b) 
are placed in the middle of the viSNE map, whereas the cells from the responder individuals 
(red, Figure S14b) are distributed in the upper and lower region of the map. Very little overlap 
is present between cells of the two groups and clearly, a lower amount of responding cells is 
present. The marker expression of these remaining cells is shown in Figure S14c. ECLIPSE 
removes mostly the CD16dimCD62L+ and CD16−CD62L− cells, leaving two quite distinctive 
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populations. No particular difference in marker expression is noted in the viSNE analysis, 
performed on the ECLISPE subsampled data. 
 
Figure S14: viSNE analysis performed on the LPS data mean-centered and scaled, after 
removal of normal cells in the responder done by ECLIPSE. 14a: cells in the viSNE map are 
coloured per different individual; 14b: cells in the viSNE map are coloured based on control 
(blue) and responder (red) group. 14c: cells from the responder individuals, in the viSNE map, 
are coloured based on expression of the single 7 markers. 
The viSNE algorithm is used mostly for data dimensionality reduction and visualization 
purposes, while the main goal of ECLIPSE is the selection of interesting cellular information 
and/or populations based on multiple marker co-expression. In principle, no quantitative 
parameter can be used for the comparison with the ECLIPSE results on the LPS data. However, 
we have shown how the viSNE analysis is susceptible to sample-to-sample variation, which has 
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influence on the resulting map. The multiset pre-processing operated by ECLIPSE 
systematically reduces this variation. 
Both ECLIPSE and viSNE performed on the ECLIPSE subsampled data reveal two distinctive 
populations, which are mostly differentiated by CD16 and CD62L marker expressions. 
However, an advantage of ECLIPSE is that the co-expression among the markers are displayed 
in one single biplot. Secondly, ECLIPSE defines response-specific cell populations, also taking 
into account normal cells that are overrepresented upon an immune response. These cells are 
not specifically defined when analyzing data with the viSNE algorithm. Next to this, the 
hallmark of ECLIPSE is the removal of normal cells, leading to a less crowed representation, 
which enables to distinguish the LPS responding cell populations better, also in the viSNE map 
(Figure S14). 
Results of Citrus on the asthma data 
We trained Citrus on the asthma data using the R GUI. The model error rates plot of the built 
models is shown in Figure S15. 
 
Figure S15: The figure shows the Model Cross-validation Error Rate vs the log(Regularization 
Threshold) for the classification models constructed on asthma data. The green circle (cv.min) 
points out the model with the smallest number of features necessary to obtain the lowest cross-
validation error, which corresponds to 25% of misclassified samples; the orange diamond 
(cv_1se) indicates the model with the smallest number of features associated to cross-validation 
error 1 std higher than the minimum error, which leads to an error of around 30%. 
The highest accuracy achievable by the analysis correspond to 25% of misclassified samples. 
Four features were necessary for this minimal error (Figure S15, cv.min). A model with a cross-
validation error 1 std higher than the minimum, corresponding to 30% of misclassification, 
requires 1 feature (Figure S15, cv.1se). The clusters detected by both models are shown below. 
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The feature identified by the model cv.1se corresponds to the abundance of cluster 41977, found 
to be more abundant in the control group (group 1) compared to the asthmatic individual (group 
2) (Figure S16). The phenotype indicated that the cluster is mostly characterized by CD4+ T 
cells, having CD3+CD4+ and CD8−CD16−CD123−CD14−CRTH2− expression levels. 
 
Figure S109: 
 
The cell clusters found by the best performing model are shown in Figure S17. Cluster 41962 
is characterized by cells with CD16+CD123dimCD8dim and CD3−CD14− expression levels; 
while cluster 41977 has a CD4+ T cell phenotype (CD3+CD4+). These clusters are more 
abundant in the control group compared to the asthmatic. This is in contrast to the ECLIPSE 
results, in which we found CD3+CD4+ cells present in the asthmatic patients after the ECLIPSE 
elimination step of normal cells. 
The last two clusters are more represented in the asthmatic group when compared to the control 
group. For these clusters, it is harder to identify the cell populations. Cluster 41979 consists of 
CD16+CD14dimCRTH2+CD123+ cells, which might be identified as monocyte derived cells. 
As shown by the cluster abundance graph on the right, there is high variability in the occurrence 
of this cellular cluster among the asthmatic patients. The last cluster 41994 has a very 
heterogeneous expression pattern, with multiple peaks per marker. |This indicates the presence 
of multiple cell types within the cluster. Based on the smaller peaks with high CD193, CRTH2 
and CD123 expression, basophils and/or eosinophils might be identified within this cluster. In 
addition, CD3+CD8+ T cells might be present in this cluster. However, co-expression of these 
markers should be verified to be able to draw these conclusions. When multiple cell types are 
present within one Citrus cluster, it is impossible to state which cell types are represented, since 
the single marker histograms do not give information about co-expression of markers. 
ECLIPSE, on the other hand, allows interpretation of co-expression from the location of the 
cell populations and the respective orientation of the loadings. 
Figure S16: The upper panel shows the phenotype of the most discriminant cluster between control and 
asthmatic individuals, found by the model associated with cv.1se error (~30%). This cluster is on average 
more present in control group (group 1) than in asthmatic (group 2), as displayed on the lower panel. Cells in 
the specified cluster can be recognized as CD4+CD3+ and CD8- T cells. 
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viSNE analysis of asthma data 
viSNE was performed on the asthma data. Due to limits in computational power, the original 
datasets consisting of almost 2 millions cells needed to be downsampled to 3000 cells per 
individual (48000 cells in total). Figure S18 shows the viSNE analysis performed on the 
arcsinh-transformed data (cofactor 5), coloured per individual (upper left panel) and for both 
groups (upper right). Substantial overlap of cells is present between the control and the 
asthmatic patients. Based on the single-marker expression profile of all cells (lower panel), we 
might conclude that most of the overlapping regions are associated to CD4+ T-cells; CD8+ T-
cells; CD16+ cells, which might be identified as neutrophils; and CD14+ cells, which might be 
identified as monocytes. Also a few smaller CD193+ clusters were found, which could be 
eosinophils or basophils. 
Figure S17: Upper panel: Histograms show the phenotype of the discriminant clusters, found by the model 
associated with smallest cross-validation rate error, corresponding to 25% misclassification. Lower panel: 
Differential abundance of these clusters between control (group 1) and asthma (group 2). 
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Figure S18: viSNE analysis performed on the asthma data. a: cells in the viSNE map are 
coloured per different individual; b: cells, in the viSNE map, are coloured based on control 
(blue) and responder (red) group. c: cell are coloured based on the expression levels of the 
single 8 markers. 
Considerable heterogeneity can be observed among the asthmatic patients. In this case, maps 
with distributions of a single or a few patients may enhance focus on subtle and patient-specific 
cell populations. Figure S19 shows the viSNE map with individuals #63 and #67, which were 
also grouped and analysed in a partial model by ECLIPSE (Figure 11). 
a b 
c  
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Figure S19: a: viSNE map obtained by the analysis of the asthma data, only the cell distribution 
of asthmatic individual #63 and #67 are shown. b: cells coloured based on the expression levels 
of the single 8 markers. 
Similar cell subpopulations seem to be present for both individuals. However, for individual 
#67 only a few cells are present in various regions. This might be a consequence of the down-
sampling, which retains the more abundant CD16+ cell population at the expenses of rarer cells. 
The phenotypical marker pattern observed in Figure S19b is similar to the phenotypes shown 
in the ECLIPSE partial model. CD16+ cells might be identified as neutrophils; 
CD123+CD193+CRTH2 cells as basophils; while CD3+CD8+ cells and CD3+CD4+ cells 
might be assigned to CD8+ T cells and CD4+ T cells, respectively. A key disadvantage for easy 
identification of the various cell populations is the representation of the marker expressions in 
single plots per marker. 
a 
b 
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Supplementary Material IV 
Manual sequential gating of the asthma red cluster and projection into ECLIPSE space 
Manual gating of the cells of the individual belonging to the red cluster (Figure 10c) was 
performed in FCS express 5, according to the surface markers phenotype as shown in Figure 
S20. The gating demonstrates the absence of double positive CD4/CD8 T cells. Double negative 
CD4/CD8 T cells are present in a very low percentage. These cells, probably also present in the 
control individuals, were eliminated by the ECLIPSE algorithm. We can conclude that the 
mutual direction of CD4 and CD8 markers in the ECLIPSE space represents a big part of the 
variation of the data well, associated with the presence of different types of T cells (CD4+ and 
CD8+). 
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Figure S20: Manual sequential gating of the cells from the individuals belonging to the red 
cluster, in figure 10c. The gates are differentially coloured. 
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CD8+ T cells (CD3+CD8+CD4-, yellow gate) are not easily visualized in the first two PCs of 
the ECLIPSE model (Figure S21, left panel, PC1-PC2 plot). The CD8+ T cells are positioned 
in the middle of the plot, overlapping with other cell populations. Obviously, the other markers 
are more important to explain the variance of cells this 2PCs model (Figure 10C), since all the 
other markers show longer loadings when compared to the CD8 loading. If the CD8+ T-cells 
were more important, the loading would be longer and the cell population would be visible in 
these first 2 PCs. The investigation of the ECLIPSE space built on PC1 and PC3 made the 
CD8+ T cells better distinguishable (figure S21, right panel, PC1-PC3 plot and figure S22). 
 
 
Figure S21: ECLIPSE partial model of the red cluster: the left panel shows the space built with 
PC1-PC2, the left panel shows the space of PC1-PC3. The cell scores in the plots are coloured 
accordingly to the gates found by the manual gating procedure. 
 
Figure S22: Density representation of the ECLIPSE partial model of the red cluster, showing 
PC1 and PC3. 
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CD4+ T-cells were easily visualized in the left part of the ECLIPSE plot (figure 10c, ECLIPSE 
paper), with two main distinctive populations. These populations are different because they 
express different levels of the marker CD3. Based on the orientation of the loadings in space 
spanned by PC1 and PC2, we would expect to find CD3brightCD4+ cells situated closer to the 
CD3 loading; while CD3dimCD4+ cells are expected to lie more to the left, in the direction of 
the CD4 loading and a bit further away from the CD3 loading. This was confirmed when 
backgating the cells, as shown in Figure S23 and S24. 
 
 
Figure S23: Manual sequential gating of the cells from the individuals belonging to the red 
cluster, in figure 9c. Gates for CD3+ cells are shown and coloured differently. 
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Figure S24: ECLIPSE partial model of the red cluster: the left panel shows the space built with 
PC1-PC2, the left panel shows the space of PC1-PC3. The cell scores in the plots are coloured 
accordingly to the expression of the marker CD4 and CD3, in the CD3+ gate. 
 
Supplementary Material V 
ECLIPSE and Citrus analyses on synthetic datasets 
Immunological response to a stimulus or a disease can comprise changes in relative abundance 
of a particular cell population and/or changes in expression levels of certain markers can also 
lead to the appearance of new cell phenotypes. The detection of both types of changes is 
essential for a comprehensive understanding of the etiology of the immune response. 
A two-dimensional synthetic dataset was created to show the performance of ECLIPSE and 
Citrus in identifying cell populations, characterized by differences in terms of abundance and 
expression levels of different markers. The synthetic dataset consists of 10 controls and 10 
responders. The control group presents a single cell population with higher abundance than the 
response group. Heterogeneity has been introduced into the response group as the samples have 
diverse cell subpopulations, one of which consists of a small subset of 20 cells present only in 
one responder. This heterogeneity can be observed in the 2D scatter plot, Figure S25 (the small 
cell population in yellow in the top right corner belongs to Responder 10), and in the histograms 
shown in Figure S26; contour plots showing the differing relative abundance of cell populations 
between controls and responders are shown in Figure S27. 
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Figure S25: 2D scatter plot of the synthetic data. Cells from the control individuals are 
coloured in blue, while cells from the responders are differently coloured per individual. 
 
Figure S26: Histograms showing the expression of the 2 markers included in the synthetic data. 
Histograms of the control individuals are depicted in blue, while the histograms of the 
responders are in red. 
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Figure S27: Panel A: contour plot of the cells distribution of control individuals. A single cell 
population is present for all the controls; Panel B: contour plot of cells distribution for response 
individuals. 
 
Citrus was applied to the dataset with a Minimum Cluster Size Threshold (MCST) 
corresponding to 10 cells, so that the method could identify the rare subset. The accuracy of the 
constructed models is shown in Figure S28, which reports the model cross-validation error rate 
versus the regularization threshold associated to the number of features identified. Seven 
features were detected by the model with the minimum error (cv.min), while the model with a 
cross validation error 1 std higher than the minimum (cv.1se) identified two most discriminant 
features. 
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Figure S28: The figure shows the Model Cross-validation Error Rate vs the log(Regularization 
Threshold) for the classification models built on the simulated data. The green circle (cv.min) 
points out the model with the smallest number of features necessary to obtain the lowest cross-
validation error, which corresponds to 10% of misclassified samples; the orange diamond 
(cv_1se) indicates the model with the smallest number of features associated to cross-validation 
error 1 std higher than the minimum error, which leads to an error of around 15%. 
 
The features returned by both models are visualized in Figure S29. In both cases, the relative 
abundance of the identified cell clusters is higher in the control group compared to the response. 
These clusters correspond to the population with lower expressions of Marker1 and Marker2, 
created as more abundant for the control samples. Although the information of differential cell 
population abundance might be relevant for describing an immune response, evidence about 
such relevant response-specific cell populations is missing from the optimally parsimonious 
Citrus model. 
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Figure S29: Panel A: Histograms show the phenotype of the discriminant clusters, found by the 
model associated with cv.min error (10% of misclassification). Differential abundance of these 
clusters between control (group 1) and response group (group 2) can be observed in the right 
panel: these are all found more abundant in the control group. Panel B: Histograms show the 
phenotype of the discriminant clusters, found by the model associated with cv.1se error (15% 
of misclassification). Differential abundance of these clusters between control (group 1) and 
response group (group 2) can be observed in the right panel: they are more abundant in the 
control group. 
a 
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Secondly, we performed an ECLIPSE analysis on the synthetic dataset. The Difference between 
Densities (DbD) plot (Figure S30) clearly shows the difference between the two groups. 
Advantageous is the possibility to estimate the difference between densities of a single 
responder against the control group estimate (Figure S30B). This will enhance the resolution 
on a specific individual and it is helpful when one sample is available for the response 
class/classes. 
 
Figure S30: Panel a: Difference between Densities plot, obtained by subtracting the KDE cell 
distribution of 10 responders from the cumulative KDE of the control cells distribution. The 
negative intensity (red) indicates the location where cells over-produced in the responder are 
more likely to be present; the positive intensity (blue) indicates the location where control cells 
are more likely to be present. Panel b: Difference between Densities plot of the KDE of cell 
distribution of a responder (ID #9) subtracted from the cumulative KDE of the control cells 
distribution. 
  
a 
b 
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Response cells overlapping with the control marker variability were removed from the dataset 
and the remaining cells are displayed in Figure S31. The small population existing of 20 cells 
is still visualized (top right corner). Few cells are retained also for the control group, due to the 
individual variability we introduced between the control samples. 
 
Figure S31: 2D scatter plot of the synthetic data, after the elimination of normal cells performed 
by ECLIPSE. Cells left for the control individuals, due to personal variability, are coloured in 
blue, while cells from the responders are differently coloured per individual. 
The results of the analyses on the synthetic data showed how ECLIPSE outperforms Citrus in 
presence of a heterogeneity within the response class. In fact, Citrus is a two-class classifier 
method which needs numerous samples with similar phenotypically properties within both 
groups to find their signature features. Contrarily, ECLIPSE is a one class classifier method 
that requires only a group of control individuals. This is necessary to define a reference, against 
which a single patient or a group of patients, even highly heterogeneous in their response, can 
be compared. The removal of normal cells will put more focus on the response specific 
subpopulations of each individual, including rare cell subsets. 
In this example, the dimensional reduction step of ECLIPSE was not needed because the data 
had only two dimensions. In order to show that the SCA-based transformation will not affect 
the discovery of cells subpopulations we performed the analyses on a 3D datasets, obtained 
from the first one after specific transformations. 
A third random aspect was added to the first dataset; the matrix obtained was rotated by using 
orthogonal Procrustes rotation8, which allowed to introduce a more realistic correlation across 
all the three variables. A 3D scatter plot of the new dataset and histograms of the three marker 
expression levels are shown below (Figure S32 and S33). 
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Figure S32: 3D scatter plot of the 3 dimensional synthetic data. Cells from the control 
individuals are coloured in blue, while cells from the responders are differently coloured per 
individual. 
 
 
Figure S33: Histograms show the marker expression of the three markers created for the 
synthetic data. Distributions from control individuals is displayed in blue, while distributions 
from response are in red. 
 
We applied the Citrus method on this new dataset. The cross-validated error rates of the model 
obtained, in Figure S34, indicate the model with only one feature as optimal. In this case, 
different relative abundance of cell populations is not identified as relevant feature (Figure S35). 
As for the previous Citrus analysis, the rare cell subset is not detected. 
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Figure S34: The figure shows the Model Cross-validation Error Rate vs the log(Regularization 
Threshold) for the classification models constructed on the synthetic dataset. The lowest cross-
validation error (cv.min and cv.1se) is obtained with the model using one feature. This 
corresponds to an error rate of around 2.5%. 
 
 
Figure S35: The histogram shows the phenotype of the cells belonging to the cluster (red) 
selected by the cross-validated model and found more abundant in the responder. The 
background histograms (blue) shows the rest of the data, not included in the cluster. 
 
ECLIPSE analysis was performed on the three-dimensional dataset, whose dimensionality was 
reduced with Simultaneous Component Analysis to two components. Figure S36 shows the 
Control Model with the density estimation of cell score distributions for the control (blue) and 
response group (red), together with the marker loadings. The axis show the variance explained 
by the model. The deviation of the responders (Figure S36B) from the reference group 
principally occurs along the first component PC1 and is mainly described by Marker1. Marker2 
and Marker3 mostly explain the specific variability of cells along the second component PC2. 
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Figure S36: Panel A: shows the density estimate of the control cells scores distribution. Panel 
B: shows the KDE estimates of the response cells scores distribution. Biplots of the KDE 
estimates in the Control Model, built on the variability of the control individuals. The loadings 
of Control Model are plotted as vectors: their length indicates the contribution of each marker 
to the cell-to-cell variability; the mutual directions suggest a positive (same direction) or 
negative (opposite direction) co-expression. 
 
 
a 
b 
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Figure S37: Density estimate of the cells scores distribution from the responder individuals is 
subtracted from the density estimate of the control individuals. The negative intensity (red) 
specifies the location where cells over-produced in the responder are more likely to be present, 
while the positive intensity (blue) indicates the location where healthy cells are more likely to 
be present. The white area between the red and blue areas corresponds to a value of KDE=0, 
which can indicate bins with no cells or equal intensity of control and responder estimates. 
 
Responder cells with a marker profile variability overlapping with the control variability were 
removed. A new SCA-based space is built on the variability of cells left after this removal and 
it specifically focuses only on the marker expression specific for the responder cells. The 
resulting ECLIPSE space is shown in Figure S38, which does show the rare cell population in 
down right corner. Moreover, the loadings show the correct co-expression between Marker 2 
and 3 for this rare cell population which was masked in Figure S37, due to the high variability 
in the control cells of all markers. 
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Figure S38: ECLIPSE model built on the cells of the responder individuals, after removal of 
normal cells (KDE representation, panel a; single cells representation panel b). The loadings 
show the marker co-expression specific for the response-specific cell subsets. The small 
population, consisting of 20 cells, is visible on the bottom right corner. 
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Abstract 
River water is an important source for Dutch drinking water. For this reason, continuous 
monitoring of river water quality is needed. Though routinely chemical analyses may detect 
unknown contaminants in the river, complementary bioassays are generally needed to estimate 
the toxicity of these unknown contaminants. Phytoplankton are often used in bioassays as they 
are the primary food source in aquatic life and effects of pollutants on these communities may 
therefore have profound effects on the entire food chain. Current phytoplankton bioassays, 
quantification and taxonomic identification by microscopy are too time consuming and 
laborious to be applied as early warning and generally lack sensitivity. Contrarily, near real 
time monitoring of phytoplankton with flow cytometry may provide sufficient data on the state 
and species composition of the phytoplankton community to enable early warning information 
on river water quality. This however requires advanced chemometrics, as the resulting 
fingerprints need to be processed into information about abnormal phytoplankton behaviour. 
Thousands of phytoplankton cells were measured hourly from the Dutch river Meuse for 224 
days by scanning flow cytometry. To handle this large amount of data we adapted the 
Discriminant Analysis of Multi-Aspect CYtometry (DAMACY) method, initially developed 
for medical diagnostics, to monitor the “normal condition” of the phytoplankton community 
imposed by diurnal, meteorological and other exogenous influences. DAMACY first describes 
the cellular variability and distribution of phytoplankton in each measurement, and then aims 
to find subtle differences in these phytoplankton distributions that predict normal environmental 
conditions. Our results demonstrate that advanced chemometrics combined with scanning flow 
cytometry can capture the dynamic change of phytoplankton species and phenotype in normal 
environmental conditions during the year. Deviations from the predicted normal environmental 
conditions could detect when phytoplankton are affected by non-natural contaminants in the 
river water. Flow cytometry in combination with advanced chemometrics may be used for an 
automated hourly assessment of river water quality and as a near real-time early warning for 
detecting toxic (un)known contaminants. 
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Introduction 
In the Netherlands river water is an important source for drinking water. The river Meuse solely 
provides drinking water for six million people in the Netherlands (and Belgium). This is why, 
continuously monitoring of river water quality is essential. Over hundreds of compounds, 
including industrial chemicals, heavy metals from mining, herbicides and pesticides are 
routinely measured. These analyses are highly regulated and targeted to specific, known toxic 
compounds. However, an increasing number of new chemical substances are discharged into 
the river, which may be harmful. Therefore, the Dutch government agency Rijkswaterstaat also 
screens the water for unknown contaminants at the Dutch-Belgium border to further protect the 
downstream drinking water intake. As no regulation exists for such unknown contaminants with 
uncharacterized effects on water quality, complementary analyses are essential. Monitoring the 
state of the hydrobiology in the river may provide an informative data source on the biological 
response to acute freshwater toxicity by both known and unknown contaminants. 
There are several key requirements to such a platform for an early warning system for new 
unknown contaminants. High frequency and therefore high-speed measurements of aquatic 
organisms should be uninterrupted measured on-line in the river. The data also needs to contain 
sufficient information to actual predict freshwater toxicity. Phytoplankton are at the bottom of 
the food chain and are thus fundamental key indicators of the stability of the entire food chain. 
Finally, the measurements should also be reproducible, if the exact same algae is measured one 
month later the measurements should give the same values. These conditions will allow the 
measurements of the phytoplankton be sensitive enough to detect (un)known contaminants in 
the river water. 
A new approach that meets these conditions, is the use of an on-line scanning flow cytometer. 
In 2013 Rijkswaterstaat together with Cytobuoy BV and ThomasRuttenProjects started a pilot 
in the river Meuse to test the possibilities for near real time measuring phytoplankton 
composition on-line by flow cytometry(Rijkeboer et al. 2017). A series of hourly measurements 
was performed automatically by the scanning flow cytometer CytoSense (CytoBuoy b.v., 
Woerden, the Netherlands), installed at a monitoring station in the river Meuse near Eijsden at 
the Dutch-Belgium border. Scanning flow cytometry can measure laser induced scatter and 
fluorescence properties of individual algal cells, colonies and aggregates (Dubelaar et al. 2004). 
These optical properties are related to the size, shape and condition of the algae. The flow 
cytometer is able to measure thousands of single cells in several minutes performed every hour 
on-line in the water. Thus, the flow cytometer can highly frequent, fast and with high resolution 
measure the composition and condition of the algae that is needed to create an early warning 
system to detect (un)known contaminants in the river water. 
Finally, advanced chemometric data analysis is needed to consider interacting environmental 
variables, such as light/dark cycle, amount of light, seasonal changes, water temperature and 
cell division cycle. The variance caused by (un)known contaminant is left after removal of the 
variance caused by the masking environmental variables. First, we use principal component 
analysis (PCA) to describe the comprehensive cellular variability of the phytoplankton. The 
advantage is that we may be able to describe subtle phenotypic changes within a phytoplankton 
species, which may indicate a minor toxicological change. This minor toxicological change 
may already be an early warning before a major ecological shift occur. We developed the 
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method Discriminant Analysis of Multi-Aspect CYtometry data (DAMACY)(Tinnevelt et al. 
2017), which is already validated and in use for clinical flow cytometry to model the single cell 
variability and relate it to clinical phenotypes. The method is able to describe the single cell 
distribution of the data by first using principal component analysis (PCA) to describe the 
comprehensive cellular variability and subsequently transform the PCA space into a distribution 
by creating smoothed histograms of the PCA scores. This will result into a fingerprint of every 
hourly measurement, which can then be used to predict the interacting environmental variables 
such as the night/day rhythm, day length, water temperature and other effects. A better 
understanding of the interacting environmental effects on phytoplankton, may help to define 
good water quality. When all environmental effects are well modelled, abnormal deviations 
from the prediction may indicate a toxicological change. Discussed in this article are the hourly 
measurements of phytoplankton with scanning flow cytometry in the Meuse river near Eijsden, 
The Netherlands from March until October in 2015. 
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Material and methods: 
Technology 
The data were collected using a CytoSense flow cytometer (CytoBuoy b.v., The Netherlands, 
(Dubelaar et al. 2004). The flow cytometer is installed at the monitoring station in the river 
Meuse near Eijsden at the Belgian border. The station is used for quality control of the river 
water that enters the Netherlands. Every hour 40 thousand litre of Meuse river water is pumped 
through the piping system of the station. The high speed is needed to circumvent phytoplankton 
growth in the pipes. Additionally, the pipes are once a week cleaned with a concentrated HCl 
solution. 
 
Every hour the flow cytometer automatically samples 2-5ml (dependent on the particle 
concentration) from the piping system. In the CytoSense the sample is injected and accelerated 
into a sheath fluid which flows at 2m/s through a quartz flowcell. All suspended particles are 
aligned in the narrow centralized single file and flowing at high speed through a focused laser 
beam consisting of two colours: blue (488 nm) and green (552 nm) laser light. Each object 
passes the focus individually and during its intersection scatters the laser light and also, 
depending on the presence and type of any natural intracellular photosynthetic pigments, will 
emit fluorescence in various colours. Forward scatter (FWS), sideward scatter (SWS) and three 
fluorescent channels were measured: yellow 550-600 nm (phycoerythrin), orange 600-650 nm 
(Chl-b and phycocyanin) and red > 650 nm (Chl-a and Chl-c).(Dubelaar et al. 2004) Sideward 
scatter was split into a Low Sense (LS) part that measures up to very large cells and a High 
Sense (HS) part that measures down to very small cells. Measuring channels are in total five 
high sensitivity channels: forward scatter, sideward scatter, yellow -, orange - and red 
fluorescence as well as three low sensitivity channels: sideward scatter, orange - and red 
fluorescence. Every single phytoplankton cell generates a signal from each detector whilst 
passing through the laser beam. In typical flow cytometers and their applications, the traversing 
cells are small as compared to the laser focus, yielding uniform detector signal shapes with only 
the signal amplitude (height) as variable signal which is typically digitized as a single number. 
Most phytoplankton cells and especially the larger filaments and colonies are typically (much) 
larger as compared to the sharp laser focus (5 µm fwhm) in the CytoSense yielding detector 
signal shapes that are governed by the shape and internal structure of the particle: a one-
dimensional scan. Unlike other flow cytometers these scans are fully captured and digitized for 
each particle in the CytoSense. This is especially crucial for phytoplankton, as each optical 
group has a different shape and size. 
Essential is the extremely large flowcell and tubing orifice of the CytoSense and its scanning 
signal format which accommodate a particle size range from submicron cells up to organisms 
and aggregates of a millimetre to be drawn into the system and analysed. This covers aselective 
(unbiassed) sampling over the whole microbial size range and allows autonomous use of the 
system without clogging. In addition, it yields linear determination of biomass of particles over 
the whole size range. The performance, e.g. to avoid variability due to e.g. reduced laser 
intensity, polluted sheath fluid or flow cell, reduced sensitivity of the detectors is monitored by 
several sensors. The sheath fluid is filtered each cycle to remove all sludge and phytoplankton 
cells that were left behind. Every 24 hours a biocide/bead solution is injected into to flow 
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cytometer. These beads (3 μm diameter, 488 nm excitation maximum, Cyto-Cal) are 
fluorescence-stable for at least half a year and are used to check if the FCM is still stable and 
showing the same output. Therefore, only twice-yearly maintenance is needed for visual 
inspection of the machine, to replace tubing and filters, to clean the flow cell and to add new 
calibration beads/biocide(Rijkeboer et al. 2017). 
Additional monitoring data 
Besides flow cytometry, additional monitoring data are measured. Organic contaminants were 
measured using three systems. A first system SIVEGOM uses a XAD-4 column connected to 
either a FID or MS detector to measure aliphatic and phenolic organic molecules to detect 
chlorinated solvents, pesticides and herbicides. The second system SIVEVOC is used to detect 
volatile organic compounds (VOCs) using Purge and Trap injector coupled to a GC/MS 
(Miermans). The third system SAMOS uses liquid chromatography (LC) coupled with UV 
detector or mass spectrometer to measure all polar organic compounds (Slobodnik et al. 1997). 
These systems together cover a large range of chemical substances. Bioassays were also 
measured with the Algae Toximeter (BBE, Moldaenke), that measures the photosystem activity 
of a standardized phytoplankton species exposed to a water sample from the river. 
 
Also, other environmental variables were measured such as water temperature, river flow, 
nutrient values for example nitrate and oxygen concentration as well as weather variables for 
example solar radiation. 
Data (Pre-)processing 
The river was online sampled hourly during 224 days in 2015 (from March until October). Each 
sample contains more than 2000 cells. The dataset can be rearranged into array 𝐃 = [
𝐃1
⋮
𝐃𝐼
] of 
size (∑ 𝑁𝑖
𝐼
𝑖 = 1 ×  𝐽 × 𝑃𝑛 ) where 𝑁𝑖 is the number of cells per measurement 𝑖 = 1,… , 𝐼; with 
𝑗 = 1,… , 𝐽 indicates the channels and 𝑝 = 1,… , 𝑃𝑛 the number of points measured per cell 𝑛 =
1, … , 𝑁𝑖. 
 
First the flow cytometry data are log transformed and subsequently interpolated using equation 
1 in such a way that each cell has 𝑃∗ = 30 data points. 
Equation 1 𝑦 = 𝑦0 + (𝑦1 − 𝑦0)
𝑥 − 𝑥0
𝑥1 − 𝑥0
 
Where (𝑥0, 𝑦0) and (𝑥1, 𝑦1) are the known values and 𝑦 is the value in between on position 𝑥. 
The number of data points per cell 𝑃𝑛 is saved as additional variable and repeated 30 times to 
equalize the importance compared to channels. Finally, the array is unfolded to create a two-
dimensional matrix per measurement 𝐗𝒊 and saved in array 𝐗 = [
𝐗1
⋮
𝐗I
] of size (∑ 𝑁i
𝐼
𝑖 = 1 × 𝐽
∗ ), 
where 𝐽∗ is of size (𝐽 + 1)  × 𝑃∗. In this experiment, each measurement 𝐗𝑖 contained 𝑁𝑖 cells 
as rows and (𝐽 + 1)  × 𝑃∗ = (8 + 1)  ×  30 = 270 variables as columns. 
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In the following step, we centred the data to create a common point of reference to quantify the 
variability in optical properties. 
Equation 2 A 
𝐦𝑖
T = 
∑ 𝐗𝑖
𝑁𝑖
𝑛=1  
𝑁𝑖
 
 B 
𝐦T =
∑ 𝐦𝑖
T𝑰
𝑖=𝟏
𝐼
 
 C 𝐗mc =  𝐗 −  𝟏𝐦
T 
where 1 is a column vector of length ∑ 𝑁𝑖
𝐼
𝑖=1  and matrix 𝐗mc holds the mean-centred data of 
dimensions equal to 𝐗. 
In the final step of pre-processing, we scale the centred data 𝐗𝑚𝑐 using the pooled standard 
deviation as shown in equation 3. This is used because each variable 𝑗 contains a pulse shape 
and the variance at the edges are very small compared to median of the pulse shape. Moreover, 
each measurement contains a different number of cells and the pooled standard deviation 
compensates for that. 
Equation 3 A 
𝐬𝑖 =
√∑ ∑ 𝐗mc2 𝑖𝑝
30
𝑝=1
𝑵𝑖
𝑛=1
𝑃∗𝑁𝑖
 
 B 
𝐬𝐩𝐨𝐨𝐥𝐞𝐝 = √
∑ (𝑁𝑖 − 1)𝐬𝑖
2𝐼
𝑖=1
∑ (𝑁𝑖 − 1)
𝐼
𝑖=1
 
 C 𝐒 = diag(𝐬𝐩𝐨𝐨𝐥𝐞𝐝) 
 D 𝐗𝐜𝐬 = 𝐗𝐦𝐜𝐒
−1 
 
Base model 
PCA (Principal Component Analysis) 
The base model describes the variability of all the phytoplankton cells in each sample. One of 
the most widely used methods to describe variance in the data is Principal Component Analysis 
(PCA) which reduces the data dimensionality while retaining most of the variability (Bro and 
Smilde 2014). 
 
PCA decomposes the pre-processed data 𝐗cs into two matrices (Bro and Smilde 2014) using 
equation 4. 
Equation 4  𝐗𝐜𝐬 = 𝐓𝐛𝐚𝐬𝐞𝐏𝐛𝐚𝐬𝐞
𝐓 + 𝐄𝐛𝐚𝐬𝐞 
The single-cell scores 𝐓𝐛𝐚𝐬𝐞 = [
𝐓𝐛𝐚𝐬𝐞,1
⋮
𝐓𝐛𝐚𝐬𝐞,𝐼
] are the coordinates in the reduced PCA space and 
show the phytoplankton cell variability within each sample in 𝐓𝐛𝐚𝐬𝐞,𝑖 of size (𝑁𝑖 × 𝐾base). The 
loadings 𝐏𝐛𝐚𝐬𝐞
𝐓  of size (𝐾base  ×  𝐽
∗) describe how each variable contributes to the variance 
described by the PCA model. The data dimensionality is reduced to the number of  𝐾base 
Principal Components (PCs), where for flow cytometry data 𝐾base < 𝐽
∗ << 𝑁𝑖. The residuals 
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𝐄𝐛𝐚𝐬𝐞 contains the variability that is not described by the PCs. The loadings for each PC describe 
unique information as they are mutually orthogonal (𝐏𝐛𝐚𝐬𝐞
T 𝐏𝐛𝐚𝐬𝐞 = 𝐈). 
Because the total number of cells 𝑁𝑖  differs greatly per measurement (2,000 in spring and 
10,000 or higher in summer), the loadings 𝐏𝐛𝐚𝐬𝐞
𝐓  will be highly biased towards those samples 
for which most phytoplankton cells have been measured. Therefore, we adjusted the standard 
equation 4 into equation 5. 
Equation 5 A 
 𝐗csn = [
𝐗1𝑁1
−1/2 
 
⋮
𝐗I𝑁I
−1/2
] 
 B 𝐗csn = 𝐓𝐛𝐚𝐬𝐞∗𝐏𝐛𝐚𝐬𝐞∗
𝐓 + 𝐄 
 C 𝐓𝐛𝐚𝐬𝐞 = 𝐗cs𝐏𝐛𝐚𝐬𝐞∗ 
 
The relations between cell variability and the optical properties can be combined in a 
biplot(Gower et al. 2011)(see Figure 1). 
Histogram Construction 
In the next step histograms are constructed, because the scores 𝐓𝑖  cannot be quantitatively 
compared between measurements, as each score relates to a single phytoplankton cell within 
only one sample. Therefore, for each score submatrix 𝐓base𝑖, we sum the number of cells in 
each bin (location in the PCA space), which results into a histogram matrix 𝐇𝑖  of size 
(∏ 𝐹K𝑘=1 ), with 𝑓 = 1,… , 𝐹 indicating the bins within the histograms. 
The bin width is based on the range of the scores on every PC, using equation 6. 
Equation 6 
𝛿𝑘 = 
𝐩𝐞𝐫𝐜𝐞𝐧𝐭𝐢𝐥𝐞𝟗𝟗. 𝟗𝟓(𝐭𝑘) − 𝐩𝐞𝐫𝐜𝐞𝐧𝐭𝐢𝐥𝐞𝟎. 𝟎𝟓(𝐭𝑘)
𝐹
 
where 𝐭𝑘 (of length ∑ 𝑁𝑖
𝐼
𝑖=1 ) is the vector with all the single-cell scores for all individuals, for 
Principal Component 𝑘. Note that the bin width is determined without considering the 0.1% 
extreme values. 
As the number of cells that is measured per sample is most often non-informative due to river 
debit. Each histogram was normalized by dividing by the total number of phytoplankton cells 
measured in the sample N𝑖, using equation 7. 
Equation 7 
𝐇𝑖 = 
𝐇𝑖
𝑁𝑖
 
 
Furthermore, the histograms can be plotted as a density plot together with the loadings, resulting 
in a biplot (Figure 2). This histogram reveals the cell variability, where we can see the different 
phytoplankton distribution. 
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Top model 
The base model describes the algal variability and creates a phytoplankton distribution, namely 
a histogram for every measured time point. The top model uses the variability between 
histograms to predict the phytoplankton phenotype specific to environmental variables, such as 
the day/night cycle, day length and water temperature. The environmental variables can either 
be a categorical variable such as day or night, or a continuous variable, such as day length and 
water temperature. In the case of a categorical variable a binary dummy vector 𝐲 is made with 
length  I . Orthogonal partial least squares (OPLS) is used to predict these environmental 
variables. 
We first vectorise the histograms, such that every histogram 𝐇𝑖 is rearranged into a row vector 
𝐡𝑖
T  of length 𝐹𝐾𝑏𝑎𝑠𝑒 . These vectors may then be collected in a second matrix 𝐂  with 
dimensions(𝐼 ×  𝐹𝐾𝑏𝑎𝑠𝑒). Subsequently, the variables (bins) in matrix 𝐂 with small variance (<
10−6) are not used in the top model, as these variables do not contribute much to the top model. 
The variables (bins) that do vary (𝐂∗) are then used in the orthogonal partial least squares model, 
see equation 8. 
Equation 8 A 𝐂∗ = 𝐭𝐭𝐨𝐩𝐩𝐭𝐨𝐩
𝐓 + 𝐓𝐨𝐏𝐨
𝐓 + 𝐄𝐭𝐨𝐩 
 B 𝐲 = 𝐭𝐭𝐨𝐩𝐪𝐭𝐨𝐩 + 𝐞 
 
where 𝐭𝐭𝐨𝐩  contain the predictive scores of length 𝐼 , and 𝐩  of length 𝐹
∗ contain the 
corresponding loadings of the histogram data 𝐂∗  and scalar 𝐪top  contains the loading of 𝐲, 
matrices 𝐓𝐨  and 𝐏𝐨
𝐓  are respectively the scores and loadings of the space in 𝐂∗ that is 
uncorrelated to 𝐲 and are not further considered in this study, like the model residuals of 𝐂∗ in 
matrix 𝐄OPLS of size (𝐼 ×  𝐹
∗) and the residuals of 𝐲 in scalar 𝐞. 
In addition to the model results above, the OPLS-DA algorithm provides a weight-vector 𝐰top 
of length 𝐹∗ that indicates per bin whether it is important for the variance in 𝐲. The prediction 
of new samples may be calculated in equation 9. 
Equation 9 ?̂? = ( 𝐂new
∗ − 𝐓𝐨new𝐏𝐨
𝐓)𝐩𝐭𝐨𝐩𝐪𝐭𝐨𝐩 
 
Instead of predicting an environmental variable, we may also describe the variance between 
different time points using Principal Component Analysis on histograms 𝐂∗ using equation 4. 
We then attain the top PCA scores 𝐭𝐭𝐨𝐩𝐏𝐂𝐀  and the loadings 𝐩𝐭𝐨𝐩𝐏𝐂𝐀
𝐓 , where the top PCA scores 
describe each time point 𝑖  in the reduced space and loading correspond to the bins in the 
histogram describe the reduced space. 
Performance and validation 
The whole model is double cross-validated where the data of days without pollution was first 
split in a training set (even days) and a validation set (uneven days). Secondly, the training set 
was split in a calibration set (even hours) and a test set (uneven hours). The model parameters: 
number of bins, smoothing factor, number of PCs and number of orthogonal latent variables 
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were varied and tested on the test set. The model parameters that resulted in the best prediction 
of the test set were used in the final model. The best predictable model was based on the 
harmonic mean of sensitivity and specificity for categorical 𝐲  variables and regression 
coefficient R2 was calculated for continuous 𝐲 variables, see equation 10 and 11. The final 
model was based on the training set and the final prediction was calculated based on the 
validation set. This was repeated with the even and uneven day/hours were switched such that 
all time points have a final prediction. The data of days with pollution were projected into both 
models and the average was taken as prediction. 
 
Equation 10 A ?̂? =  {
1 if ?̂? > 0.5 
0 otherwise
 
 B 
𝑐𝑙 =
∑(𝛿?̂?,𝐲,𝑙)
∑(𝛿 𝐲,𝑙)
 
 C 
ℎ =
2 c0c1
c0 + c1 
 
Equation 11 
𝑅2 = 1 −
∑(y − ?̂?)2 
∑(y)2 
 
 
Water quality measure: Deviation from prediction 
After modelling the phytoplankton variability as best as possible with the optimal model 
parameters, we can use the model to look at the deviations from predicted/expected. These 
deviations may then be caused by non-natural contaminants and serve as a water quality 
measure, as most phytoplankton variance from environmental variables is already modelled. 
 
In process control, normal operating conditions are used like T2 and Q2, see equation 12 and 
13.(Joe Qin 2003, MacGregor and Kourti 1995) These can be based on the scores and loadings 
of the top PCA model or the top OPLS model. These measures may work perfectly if the system 
or process is always the same and you do not expect large dynamic changes. However, the 
phytoplankton do have dynamic changes both in fluorescence activity and relative abundance 
of phytoplankton species. Therefore, it may be better to look at the deviation of prediction using 
the sum of squared prediction error (SPEy) in equation 14. For example, if due to low 
fluorescence activity, the model predicted night but phytoplankton were measured during the 
day, something may have happened to the phytoplankton that caused the unexpected low 
fluorescence activity. However, we may need to normalize the SPEy according to how well that 
variables can be predicted in the non-populated data. In that way a small deviation on a good 
predicting variable are more important than a larger deviation on a bad predicting variable, see 
equation 15. Finally, a 95- or a 99-percentile may be calculated on the measures of all the time 
points without a pollution. Values above this threshold may be caused by a non-natural 
contaminant. 
Equation 12 
T𝑖
2 = ∑𝒕𝑖,𝑙
2
𝐿
𝑙=1
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Equation 13 Q𝑖
2 = 𝐂∗𝑖(𝐈 − 𝐏𝐏
𝐓)𝐂∗𝑖
𝐓
 
Equation 14 
SPEy𝑖 = ∑(𝑦𝑖,𝑙 − ?̂?𝑖,𝑙)
2
𝐿
𝑙=1
 
Equation 15 
𝑛𝑆𝑃𝐸𝑦𝑖 = ∑
(𝑦𝑖,𝑙 − ?̂?𝑖,𝑙)
2
∑ (𝑦𝑖,𝑙 − ?̂?𝑖,𝑙)
2𝐼
𝑖=1
𝐿
𝑙=1
 
Results 
Base model 
In the first step of the analysis a Principal Component Analysis (PCA) model is built to describe 
a large part of the variance of all measured algae. Figure 1 shows 6 examples of the 
phytoplankton measured at different times. Principal Component 1 (PC1) mainly describes the 
variance of the fluorescence channels, the loadings point to the right, which means that single 
phytoplankton cells (dots) at the right side of each plot have a higher fluorescent intensity on 
all fluorescence channels. PC2 describes the forward and sideward scatter as well as the cell 
size, these loadings point downwards, so single phytoplankton cells at the top of each plot have 
a smaller scatter and cell size. 
 
Figure 1: Biplots of six time points. The three upper plots are made from measurements at 1 
o’clock in the night and the three bottom plots at 13 o’clock in the afternoon. The arrows show 
the loadings, the original variable expression in the reduced space and each single dot is a 
single algae measured. 
From left to right a difference in season can be seen in Figure 1. In May (left plots), few cells 
were measured and most cells are at the left side of the plot, thus have a low fluorescent 
intensity. Compared to June/July (middle plots), where more cells (dots) can be seen and also 
more cells at the right side of the plot, thus with a higher fluorescence intensity. The situation 
in October was again more similar to that in May, where few cells were measured which also 
have a low intensity. A difference between night (upper three plots) and day (lower three plots) 
is hard to see, because the number of cells measured is changing between the plots/time points. 
The number of cells is highly dependent on the bloom of phytoplankton in summer, but also 
215 
 
dependent on the volume and flow rate of water in the river. Higher river discharge means a 
lower phytoplankton concentration. Therefore, we create two-dimensional Histograms of each 
score plot and only look at relative changes of the phytoplankton communities. An example of 
these 2-D histograms is shown in Figure 2. You see that the density of the whole population is 
slightly shifting to the right during the day (lower three plots) compared to night (upper three 
plots) and new phytoplankton populations appear during summer, which have a higher 
fluorescence intensity on all channels. 
 
Figure 2: 2-D histograms of the scores of Figure 1. The three upper plots are made from 
measurements at 1 o’clock in the night and the three bottom plots at 13 o’clock in the afternoon. 
The loadings are plotted as arrows on top of the histograms, the darker the colour means 
relatively more cells are present. 
Top model 
In the top model we quantify the changes in the phytoplankton distribution correlated to the 
different environmental variables. A top predicting model for each environmental variable was 
made using the optimal parameters, see Table 1. The three best predictable environmental 
variables are Light/Dark classification, day length and water temperature in the flow cytometer 
followed by the nitrate (NO3) and oxygen concentration in the water. Other nutrient variables 
as well as solar radiation are reasonably well-predicted, with an R2 between 0.4-0.73, which 
shows that phytoplankton cells are influenced (in number and in fluorescence) by nutrient 
variables and solar radiation. Finally, it is striking that CHLFa and 
Cyanobacteria/Cryptophyceae was not well predicted (0.38 and 0.25 respectively). These 
variables are global descriptors of the phytoplankton. Below we highlighted the prediction 
DAMACY maps for light/dark classification, day length regression and temperature inside the 
cell regression. 
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Table 1: Prediction quality for each evaluated environmental variable. The variables in italics 
have a poor prediction and were not used to detect outlier events 
Environmental Variables F /R2 
 Part A Part B Average 
Light/dark 0.821 0.834 0.827 
Day length 0.931 0.930 0.930 
Sample water temperature 0.901 0.901 0.901 
Oxygen(mg/l) 0.714 0.678 0.696 
Temperature (1,5 m height) 0.590 0.586 0.588 
Minimum temperature (10 cm 
height) 0.546 0.570 0.558 
Global solar radiation 0.424 0.383 0.403 
Fe (mg/l) 0.535 0.539 0.537 
Kj N (mg/l) 0.533 0.487 0.510 
NO2 N (mg/l) 0.699 0.662 0.680 
NO3 N (mg/l) 0.730 0.720 0.725 
P (ug/l) 0.576 0.541 0.559 
P nf (ug/l) 0.646 0.599 0.622 
PO4 P (ug/l) 0.636 0.594 0.615 
TOC (mg/l) 0.630 0.476 0.553 
DOC (mg/l) 0.622 0.447 0.535 
CHLFa (ug/l) 0.349 0.409 0.379 
ZS (mg/l) 0.463 0.482 0.472 
Debit(m3/s) 0.627 0.642 0.635 
Ammonium(mg/l) 0.373 0.327 0.350 
Cyanobacteria/Cryptophyceae 0.238 0.271 0.254 
 
Phytoplankton have a dynamic behaviour during day and night as seen in Figure 3. During 
daytime (red coloured bins, C) the photosynthesis is active and these phytoplankton have more 
fluorescence measured (the fluorescence channels are pointing in that direction). During night 
time (blue bins, A, B and D), the phytoplankton are dividing. This leads to the emergence of 
three clusters: one cluster of smaller cell size who just divided, with a low scatter and no 
fluorescence (A, moved away from all loadings compared to C). A second cluster of cells (B) 
with the same scatter as daytime phytoplankton (C), but do not have any fluorescence signal 
(moved away from all fluorescence loadings but went in direction of the scatter loadings 
compared to C). Thirdly a cluster of large cells (D) with high scatter and also yellow and orange 
(high sense) activity, probably right before dividing (Most clearly seen in PC2 and PC3 where 
D is in direction of scatter and Yellow and Orange HS loading). In Figure 4 you can see the 
median interpolated pulse shape of the cells of each area marked in Figure 3. 
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Figure 3: DAMACY map based on light/dark classification. Red bins correspond to 
phytoplankton more present during day and blue bins during night. The loadings (arrows) show 
the maximum direction of the variables. 
 
Figure 4: Median interpolated pulse shapes of the cells in the area A (blue), B (orange), C 
(yellow), D (purple) and E (green) of Figure 3,5 and 6. The horizontal axis describes the 
interpolated measurement points the cell passes the laser and the y-axis the intensity. The 
bottom-right bar plot shows the median number of measurement points before interpolation 
(Cell Size) 
Large changes in phytoplankton communities are seasonal, which relate to the day length, the 
time between sunrise and sunset. For example, during spring/summer bloom multiple new 
phytoplankton species appear and disappear. The PCA model is the same as in Figure 3 and the 
same areas are marked, but the OPLS weights are different compared to the Day/Night model, 
thus different areas are highlighted as important for the day length, see Figure 5. The 
phytoplankton with a high scatter (D) belong to a long day length with high yellow and orange 
fluorescence compared to phytoplankton (E) during a short day especially seen in PC2 vs PC3 
in the lower left corner. A mixed area of purple (a combination of red and blue in the other 
dimension) can be seen near the origin. Less intense colour as seen in area A, B and C means 
that the weights are lower and these areas are less important for predicting day length than for 
are D and E. 
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Figure 5: DAMACY map based on day length regression. Red bins corresponds to 
phytoplankton more present during shorter day length and blue bins during longer day length. 
The arrows show the maximum direction of the variables. 
In Figure 6, a separation between phytoplankton in red coloured bins (A and B) that correspond 
to a high water temperature, which have low scatter. These were also important in Figure 3 for 
phytoplankton more present during night time. The blue bins that correspond to a low water 
temperature have phytoplankton cells with a high scatter and fluorescence activity in Orange 
HS and Yellow HS. 
 
Figure 6: DAMACY map based on water temperature regression. Red bins corresponds to 
phytoplankton more present during higher water temperature and blue bins during lower water 
temperature. The arrows show the maximum direction of the variables 
Deviation from prediction: Water quality measure 
Finally, we used different strategies to find pollution events based on the phytoplankton 
distribution. Three systems were used to daily measure chemical compounds, namely 
SIVEVOC, SAMOS, SIVEGOM and found six di-isopropyl events and eight unknown 
contaminant events that correspond to 877 of the total 5144 measurements. Table 2 shows the 
percentage of these 877 contaminants events found with different approaches. The best 
approach to find the non-normal phytoplankton measurement was using DAMACY to predict 
the environmental variables and use the normalized sum of squared prediction errors (nSPEy), 
these were normalized for the total squared prediction error of each variable. With this approach 
we could find 27.7% with 5% false positive or 19% with 1% false positive of the found pollution 
events which correspond to one of the six di-isopropyl alarms and six out of eight unknown 
contaminant alarm. Figure 7 shows the nSPEy for each alarm and for all the measurements 
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without any contaminants in a boxplot where the blue box represents the 95th confidence 
interval and the whiskers the 99th confidence interval. Not considering the environmental 
variables that influence the dynamic changing and using standard PCA methods for outlier 
detection did not find any pollution events more than the false positive rate of 5%. 
Table 2: Percentage of outliers found in the measurements of contaminated events. The 
threshold is based on the non-contaminated measurements using the 95 or 99 percentile. The 
models are either built with the pollution events or without. Note that each predicted 
measurement was never been used by the DAMACY model. 
 Models built with pollution events Models built without pollution 
events 
 95% threshold 99% threshold 95% threshold 99% threshold 
OPLS T2 6.3% 2.2% 5.8% 2.2% 
OPLS Q2 3.5% 1.8% 5.7% 2.4% 
SPEy 16.5% 5.5% 19.8% 11.4% 
nSPEy 21.2% 7.2% 27.7% 19% 
PCA T2 .5% 0% 2.5% .8% 
PCA Q2 3% 1.1% 9% 3.4% 
 
Figure 7: The normalized deviation from prediction of the environmental variables. Each 
pollution event and all the measurements without pollution were summarized in a boxplot. The 
red line in the boxplot shows the median value, the blue box is the 5 and 95 percentiles, the 
black whiskers the 1 and 99 percentiles. The orange line shows the 95th percentile threshold 
and the pink line the 99th percentile of the measurements with no contaminations. Above the 
95th percentile was D3 (di-isopropyl ether) and U2, U3, U4, U6, U7 and U8 (unknown 
contaminants). 
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Discussion 
High frequency measurements of the phytoplankton in the Meuse river with a scanning flow 
cytometry may be used to monitor dynamic changes of phytoplankton and other associations 
with environmental variables. Models based on these distributions may predict the 
environmental variables such as diurnal cycles, day length and water temperature on the 
phytoplankton. Also, other weather conditions and nutrient variables can be predicted, although 
the strength of the association is less strong for other weather conditions, yet significant. The 
day and night cycle of phytoplankton is already known for quite a while(Harding et al. 1981). 
However many of these studies were performed offline, for considerably shorter periods on a 
lab-scale. These experiments mimic environmental conditions, but still are different from on-
line measurements in the river, which represent almost in-situ conditions. Other studies with 
the flow cytometer also found seasonal effects, but these experiments only sample weekly or 
bimonthly, while we show a far more gradual seasonal effect(Grégori et al. 2001, Li and Dickie 
2001). 
Many studies(Carr et al. 1996, Demers et al. 1992, Pomati et al. 2011, Rutten et al. 2005, 
Wilkins et al. 1999, Wilkins et al. 1994) also describe the flow cytometry results into distinct 
phytoplankton subpopulations that are related to the different phytoplankton species known by 
taxonomic microscopy. In our research we decided not to focus on the different phytoplankton 
species but instead we described the phytoplankton variability and created phytoplankton 
distributions. In these distributions small shifts in phytoplankton can be detected that are needed 
to study the dynamic changes in phytoplankton caused by environmental variables and to find 
abnormalities in the phytoplankton community. These small shifts could otherwise not be 
detected as they belong to the same distinct phytoplankton subpopulation. 
For the first time monitoring biological water samples could detect (un)known contaminants in 
the river Meuse. Bioassays measured with the Algae Toximeter (BBE, Moldaenke) did not 
detect any toxicity during the same period. Flow cytometry may thus be able to early detect 
chemical contaminants affecting the phytoplankton before any major toxicity. The scanning 
flow cytometer together with advanced chemometrics may therefore be used to detect pollution 
events and to know whether an unknown contaminant is affecting the phytoplankton variability. 
With these measurements we could describe the environmental variables with the changes in 
variability of the phytoplankton. Deviations of the predicted environmental variables compared 
to measured environmental variables could be used to detect one of the six di-isopropyl alarms 
and six out of eight unknown contaminant alarm, which was not necessarily correlated with the 
concentration of these contaminants. Many di-isopropyl ether pollution events were not 
affecting the phytoplankton, which may be because di-isopropyl is poorly soluble in water; it 
may therefore hardly interact with phytoplankton. The combination of flow cytometry, 
chemical analysis and advanced chemometrics may therefore be used to monitor river water 
quality and to detect harmful unknown chemical contaminants in the river. Additional research 
may then be applied to identify the unknown chemical compound and its origin. 
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Conclusion 
Flow cytometry is able to high frequently measure the single algal cells. These single cell 
measurements can be used by DAMACY to describe the phytoplankton distribution and use the 
phytoplankton distribution to predict dynamic environmental variables such as day/night cycle, 
water temperature and day length. Deviation from these predictions can then be used to detect 
(un)known chemical contaminants that are affecting phytoplankton and thus water quality. This 
provides the opportunity of realising an early warning system for (un)known contaminants. 
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In the next chapter: “Fast microplastics identification with stimulated Raman scattering 
microscopy” I contiributed scienticfially to the multivariate data analysis for selecting the 
minimum number of required wavenumbers with sparse-PLS-DA, see paragraph 
“Calibration”. I furthermore contributed to writing, reviewing and editing the entire 
manuscript for publication. 
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Abstract 
The abundance of plastic products in modern society has resulted in a proliferation of small 
plastic particles called ‘microplastics’ in the global environment. Currently, spectroscopic 
techniques such as Fourier-transform infra-red (FTIR) and spontaneous (i.e. conventional) 
Raman spectroscopy are widely employed for the identification of the plastic microparticles, 
but these are rather time consuming. Stimulated Raman scattering (SRS) microscopy, based on 
the coherent interaction of two different laser beams with vibrational levels in the molecules of 
the sample, would enable much faster detection and identification of microplastics. Here, we 
present for the first time an SRS based method for identifying five different high production-
volume polymer types in microplastics extracted from environmental or consumer product 
samples. The particles from the extracts were collected on a flat alumina filter and six SRS 
images were acquired at specifically chosen wavenumbers. Next, we decomposed this spectral 
data into specific images for the five polymers selected for calibration. As a proof of principle, 
we identified polyethylene terephthalate (PET) particles extracted from a commercial personal 
care product, demonstrating also the thousand-fold higher speed of mapping with SRS 
compared to conventional Raman. Furthermore, after density separation of a Rhine estuary 
sediment sample, we scanned 1 cm2 of the filter surface in less than 5 h and detected and 
identified 88 microplastics, which corresponds to 12,000 particles per kg dry weight. We 
conclude that SRS can be an efficient method for monitoring microplastics in the environment 
and potentially many other matrices of interest. 
 
Keywords: SRS, environment, pollution, spectroscopy, imaging 
224 
 
Introduction 
One major side effect of the abundance of plastic products in modern society is microplastic 
pollution, where small size polymer particles of diverse origins and types enter the environment. 
There is a growing public awareness and an increase in the body of literature on this subject[1–
6], but much is still unknown about the full extent, ecotoxicological impact and environmental 
fate of this type of pollution. Microplastics are usually defined as plastic particles smaller than 
5 mm in diameter with no lower limit[7]. They constitute a wide range of chemically complex 
materials, often with additives and fillers influencing properties such as color, density and 
durability. Moreover, they are hard to specifically label with, for instance, fluorogenic dyes. 
This diversity in properties and wide particle size range means that as a group of analytes, they 
are challenging to efficiently detect and identify in complex environmental matrices. 
Analysis of microplastics in the micro-size range in environmental samples, for instance in 
marine sediments, often relies on density separation, sample clean-up and filtration, followed 
by visual inspection[8]. However, this identification method might result in large numbers of 
false positives, or false negatives, i.e. classification of particles as microplastics when they are 
not, or missing plastic particles, respectively[9]. For these reasons, identification methods that 
are specific for the polymers’ chemical structure are necessary for reliable monitoring. 
Therefore, spectroscopic techniques such as Fourier-Transform Infra-Red (FTIR), spontaneous 
(i.e., conventional) Raman spectroscopy and pyrolysis-Gas Chromatography–Mass 
Spectrometry (pyro-GC-MS) have been employed to identify microplastics. While pyro-GC-
MS is usually employed for confirmation of a few manually separated particles of interest[10], 
the optically based vibrational spectroscopic techniques FTIR and Raman scattering can scan 
the surface of a filter containing sample particulates. Such spectroscopic techniques are non-
invasive so the particles remain available for further analysis if necessary. 
Unfortunately, these methods can be very time consuming, especially when mapping large filter 
surfaces with a spatial resolution of the order of micrometers[11]. Therefore, most methods based 
on FTIR or Raman micro-spectroscopy rely on visual inspection to pre-select the particles 
suspected as microplastics for spectroscopic confirmation[10,12–17], rather than scanning the 
whole surface of the filter. The acquisition time of spontaneous Raman mapping is typically >1 
s per pixel[16,17] to be multiplied with the total number of pixels. Similarly long mapping times 
are required for single-detector FTIR, but with a focal plane array (FPA) detector the total image 
acquisition time with FTIR can be reduced by two or three orders of magnitude[18,19]. Being 
able to analyze more samples within a reasonable analysis time would be crucial for providing 
reliable statistics on the occurrence of microplastics at a given sampling site. 
An alternative label-free technique that could provide very fast mapping speeds is Stimulated 
Raman Scattering (SRS), where two laser beams coincide on a sample. The signal is then 
generated when the beams’ photon energy difference matches a vibrational state of the 
molecules in the focal volume. Detection is usually achieved by amplitude modulating one of 
the beams before the sample, and detecting the modulation transfer imposed on the other beam. 
The signal intensities at different wavenumbers follow the spontaneous Raman spectrum of the 
target analyte. SRS is often used for imaging, since the signal acquisition time per pixel, and as 
a result also the total mapping time, can be reduced by several orders of magnitude compared 
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to spontaneous Raman[20,21]. With the help of very fast electronics even video rate acquisition 
has been demonstrated[22]. In SRS imaging, the signal response of the chemical components in 
the focal volume at a specific wavenumber serves as the contrast mechanism. For instance, in 
several biological applications the wavenumber difference of the two laser beams was tuned to 
the C-H stretching vibration at ca. 2850 cm-1 to image the lipid distribution[20,22–26]. 
In the context of microplastics, Cole et al.[27] used a technique similar to SRS, coherent anti-
Stokes Raman scattering (CARS), to track the ingestion of well-defined plastic particles by 
zooplankton by imaging a spiked sample. To the best of our knowledge, SRS (or CARS) has 
not yet been used for the detection of a range of microplastics in an environmental sample. 
However, because of the wide variety of different types of polymers and copolymers potentially 
present in plastics in environmental samples, SRS analysis at a single wavenumber setting 
would not be sufficient to detect all polymer materials. There is no single vibrational frequency 
that is specific for all polymers and at the same time selective over other compounds. 
In this paper, we propose an SRS microscopy approach[23,28,29] for faster detection of plastic 
microparticles with only a limited number of measurements. We selected five polymers with 
high global production volumes[7]: polyamide 6,6, polyethylene terephthalate, polystyrene, 
polypropylene and high-density polyethylene, noted as Nylon, PET, PS, PP and PE; 
respectively. To determine the optimal wavenumbers, we first measured conventional Raman 
spectra of these selected plastics. A method using the full Raman spectra was used to determine 
the wavenumbers that provide the best discrimination. After calibrating with these five 
reference compounds at six SRS wavenumber settings, we could then automatically identify 
these polymer species in subsequent samples. 
We first test this approach on an artificial test mixture of the five polymers, by evaluating the 
crosstalk terms between the identification channels. Next, we illustrate this concept with the 
detection of microplastics from a commercial glitter nail-polish product (containing PET 
particles as stated on the label), and show how the automated data processing offers both 
identification and size determination of the particles collected on a flat filter. We also show the 
relative gain in overall mapping speed in comparison with conventional Raman. We then 
demonstrate the identification of five types of microplastic particles from a sediment sample 
from the Rhine estuary using SRS and multiplexed data processing. 
Experimental 
Sample preparation: 
An artificial test mixture of the five polymers was made by grinding each polymer type with 
sand paper, and placing one or a few grains, of each polymer, in close proximity on a glass 
slide. The order from left to right was: Nylon, PET, PS, PP and PE. After applying water for 
refractive index matching on the glass slide, a cover slip was placed on top. 
Glitter nail-polish (Multidimension topcoat ‘a cut above’, Essie) was subjected to microwave 
destruction with nitric acid as described by Bettinelli et al.[30], followed by direct filtration on 
an Anodisc alumina filter membrane (pore size: 2 µm, Whatman). The filter was placed between 
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a microscope slide and a cover slip and wetted to improve refractive index matching necessary 
for SRS imaging. 
A sediment sample from the Rhine estuary was prepared using a procedure similar to the one 
described by Karlsson et al.[31]. In short, we mixed 26 g of dry sediment with saturated salt 
solution (density 1.2 g/cm3), and let it settle for > 5 h. Next, saturated NaCl solution was slowly 
pumped into the bottom of the flask (with a thin layer of 6 ml of ethanol on top to prevent 
microplastics from adhering to the glassware), until the surface layer was raised past a valve. 
We then separated the supernatant and filtered it with a vacuum pump over a 25-mm diameter 
Anodisc filter membrane. This filter was selected because of its low Raman background[32] and 
its flatness, which is crucial for the narrow focal depth of SRS. The filter’s effective membrane 
surface diameter was measured to be 21 mm. Afterwards, we applied 20 mL of pentane to 
remove oil residues, followed by 20 mL of 30% hydrogen peroxide for >20 minutes in order to 
remove biotic residues. We rinsed the filter with >100 mL of Milli-Q® analytical grade water 
and while wet we placed it between a microscope slide and a coverslip, and sealed it at the 
edges to avoid evaporation. We took standard precautions to avoid contamination of the filter 
while handling, such as wearing protective lab gear, covering glassware with aluminum foil 
after cleaning, and working in a fume hood. Reagent-only measurements (i.e., without sample) 
were included to determine procedural blanks. 
SRS Set-up 
The SRS microscopy setup was mainly as described previously[33] and is shown in Fig. 1. 
Briefly, a frequency-doubled Nd:YAG laser (Plecter Duo, Lumera) with 80 MHz repetition 
rate, 8 ps pulses, 532 nm output pumps an optical parametric oscillator (OPO, Levante Emerald, 
APE) with 790 – 950 nm tunability range. A second output beam of the laser at 1064 nm was 
amplitude modulated with an acousto-optical modulator (3080194, Crystal Technology) at 
3.636 MHz. The laser and OPO beams were overlapped temporally with a delay stage, 
combined with a dichroic mirror and sent into a laser scanning microscope (LSM 7MP, Zeiss) 
with a 32x water immersion objective (C-achroplan W, numerical aperture (NA) = 0.85) to scan 
the sample. A single frame has a size of 380 by 380 µm. For scanning larger areas an x-y raster 
stage was used (tile scan). The distance between neighboring measurement points (i.e. pixel 
size) was 3 µm. The average applied powers on the sample were 20 mW of the 1064 nm beam, 
and 10 mW of the OPO output beam. At these powers, no photo-induced damage was observed 
with SRS. 
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Figure 1: SRS setup. OPO: optical parametric oscillator. DS: delay stage. AOM: acousto-optical 
modulator. DM: dichroic mirror. LSM: Laser scanning microscope. O: objective. S: x-y raster 
stage. C: condenser. F: short-pass filter. D: photo-detector. LIA: lock-in amplifier. PC: 
computer. Samples are scanned frame by frame (380 by 380 µm), and together with the x-y 
raster stage; a larger area of the filter can be mapped. 
The light was collected with a water immersion condenser (NA= 1.2) below the sample, after 
which the 1064 nm beam was blocked. The stimulated Raman loss signal was detected at the 
OPO wavelengths with a photodetector (DET36A, Thorlabs) integrated with a home built trans-
impedance amplifier, reaching shot noise limited detection[33]. The signal was demodulated 
with a lock-in amplifier (HF2LI, Zurich instrument) with 100 µs time constant, and used to 
reconstruct images with the microscope software (ZEN2011). This time constant is a balance 
between the imaging speed and the SNR from some of the calibration polymers. 
Calibration 
In order to be able to identify five polymers with a limited number of SRS measurements, we 
first needed to select five Raman wavenumbers for maximum discrimination. A conventional 
Raman spectrometer (inVia Reflex, Renishaw) was used to acquire reference spectra of five 
polymers: Nylon, PET, PS, PP and PE. The spectra were verified by comparing them with the 
literature. Differences between spectral intensities were corrected using Standard Normal 
Variate (SNV)[34] as shown in Fig. 2. Then, we used sparse Partial Least-Squares Discriminant 
Analysis (s-PLS-DA) as described by Cao et al.[35] to find the five most discriminating 
wavenumbers to separate this set of polymers. Note that this method does not select the purest 
peaks, i.e. peaks that only have a signal for a single polymer. Instead, the method favors some 
overlap, as seen in Fig. 2, because more non-zero data points per polymer will result in a better 
discrimination. For example, the method selected the wavenumber 1631 cm−1 on the slope of 
the amide peak, in order to classify Nylon (high signal) and also to confirm PS and PET (low 
signal) and to exclude PE and PP (no signal). Additionally, a sixth wavenumber was included 
at 1800 cm-1, where there are no vibrations for the targeted polymers, in order to be able to 
correct for SRS artifacts. 
 
Figure 2: Conventional Raman spectra of the five targeted polymers selected for calibration 
with standard normal variate correction. The circles indicate the wavenumbers selected by s-
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PLS-DA at: 1631, 1615, 1603, 1465 and 1294 cm-1. Wavenumber 1800 cm-1 was added to 
enable rejection of SRS artifacts. 
We constructed a matrix X by measuring the five reference polymers at these six wavenumbers 
with SRS, and used ordinary Least Squares to construct 𝐁, (see equation 1). 
(1) 𝐁 = (𝐗𝐓𝐗)−𝟏𝐗𝐓𝐘 
where matrix 𝐁 (with dimensions 6 × 5) contains the regression coefficients, 𝐗𝐓 is the transpose 
of matrix 𝐗, and 𝐘 (5 × 5) is a dummy binary class matrix where the rows correspond to the 
spectrum and the columns to the polymer type. 
Acquisition and data processing 
For microplastics detection with SRS, we acquired six images of a sample on the filter at the 
six chosen wavenumbers. At each location (pixel), the six intensities were joined into a vector 
and multiplied with the matrix 𝐁, resulting in a five-element vector. The vector set was then 
decomposed into five images, each representing a different polymer. The pixel intensities are 
scores for the identification of the polymers. 
We rejected false positives generated by noise and artifacts in the SRS signal by thresholding 
the polymer images, thus creating binary images showing the detected polymers on a dark 
background. To set the threshold, we took the standard deviation above the average of each 
image, multiplied with a factor obtained at the wavenumber with no expected SRS signal (1800 
cm-1). This factor is defined as the ratio between the SRS signal intensity at 1800 cm-1 and the 
value of the standard deviation above the average at the 1800 cm-1 raw image, with a minimum 
of 1. The threshold rejects the false identification of polymers due to random noise intensity 
combinations in the raw SRS images, and the factor addition helps to reject spurious signals 
that can originate from the Kerr effect or transient absorption from e.g. soot particles. In 
addition, we removed small pixel clusters with an opening image processing function[36] with a 
kernel of 4 by 4 pixels. In other words, a particle is counted only if several adjacent pixels have 
a score above the threshold. Finally, we multiplied the binary images with the scored images. 
Results 
Artificial test mixture 
An area of 1.1 mm width and 3.6 mm length of the five polymers sample was measured at the 
six aforementioned wavenumbers with SRS, and processed as described in the image 
processing section. To appreciate the SRS signal strength we show in Figures 3 A and 3 B the 
raw SRS images of a PET and a PS particles at 1616 cm-1 and 1465 cm-1, respectively. The 
corresponding cross section traces are shown in 3 C and 3 D, where the cross-section signal is 
expressed as the relative power between the generated stimulated Raman loss (SRL) power and 
the pump power applied on the sample. The SNR of the PET at 1616 cm-1 is 223, while the 
SNR of PS at 1465 cm-1 is ca. 2. The latter case suggests that the limiting factor in acquisition 
speed is the low SRS signal off peak for some of the polymers. The full SNR information is 
shown in Table S1 (Supporting Information) for all polymers at all wavenumbers. The signal 
of a polymer was calculated from an averaged area at the same location of an identification of 
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this polymer, as shown in Figure 3 J. Signal cross section traces of all polymers at all 
wavenumbers are shown in Figure S1 (Supporting Information). 
 
Figure 3: : Raw SRL images of PET and PS particles at 1616 cm-1 and 1465 cm-1, respectively, 
are accordingly shown in (A) and (B). Figures (C) and (D) are signal cross section graphs with 
the signal strength and position as indicated by the white lines in (A) and (B), respectively. 
Signals values are indicated as the ratio between the stimulated Raman loss light power and the 
applied pump power. (E) to (I) are identification images of Nylon, PET, PS, PP and PE, 
respectively, where perfect identification is expressed in white. In the SRS overlay image (J) 
five binary versions of the five identification images were color coded and overlaid as follows: 
Nylon: red; PET: orange; PS: green; PP: magenta and PE: yellow. scale bar: 100 µm (same for 
graphs (E) to (I)). 
In order to evaluate the identification of the particles and the crosstalk between them, we 
normalized the five element vectors, which represent the five detected polymers in each 
corresponding pixel, and plotted it in Figures 3 E-I with a scale between -1 and 1. Each image 
shows the part of the sample that contains the polymer type which it meant to detect. A value 
of 1 (white) indicates a perfect identification, while a value of 0 indicates detection in other 
channels (i.e. high crosstalk). Negative values are associated mainly with noise. A complete 
evaluation of the identification and crosstalk for all five particles, from Figure 3 E-I, is shown 
in Table 1, together with an evaluation of the identification scores from the background. 
Table 1: Identification scores (bold) and crosstalk scores of plastic microparticles. Identification 
scores of a particle were averaged from the particle’s area indicated in Figure 3 J and shown at 
different detection channels. The last row contains an average of an identification scores from 
an empty area of the sample, i.e., where no particles were identified. 1 is a perfect identification 
in a given channel, and 0 means that there is no indication of that particular polymer being 
identified. Negative numbers can appear due to noise propagation through the identification 
procedure. 
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Nylon 
channe
l 
PET 
channe
l 
PS 
channe
l 
PP 
channe
l 
PE 
channe
l 
Nylon 0.88 -0.09 0.02 -0.07 0.10 
PET 0.01 0.94 -0.02 -0.02 0.12 
PS -0.08 -0.18 0.92 0.03 0.09 
PP -0.09 -0.18 -0.04 0.89 0.06 
PE 0.02 -0.07 0.05 -0.03 0.91 
Backgrou
nd -0.01 -0.26 0.04 -0.02 0.03 
 
After the identification procedure, the five binary images were combined to one overlay image, 
shown in Fig. 3 J, with the following color map: Nylon is red; PET, orange; PS, green; PP, 
magenta and PE, yellow. The placement of the five plastic microparticles in the artificial sample 
was in the same order. 
Nail polish 
A nail polish sample was extracted and filtered as described above. A filter area of 3.4 mm 
width and 6.8 mm length was measured with SRS at the six aforementioned wavenumbers, and 
processed as described in the image processing section. The five binary images were combined 
to one overlay image with the following color map: Nylon is red; PET, orange; PS, green; PP, 
magenta and PE, yellow. The sample after preparation should only contain particles that are 
inert under the conditions of the preparation process. As indicated in the nail polish product 
description, an abundance of PET particles was expected. 
Fig. 4 C shows the overlay SRS image, where most particles, 103, were identified as PET, one 
identified as Nylon and one as PS. The latter two are very small and hardly visible in Fig. 4 C; 
see Figure S2 in the Supporting Information for an enlarged view. The objects’ spatial 
distribution mostly corresponded to the white light image shown in Fig. 4 A. However, some 
objects that did appear in Fig. 4 A were missing or appear eroded in Fig. 4 C. This can be 
explained by the non-linear SRS signal acquisition: SRS is a multi-photon process where the 
signal is only generated in the overlapping focal volumes, and as a result the out-of-focus 
regions are not shown in the SRS image. 
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Figure 4: SRS and Raman mapping of a nail-polish extract. The tile scanned white light image 
of the measured area is shown in (A); scale bar: 500 µm. A particle (indicated by the orange 
arrow) in this image was measured with conventional Raman for confirmation, and its spectrum 
is shown in (B) (orange spectrum, particle). The blue curve is a Raman reference spectrum of 
PET for comparison. In the SRS overlay image (C) five binary versions of the five identification 
images were color coded and overlaid as follows: PET: orange; Nylon: red; PS: green; PP and 
PE were not found; scale bar: 500 µm. (D) is a spontaneous Raman mapping from the area 
marked with a white square in (A) and (C), fitted with direct classical least squares to a reference 
spectrum of PET. (E) is the same area of the PET identified image with SRS, with greyscale 
values indicating the identification scores. Scale bars in (D) and (E): 200 µm. 
The identification of one particle was verified by comparing its spontaneous Raman spectrum 
with a PET reference spectrum (Fig. 4 B). A subset from Fig. 4 C is shown in Fig. 4 E in 
grayscale, where the intensity represents the score of the identification. This can be compared 
with spontaneous Raman mapping, shown in Fig. 4 D, which was fitted to a reference PET 
spectrum. The separation between Raman measurements points was 3 µm to match the 
acquisition resolution of SRS. Acquisition time of the Raman mapping was 1 s per spectrum 
and a total of 24 h for the image in Fig. 4 D, which is significantly slower than the total time 
needed for an overlay image with SRS acquisition. To illustrate this difference when mapping 
larger areas: it took 4.5 h to acquire a 1 cm2 overlay image with SRS (for instance see Fig. 5 
A), whereas with conventional Raman one could map the same area in 116 days. However, it 
should be noted that the spectral information contained in the conventional Raman mapping 
can potentially be used to identify many more polymer species. 
Sediment sample from Rhine estuary 
Analysis of a 1 cm2 area of the filter holding the solid residues from a Rhine estuary sediment 
sample resulted in the identification of 88 plastic microparticles in total. The number of particles 
detected per polymer type is presented in Table 2. Fig. 5 A to Fig. 5 E show some of the detected 
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particles, with greyscale indicating the scores of the identification strength. Fig. 5 F is the white 
light image of a particle identified as polystyrene (in Fig. 5 E). We verified the identification of 
the particle as PS by acquiring its spontaneous Raman spectrum, as shown in Fig. 5 H. 
Interestingly, the conventional Raman spectrum of the particle in Fig. 5 F also shows a strong 
fluorescence background, which does not play a role in SRS. 
 
Figure 5: Identification of particles from sediment sample from the Rhine estuary. Nylon, PET, 
PP, PE and PS particles are shown in (A),(B),(C),(D) and (E), respectively. The greyscale 
indicates the scores of the fits, where white is a perfect fit, and the background is suppressed to 
zero, as described in the Acquisition and data processing section. Bars are 50 µm. (F) is a white 
light image of the same area as in (E). For confirmation, the particle’s conventional Raman 
spectrum (G, in green) is compared with a reference Raman spectrum of PS in blue. 
By extrapolating these results of detected particles from 1 cm2 to the total effective filter surface 
(3.46 cm2), and the sampled weight to one kg, the number of particles can be expressed as the 
number of particles per kg dry sediment, resulting in a total of ~12,000 particles /kg dry wt in 
the Rhine estuary sediment sample for all target polymer types combined as shown in Table 2. 
This is slightly higher than the values reported by Leslie et al.[1] on microplastics particles in 
sediment from the same location. In comparison, suspended matter (SPM) samples collected 
from the river Rhine further upstream at the Dutch-German border contained 1700 – 4900 
particles per kg SPM dry weight, which with a typical SPM level of 20 g/m3 would correspond 
with 30-100 particles per m3. 
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Table 2: Numbers of microplastic particles identified with SRS from 26 g of Rhine estuary dry 
sediment sample on a 1 cm2 filter surface and their 2D area. Considering the effective surface 
of the filter (3.46 cm2), we can extrapolate to the number of particles per kg of sediment (dry 
weight). 
Polymer 
Number of 
identified 
particles 
Area (µm2) of 
particles found 
Identified 
particles per kg 
Nylon 20 4,000 2,700 
PET 7 1,200 1,000 
PS 14 8,400 1,900 
PP 9 1,500 1,200 
PE 38 9,200 5,200 
Sum 88 24,300 12,000 
 
Blank measurements 
Three procedural blank samples were prepared, measured and processed the same way as the 
sediment sample. The objects detected in the blank could either be the result of misidentification 
because of noise, SRS artifacts such as Kerr effect or transient absorption, or could be due to 
contamination with real microplastics during the preparation process. The average blank 
detection rate was 12 objects/cm2; blank correction was not applied. 
Discussion and conclusion 
In this proof-of-principle study, we applied Stimulated Raman Scattering microscopy (SRS) to 
detect and identify microplastics by sequentially scanning at six wavenumber settings a selected 
region of solid sample residues on a filter, and decomposing this multiplexed information into 
polymer identification data at each pixel. This procedure does not rely on visual inspection, 
thus it eliminates the bias that might arise from subjective interpretation of a given inspected 
area. After illustrating the approach for the detection of five plastic particles from an artificial 
test sample, and detecting PET particles in nail-polish sample, we used this method to detect 
88 microplastic particles from a 1 cm2 filter area of an extract of 26 g of the Rhine estuary 
sediment. This corresponds to 12,000 microplastic particles per kg sediment dry wt. Our 
approach for mapping this filter area is not only bias free, but also relatively fast (approx. 4.5 h 
per 1 cm2). Furthermore, analysis of the five polymers mixture showed high detection scores, 
and practically very low crosstalk between the detection of the different polymers, confirming 
its suitability for microplastics detection. 
Other optically based vibrational spectroscopic techniques are slower in comparison. As shown 
in Fig. 4 D, mapping with conventional Raman is at least three orders of magnitude slower, 
which is why conventional Raman (and also single detector FTIR) is often used after pre-sorting 
by visual inspection. The optimized imaging speed reported by Löder et al.[18] for FTIR with an 
FPA detector was ca. 11 h for a 1.1 cm x 1.1 cm filter surface area at a similar step size, only 
somewhat lower than our SRS approach. 
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The identification of polymers in microplastic particles with SRS has some drawbacks when 
compared to linear optical spectroscopic techniques. In our approach with signal acquisition at 
six wavenumbers, the method we applied was optimized only for the five calibrated polymers, 
which significantly limits the spectral information. Moreover, the sharp depth of focus can 
hinder detection or cause deformation of images of particles that are not in the mapping plane. 
Additionally, the opening image processing function effectively limits the resolution to 12 µm, 
since it removes small pixel clusters below that size. Nevertheless, mapping with six 
wavenumbers was sufficient for the detection of five of the most prevalent plastics with typical 
particle sizes of a few tens of microns, and the depth of focus effect was minimized by choosing 
a flat surface filter. 
To overcome the drawbacks outlined above, the future development of this method can take 
different approaches. The focal point in this method was smaller than the separation between 
neighboring points. Using a lower numerical aperture (NA) objective with a wider focal spot 
that matches the step size between measurement points, and increasing the power to maintain 
the same power density on the sample, should lead to an increased signal to noise ratio (SNR) 
for particles larger than 3 µm. The better SNR should add to the reliability of the identification, 
or, alternatively, would allow the use of a smaller kernel of the opening function, and thus the 
detection of smaller particles. Currently, the signal collection efficiency is limited by the 
commercial laser scanning microscope optics, and we will attempt to achieve a higher collection 
efficiency in the future (in forward scattering mode). An alternative way to reduce the overall 
measurement time would be to quickly scan the total surface with two wavenumbers, followed 
by mapping only the areas of interest with the other wavenumber settings. This approach will 
require automated data processing and operation of the microscope stage, which requires further 
development. 
In addition, by using the scores of detection rather than thresholding, we expect that other 
polymers with some Raman response at these six chosen wavenumbers can also be detected 
once added to the calibration set. Another approach could be the use of broadband SRS for data 
acquisition, thus combining greater spectral information with the sensitivity of SRS[37,38]. In 
conclusion, we expect that SRS based methods will play an increasingly important role in 
monitoring microplastic particles in the environment and potentially many other matrices of 
interest. 
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Chapter 8: Summary, conclusion and future perspectives 
Multivariate data analysis in flow cytometry 
A blood sample contains a high cellular heterogeneity and specific single white blood cells 
(leukocytes) may cause diseases, such as leukaemia, asthma or diabetes. Phytoplankton cells 
are very dynamic and influenced by natural factors such as day/night, season and water 
temperature. Phytoplankton cells deviating from the dynamic behaviour may be related to bad 
water quality. Thus, it is important to study and measure these single cells with a high 
throughput technique such as flow cytometry to find these specific single cells. To fully capture 
the heterogeneity, flow cytometry technology is rapidly being developed to increase the number 
of markers/characteristics that can be measured on every single cell. However, it reaches a point 
where the many variables require too many bivariate plots for the biological or medical 
researchers to analyse. Often a selection is made on combinations of variables based on prior 
biological knowledge. This leads to a hypothesis driven research, where you find only what you 
are looking for. A more data driven research with multivariate data analysis could reveal all 
information present in the data. The biological/medical researchers are then needed to interpret 
the findings instead of analysing the data. 
 
As described in the first chapter our goal was to create a multivariate data analysis method for 
flow cytometry to create more insight which specific cells are causing a specific phenotype. 
Each flow cytometry measurement contains ten thousands to millions of cells measured on a 
relatively few variables. The multivariate advantage shows a unique relationship between the 
variables (marker expression) that is missed when analysing this data univariately or 
bivariately. Moreover, the percentage presence of a specific cell sub(type) may not show a 
difference between phenotypes but only in combinations with other specific cell (sub)types. 
Flow cytometry has thus a unique data structure and contains information on the following four 
levels: 
1) The multivariate (co)-expression of markers on single cells 
2) Aggregation of cells into populations with similar marker expression 
3) Representation of cell populations in a specific sample/individual 
4) Differentiation of this representation in specific phenotypes 
We aimed to develop a multivariate data analysis method that shows all those four levels and 
links the marker variability on single cells to the specific phenotype. Current methods fail to 
cover all the four levels and often do not describe the continua present in the data. Moreover, 
the method should be statically validated using cross validation and permutation testing. 
In the second chapter we created the method Discriminant Analysis of Multi-Aspect 
CYtometry data (DAMACY). The DAMACY method describes the cellular variability with 
Principal Component Analysis (PCA). It subsequently creates two or more dimensional 
histograms of the single cells in the PCA space. These histograms may then be used with 
orthogonal partial least squares discriminant analysis (OPLS-DA) to discriminate between 
phenotypes. The OPLS-DA weights in DAMACY highlight which cells (2) are important for a 
specific phenotype (4). The PCA loadings show the marker (co)-expression (1) of these cell 
aggregates (2). The sample/individual representation (3) may be visualized as the histogram 
contours on the map and each sample has a prediction score based on the model. DAMACY 
238 
 
thereby creates a statistically validated model that links the individual variability in cells based 
on single cell marker (co)-expression to a phenotype in broad range of case studies. 
Data fusion in the third chapter extended the DAMACY method to cope with multiple 
aliquots. The number of fluorophores measured with flow cytometry is limited and additional 
marker/antibodies may only be measured on an aliquot with the same fluorophores. The method 
creates a histogram based on PCA for each aliquot and subsequently performs OPLS-DA on 
these samples-wise concatenated histograms. The method uses the correlations between cell 
aggregates including those of different aliquots. The number of bins in the histogram increases 
linearly with the number of aliquots, therefore, Variable Importance on Projection (VIP) was 
used to find the cell aggregates important for discrimination. The final model will thus only 
highlight all important cells to discriminate between clinical phenotypes. 
The fourth chapter described the multiset structure of flow cytometry data. Each sample 
measurement contains multiple cells measured on the same markers. The number of cells 
measured may greatly differ between measurements and therefore should be considered. We 
integrated the multiset structure in the pre-processing and analysis for PCA to correct for the 
different number of cells. Not taking the number of cells into account may be detrimental in 
interpreting the data and therefore should always be used to obtain robust results. Additional 
pre-processing options are available, calculating the mean based on complete concatenated 
data, only control concatenated data to increase the difference between control and the 
disease/challenged group or per individual sample to remove unwanted non-biological and/or 
technical variance between samples. 
The fifth chapter describes ECLIPSE, which creates a filter to remove all ‘normal’ cells based 
on the multivariate co-expression of control individuals modelled with simultaneous 
component analysis. This will reveal response related cells that may be masked by the many 
‘normal’ cells. ECLIPSE is especially useful for heterogeneous diseases where rare cells cause 
the disease. 
In the sixth chapter we used DAMACY to predict environmental variables based on hourly 
measurements of the phytoplankton in the Meuse river for 224 days. The prediction of these 
environmental variables, such as day/night cycle, day length and water temperature, were 
needed to predict whether the phytoplankton cells were behaving as normal. Standard “Normal 
Operating Conditions” could not find any abnormal variance when contaminants were found 
with chemical analysis, because the phytoplankton are very dynamic and influenced by these 
environmental variables. Deviation from the prediction of these environmental variables did 
detect some unknown contaminants that are affecting the phytoplankton and thus water quality. 
Flow cytometry in combination with advanced multivariate data analysis may thus be used to 
create an early warning for unknown contaminants in river water. 
The seventh chapter describes how stimulated Raman spectroscopy (SRS) may be used for 
fast detection of microplastics. SRS uses the interaction of two different lasers in the vibrational 
levels of the molecule, which is a thousand-fold faster than conventional Raman. However, 
only a single wavenumber is measured at a time, to keep the high speed a limited set of 
wavenumbers should be measured. Sparse-PLS-DA was used to find the most discriminating 
wavenumbers for five high production-volume polymers in microplastics. As proof-of-
principle, the method was used to detect the microplastics in a sediment sample from the Rhine 
estuary and identified 88 microplastics particles, which corresponds to 12000 microplastics 
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particles per kilogram dry weight. SRS may thus be used to effectively monitor the 
microplastics in the environment. 
Concluding remarks 
Flow cytometry is the analytical high throughput technique used to simultaneous measure 
multiple properties/variables of single cells. Many multivariate methods have been developed 
to analyse this data for disease diagnosis or water quality monitoring. However, most methods 
are clustering based which fail to capture the continua in the single cells data. Principal 
Component Analysis (PCA) does describe the continua in the data. For explorative research 
within an individual we developed ECLIPSE that first removes all ‘normal’ cells and 
subsequently models the variance of the responding cells. For discriminative research, we 
developed DAMACY (Discriminant Analysis of Multi-Aspect CYtometry data) that uses 
Orthogonal Partial Least Squares (OPLS) to discriminate or regress based on two or more 
dimensional smoothed histograms of the PCA space. The OPLS weights in DAMACY 
highlight which cells are more or less present in the studied phenotype and the loadings of the 
PCA show the marker expression of these cell aggregates. The prediction performance of 
DAMACY is on par with other multivariate methods but has an additional interpretability that 
is not present in other methods. More relevant cells can be found when using fusion DAMACY 
on multiple aliquots with different antibody panels. All the work was performed on flow 
cytometry data but DAMACY/ECLIPSE could be use on any single microparticle data. For 
example, the SRS technique may be used to effectively on-line monitor the microplastics in the 
river with DAMACY alongside with the phytoplankton in the river to obtain a systemwide view 
on the water quality. 
 
Discussion/Future work 
DAMACY and ECLIPSE already get much information out of the data. The improvement of 
the methods is still hampered by the quality of the data, compensation and the amount of 
variance explained by two/three PCs. A pipeline needs to be developed to quickly asses the 
quality of data and to add interesting PCs and remove uninteresting PCs. Additionally, other 
base models may be explored such as t-SNE and the top model needs to be adjusted in order to 
cope with confounding variables, more classes/more regression variables and experimental 
design. In this way DAMACY and ECLIPSE become more versatile and an end user can more 
easily use these methods to get the most information out of their data. 
 
The time of measurement should not have any influence on the results, thus quality control is 
important. Sometimes due to human error a sample is not prepared or analysed correctly, for 
example one fluorophore-antibody/marker forgot to be added. While standardization in most 
clinical labs and in the environmental monitoring platforms (see chapter 5) minimize such 
human variability, though often visual inspection is still needed to remove any outliers. Visual 
inspection might be more challenging for larger numbers of samples (>1000 measurements). A 
solution could be the top PCA in DAMACY (see chapter 2), which describes the individual 
variability and could be used to find batch effects, time of measurement dependency or outliers. 
Additional pre-processing or removal of these outliers may then be used to guarantee the quality 
of the data. 
Standardization in clinical flow cytometry is often hampered by compensation of the data. The 
laser intensity reduces over time and to guarantee the same values over time, calibration beads 
are used to adjust the flow cytometry. This however, may have an influence on the fluorophore 
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overlap and over time the compensation matrix may not be valid anymore. Often manual 
adjustment of the compensation matrix is used, which is subjective and not feasible for larger 
cohorts with many fluorophores (>30). While flow cytometer manufactures advertise with more 
and more fluorophores. In a case where one marker is completely overshadowed by another 
marker due to fluorophore overlap, compensation may not be feasible. In that case measuring 
one marker less would be better. Another solution would be to measure more than one detector 
per fluorophore, because then compensation can more easily unmix the fluorophores. 
DAMACY is limited to the amount of variance captured in two or three PCs. In theory a four 
or more-dimensional histogram is possible but the number of bins will grow exponentially. This 
leads to very sparse data if the same number of bins per PC is kept or to loss of resolution if the 
same number of total bins is kept. A solution could be to adjust the number of bins per PCs 
according to the variability in the data described by that PC. Another solution is to use fusion 
DAMACY (chapter 3) and create 2D histograms for each interesting combination of PCs. This 
will enable to capture more variance with DAMACY. 
DAMACY is very well-suited for data where a single major cell population is selected a priori, 
for example in studies of cell activation. The difference between major cell populations 
overshadows the variance in activation markers. Activation markers are often correlated and 
thus easily described by a PCA model. For future research, multiple panels could be designed, 
each for a specific major cell population together with many activation markers. Subsequently 
use fusion DAMACY (chapter 3) to describe the most of the immunological response. 
Alternatively, automated gating may be applied to select the major populations before fusion 
DAMACY. This will increase the interpretability because each plot will describe the cell 
activation of a specific major cell type. 
In chapter 1 we saw that PCA and t-SNE showed complementary visualization. PCA describes 
the maximum variance between the cells and gives a more global view, while t-SNE keeps the 
neighbouring cells close and gives a more local view of the data. Histograms based on the t-
SNE space could be beneficial for discrimination in DAMACY. However, to statistically 
validate the model with cross validation, new single cell data needs to be projected into the 
model. Projection in t-SNE is not defined, but may be approximated by using the same values 
in the low dimensional space as the nearest neighbour in the high dimensional space. Fusion of 
the histograms based on PCA and t-SNE could be beneficial to provide both a global and a local 
view of the data. 
ECLIPSE (chapter 6) may be used to first remove all normal cells and subsequently use 
DAMACY to discriminate between two groups. This might either be in the standard control 
versus case/response studies or be used in a study with a control group and two or more 
patient/case groups. For example, the new treatment needs to be compared to the old treatment, 
groups measured: control, old treatment and new treatment. The control data is first used to 
remove all normal cells and subsequently DAMACY might be used to find the difference 
between those two patient/case groups. 
DAMACY is initially written using control/case discrimination or single regression using (O)-
PLS. Discriminating more classes or using regression on matrix of variables with DAMACY is 
possible, only difficult to visualize as blue/red is now showing the difference between two 
classes or showing low/high in regression. In the case of experimental design, ASCA may give 
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a higher interpretability than PLS. ASCA may describe the cellular variability caused by each 
experimental factor. 
Confounding variables are variables that influence the system but are not causing the response 
of interest. In clinical research often, confounding variables are also measured, such as smoking 
and alcohol behaviour, etc. DAMACY does not consider the confounding variables and was 
initially written to discriminate between two groups, but may also be used as a regression 
method (see chapter five). In the chapter five the deviation from prediction of the confounding 
environmental variables was used, while we are actually interested in the changes of the 
phytoplankton community. It might be beneficial to remove the variability caused by the 
confounding variables in order to better predict the water quality or studied clinical phenotype. 
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Nederlandse Samenvatting 
Elk organisme bestaat uit cellen waarvan de genetische informatie hetzelfde is. Toch zijn er 
heel veel verschillende cellen in het lichaam met een specifieke functie en dus ook een 
specifieke eiwitexpressie hebben. Deze cellulaire heterogeniteit kun je niet zien door een 
gemiddelde eiwitconcentratie te meten, daarom moet de eiwitconcentratie voor elke cel één 
voor één gemeten worden. Een flow cytometer meet de fluorescentie van een groot aantal 
cellen (> 10.000) in een monster één voor één. Dit kan de autofluorescentie van fytoplankton 
zijn in een watermonster of de fluorescentie van fluorochromen geconjugeerd met 
antilichamen die aan specifieke eiwitten binden in bloedmonsters. 
 
In het vakgebied wordt vaak gebruik gemaakt van manueel univariaat of bivariaat sequentieel 
gaten, dit bestaat uit het selecteren van cellen op basis van één of twee dimensies/variabelen. 
Gaten is tijdrovend, op ervaring gebaseerd en kan leiden tot een bias. Veel automatische 
methodes worden ontwikkeld om gaten te reproduceren door te clusteren. Uit recent 
onderzoek blijkt dat verschillende soorten cellen niet een discreet verschil hebben maar een 
continuüm vormen. Om deze reden zijn cluster methodes ontwikkeld die een groot aantal 
clusters zoeken om de continua in de data vast te leggen. Het nadeel is hoe meer clusters hoe 
lastiger de interpretatie van de data is. 
 
In het tweede hoofdstuk van deze thesis staat een nieuwe methode beschreven genaamd 
“Discriminant Analysis of Multi-Aspect CYtometry” (DAMACY) die kwantitatief alle 
karakteristieke kenmerken integreert, namelijk 1) de eiwit (co)-expressies, 2) de specifieke 
cellen waarop deze zijn gemeten, 3) de distributie van deze cellen in alle monsters en 4) de 
systematische verandering in deze distributie in verschillende (klinische) fenotype. Het 
resulterende model is statistisch gevalideerd en laat al deze vier levels zien in één figuur. 
 
In het derde hoofdstuk van deze thesis staat hoe DAMACY uitgebreid kan worden voor het 
gebruik van meerdere flow cytometry buizen. De meerdere buizen zijn nodig omdat het aantal 
eiwitten per meting technologisch beperkt is. Dit is jammer, want veel hoge impact studies 
onthullen dat het meten van meerdere eiwitten tegelijkertijd leidt tot een vollediger beeld op 
het immuunsysteem. Het resulterende model is niet op zoek naar de beste biomarker maar 
laat zien welke specifieke cellen samen functioneren in een (klinisch) fenotype. 
 
Het vierde hoofdstuk van deze thesis laat zien hoe om te gaan met de multiset structuur van 
flow cytometry, elk monster bevat namelijk de eiwit expressies van tienduizenden cellen. 
Daarnaast kan elk monster kan namelijk een verschillende aantal cellen gemeten hebben. 
Hiervoor moet gecorrigeerd worden anders is het monster met meer cellen belangrijker dan 
een monster met weinig cellen. 
 
Het vijfde hoofdstuk beschrijft de methode ECLIPSE, dat een filter maakt om alle normale 
cellen te verwijderen op basis van de multivariaat eiwit co-expressies van cellen in controle 
monsters. Vervolgens kan dan naar de cellen van een response gekeken worden, die eerder 
gemaskeerd zijn door de normale cellen. ECLIPSE is erg nuttig voor heterogene ziektes waar 
zeldzame cellen de ziekte veroorzaken. 
 
Het zesde hoofdstuk van deze thesis gebruikt DAMACY om de normale natuurlijke factoren 
van de rivier de Maas te voorspellen op basis van fytoplankton voor 224 dagen. Natuurlijke 
factoren zijn bijvoorbeeld dag/nacht, daglengte en watertemperatuur. Afwijkingen van het 
model en de daadwerkelijke gemeten natuurlijke factoren was gerelateerd met vervuilingen in 
de rivier. Standaard methodes kon geen afwijkingen in de fytoplankton vinden omdat 
fytoplankton erg dynamisch zijn en beïnvloed worden door deze natuurlijke factoren. 
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Het zevende hoofdstuk van deze thesis beschrijft hoe gestimuleerde Raman spectroscopy 
(SRS) gebruikt kan worden voor het snel detecteren van microplastics. SRS gebruikt de 
interactie tussen twee verschillende lasers in de vibratie levels van een molecuul, dat is een 
duizend keer sneller dan conventionele Raman. Maar één golfgetal kan tegelijk gemeten 
worden, dus een gelimiteerde set van golfgetallen kan gemeten worden om de snelheid hoog 
te houden. Sparse-PLS-DA is daarom gebruikt om de meeste discriminerende golfgetallen te 
vinden voor de vijf meest geproduceerde plastics. Met deze methoden konden werd 88 
microplastics gevonden in een sediment monster van de Rijnmond, dit correspondeert met 
12.000 microplastics per kilogram droog gewicht. Deze methode kan dus gebruikt worden voor 
het effectief monitoring van microplastics in de natuur. 
 
Flowcytometrie is dus de analytische high-throughput-techniek die gebruikt wordt voor het 
gelijktijdig meten van meerdere eigenschappen van afzonderlijke cellen. Veel multivariate 
methoden zijn ontwikkeld om deze gegevens te analyseren voor ziektediagnostiek of 
monitoring van de waterkwaliteit. De meeste methoden zijn echter gebaseerd op clustering, 
die er niet in slagen om de continua in de gegevens van enkele cellen te vangen. Principal 
Component Analysis (PCA) beschrijft de continua in de gegevens. Voor verkennend 
onderzoek binnen een individu hebben we ECLIPSE ontwikkeld die eerst alle normale cellen 
verwijdert en vervolgens de variantie van de cellen in response individuen modelleert. Voor 
discriminerend onderzoek hebben we DAMACY ontwikkeld die “Orthogonal Partial Least 
Squares” (OPLS) gebruikt voor discriminatie of regressie van twee of meer dimensionale 
afgevlakte histogrammen van de PCA-ruimte. De OPLS gewichten in DAMACY, markeren 
welke cellen min of meer aanwezig zijn in het onderzochte fenotype en de loadings van PCA 
tonen de expressie van deze cellen. De voorspelling prestaties van DAMACY zijn vergelijkbaar 
met andere multivariate methoden, maar hebben een extra interpreteerbaarheid die niet 
aanwezig is in andere methoden. Meer relevante cellen kunnen worden gevonden bij gebruik 
van fusie DAMACY op meerdere aliquots met verschillende antilichaam panelen. Al het werk 
werd uitgevoerd op flowcytometrie-gegevens, maar DAMACY / ECLIPSE zou ook gebruikt 
kunnen worden voor elke afzonderlijke microdeeltjes data. De SRS-techniek kan bijvoorbeeld 
worden gebruikt om de microplastics in de rivier effectief te volgen met DAMACY naast de 
fytoplankton in de rivier om een systeembrede kijk op de waterkwaliteit te krijgen. 
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